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TRYPANOSOMA BRUCEI TELOMERE FUNCTIONS IN ANTIGENIC 
VARIATION 
UNNATI M. PANDYA 
ABSTRACT 
     Trypanosoma brucei is a protozoan parasite that causes sleeping sickness in 
humans and Nagana in cattle. They evade the host’s immune defense by 
periodically switching their major surface antigen, variant surface glycoprotein 
(VSG), a phenomenon termed antigenic variation. Inside its mammalian host, 
bloodstream form (BF) T. brucei monoallelically expresses its major surface 
molecule VSG from the VSG Expression Sites (ESs) located at subtelomeric loci. 
Monoallelic VSG expression ensures effective antigenic variation and maximizes 
the efficiency of T. brucei pathogenesis. In the mid-gut of its insect host (tsetse), 
procyclic form (PF) T. brucei expresses procyclins as the major surface 
molecules and all VSGs are si lent. After the migration to the salivary glands of 
the tsetse fly, T. brucei cells differentiate into metacyclic forms and express 
metacyclic VSGs (mVSGs). Therefore, VSG silencing is important for the normal 
development of T. brucei.  
     Telomeres are important for the regulation of antigenic variation. TbRAP1 was 
previously identified as an intrinsic component of the T. brucei telomere complex 
and was shown to be important for ES-linked VSG silencing in BF cells. Our 
studies further established that TbRAP1 is essential for cell proliferation and 
required for VSG silencing in PF cells. Apart form ES-linked VSGs, TbRAP1 also 
 vii 
regulates the silencing of mVSGs in both BF and PF cells. The strength of 
TbRAP1 mediated VSG silencing is stronger in PF cells compared to that in the 
BF cells. In addition, the TbRAP1-mediated VSG silencing in PF cells involves 
chromatin remodeling. 
     TbTRF, a duplex telomere DNA binding protein that interacts with TbRAP1, 
does not affect VSG silencing but regulates telomere structure. TbTRFH (TRF 
homology domain) is required for the homodimerization of TbTRF as well as for 
interaction with TbRAP1. We established several TbTRFH mutants and 
determined the critical regions required for homodimerization of TbTRF by 
performing yeast two-hybrid analysis. 
     TERRA (telomeric repeat- containing RNA) is known to play an important role 
in the regulation of the higher order chromatin structure at telomeres in 
mammalian cells. We characterized TERRA in T. brucei in order to determine its 
role in VSG silencing. We determined that a significant amount of TERRA is 
transcribed from the active ES-linked telomere. Also, TbTRF and TbKU80 
interact with TERRA in vivo. Telomere proteins were found to play an important 
role in regulating TERRA levels. Most importantly, lower levels of TERRA led to 
mild de-repression of silent VSGs in BF form T. brucei cells, indicating that 
TERRA indeed is involved in VSG silencing.  
     Our study provides insight into various mechanisms of how telomeres 
contribute to antigenic variation regulation in T. brucei, which helps to better 
understand pathogenesis of T. brucei and to achieve its eradication. 
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CHAPTER I 
INTRODUCTION 
 
 
African trypanosomiasis: Cause, Clinical features, and Epidemiology 
     Trypanosomes are a large group of protozoan parasites belonging to the 
class kinetoplastida and the genus Trypanosoma causing diseases in man and 
animals. Trypanosoma brucei is the causative agent of Human African 
Trypanosomiasis (HAT), more commonly known as ‘sleeping sickness’. They 
also cause Animal African Trypanosomiasis (AAT) or ‘nagana’ in cattle. 
Trypanosoma brucei is transmitted by a blood-sucking tsetse fly belonging to 
genus Glossina. HAT occurs throughout tropical and sub-tropical sub-Saharan 
Africa, and 60 million people are estimated to be at risk (Atouguia and Kennedy, 
2000, Kennedy 2004 and Brun et al. 2010). Approximately 50 million cattle are at 
risk of trypanosome infection and the major cause of mortality is due to severe 
outbreaks leading to depressed productivity and economical set back (Shaw, 
2004). HAT is widespread in an area of about 10 million km2 in Africa (Kennedy, 
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2004), and it can be fatal if left untreated. The major pathogenic HAT-causing 
species are Trypanosoma brucei rhodesiense and Trypanosoma brucei 
gambiense. They cause East African disease and West African disease, 
respectively (Brun et al. 2010, Kennedy 2004). 97% of chronic cases of HAT are 
caused by Trypanosoma brucei gambiense and the remaining 3% that are more 
acute and severe are caused by Trypanosoma brucei rhodesiense (Simmaro et 
al. 2008).  T. b. congolense, T. b. vivax, and T. b. brucei infect cattle, sheep, 
goat, horse, and donkey. T. b. simiae infects pigs (Holmes, 2013).  
     T. b. brucei that causes African Trypanosomiasis in animals is highly 
susceptible to lytic factors present in the human serum known as trypanosome 
lytic factors (TLFs). Due to this reason, animal infecting trypanosomes are non-
infective in humans (Capewell et al. 2011). However, T. b. brucei is highly similar 
to T. b. gambiense. This property makes it suitable for laboratory research. There 
are two types of TLFs present in humans: (1) TLF-1 – a high-density lipoprotein 
particle (Rifkin, 1978) and (2) TLF-2 – a serum protein-binding complex (Raper et 
al. 1999 and Capewell et al. 2011). T. b. rhodesiense expresses serum 
resistance protein (SRA) encoded by the SRA gene. SRA binds TLF-1, making 
parasite resistant to lysis in humans (Capewell et al. 2011 and Kieft et al. 2012). 
T. b. gambiense, on the other hand, utilizes a different mechanism to prevent 
lysis. It reduces the expression of haptoglobin-haemoglobin receptor required for 
binding and uptake of TLF-1 by the parasite (Capewell et al. 2011 and Kieft et al. 
2012). 
 3 
      Thousands of people died during the time span when this disease was first 
discovered (1896-1906) (Brun et al. 2010 and Kennedy, 2010). However, the 
cases declined in the following years due to strong measures, such as mass 
sacrifice of animals, eradication of large forested regions, and increased human 
surveillance for disease and treatment (Peter, 2013). Only a few cases were 
reported in the 1960s (Brun et al. 2010, Kennedy, 2010 and Simarro et al. 2011). 
Later, the number of cases grew to 300,000 in 1998 due to the decline in human 
case surveillance and several other factors such as war, famine and 
socioeconomic instability (World Health Organization, 1998). These numbers 
declined eventually due to better vector control and treatment. In 2009, the 
number of cases reported by the World Health Organization (WHO) fell below 
10,000 for the first time (Simarro et al. 2011). However, many cases are 
unreported due to various infrastructural reasons, and hence there could still be 
many undetected or undiagnosed cases. There were estimated 12 undetected 
deaths due to HAT for every one reported in Uganda in 2005 (Odiit et al. 2005). 
Due to frequent travelling, 94 cases were also reported in non-endemic countries 
in 2010 (Simmaro et al. 2000-2010). Hence, HAT still remains a major concern in 
endemic as well as non-endemic countries. 
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Figure 1-1: Trypanosome cells and its insect vector. (A) A blood smear of a 
patient suffering from African trypanosomiasis. Trypanosome cells can be seen 
in extracellular fluid. (From Myron G Schultz, Centers for Disease Control Public 
Health Image Library) (B) A tsetse fly, the insect host of T. brucei. (From Anthony 
Bannister, Encyclopedia Britannica). 
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Symptoms, diagnosis and treatment 
     Blood-sucking infected tsetse flies bite humans leading to the onset of HAT. A 
primary lesion is a painful swelling (Chancres) appearing after 10 to 15 days of 
the initial bite. After the bite of a tsetse fly, trypanosome cells enter the 
bloodstream, lymph nodes and several other organs, such as spleen, heart, liver, 
eyes, and endocrine organs. This leads to the onset of heamolymphatic stage 
also known as stage one (Kennedy, 2004 and Kennedy, 2013). Wide ranges of 
symptoms are present such as headache, malaise, arthralgia, weight loss, 
fatigue and fever. If left untreated, patients can suffer from lymphadenopathy, 
cardiac failure, endocrine dysfunction, or fertility problems (Duggan and 
Hutchington 1996, Atouguia and Kennedy 2000, Brun et al. 2010 and Kennedy, 
2010). Trypanosome cells cross the blood-brain barrier in humans and invade 
the brain after a few weeks of infection in the case of T. b. rhodesiense infection 
or after several months in the case of T. b. gambinese infection. This is the late 
stage of HAT known as the encephalitic stage or stage two (Kennedy, 2013). 
Death could occur within few weeks in the case of T. b. rhodesiense infection. 
This stage is characterized by the occurrence of meningoencephalitis, tremor, 
abnormal movements, and speech impairment (Blum et al. 2006). Typical 
symptom of this stage is alteration in the structure of sleep and reversal of the 
normal sleep/wake cycle. Patient suffers from insomnia during  the night and 
uncontrollable episodes of sleep during the day; hence, the name ‘sleeping 
sickness’ (Buguet et al. 2005). Untreated patients will deteriorate and eventually 
die.  
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      Treatment of HAT depends on the stage of the disease. It is, therefore, vital 
to establish whether the patient is suffering from an early or a late stage of 
infection. T. b. rhodesiense infections are associated with high parasitemia and 
can be easily detected by  blood or lymph smears at the early stage (Kennedy, 
2006). T. b. gambiense infections are harder to detect using a blood smear due 
to low parasitemia levels. An antibody test has been developed called the card 
agglutination Trypanosomiasis test (CATT) for detection of the parasite (Truc et 
al. 2002). PCR has also been developed to detect the disease at its early stage. 
However, the approach needs further development, as it cannot be utilized for 
routine screening in the community (Mugasa et al. 2012). The late stage disease 
is detected by analyzing the cerebrospinal fluid for the presence of trypanosomes 
and/or elevated levels of white blood cells (WHO, 1998 and Kennedy, 2008).  
     Treatment of HAT has been unsatisfactory so far due to the lack of oral and 
less toxic drugs. Current available drugs could also be ineffective at times 
(Fairlamb, 2003).   
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Table 1: Drugs used for treatment of human African trypanosomiasis (Kennedy, 
2013). IV= intravenous, IM= intramuscular.  
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     Pentamidine is administered through an intramuscular route as a first line 
treatment of T. b. gambiense infection (Atouguia and Kennedy, 2000, Brun et al. 
2010). Life-threatening complications such as hyperglycemia, hypoglycemia, 
hypotension, and gastrointestinal troubles arise upon administering this drug 
(Atouguia and Kennedy, 2000, Kennedy, 2004, Brun et al. 2010). Intravenous 
Suramin is administered to first stage patients with the T. b. rhodesiense 
infection. Complications associated with the drug include renal failure, 
anaphylactic shock, skin lesions, bone marrow toxicity, and neuropathy (Atouguia 
and Kennedy, 2000, Kennedy, 2004, Brun et al. 2010). Trivalent organic 
arsenical Melarsoprol is the only drug available for treatment of the late stage T. 
b. rhodesiense infection. It acts on a parasite molecule called typanothione that 
maintains an intracellular reducing environment (Fairlamb et al. 1989). Drug 
resistance has been observed in Melarsoprol along with toxic side effects , such 
as encephalopathy, skin rashes, peripheral neuropathy, and cardiac arrhythmia 
(Legros et al. 1999, Kennedy, 2004, Brun et al. 2010). Eflornithine (an ornithine 
decarboxylase inhibitor) is administered for the late-stage treatment of T. b. 
gambiense infection (Burri  and Brun 2003, Kennedy, 2008). Eflornithine has 
many drawbacks such as bone marrow toxicity, seizures , and gastrointestinal 
issues (Burri  and Brun 2003, Kennedy, 2004). Hence, development of less toxic 
and better medication is required for ultimate elimination of this disease.  
Life cycle of T. brucei 
     The T. brucei is an obligate parasite and requires a host for its survival. It is 
transmitted to the mammalian host via tsetse fly.  
 9 
               
 
Figure 1-2: Life cycle of the T. brucei. (A) Schematic representation of the T. 
brucei life cycle (Dreesen et al. 2007). (B) An immunofluorescence image of a 
bloodstream form T. brucei cell stained with VSG specific antibody (green). DAPI 
staining depicts nucleus and kinetoplast. (C) High magnification electron 
microscope image depicting surface coat protein of T. brucei (black arrow) 
(Image was obtained from Rockefeller University Laboratory of Medical 
Parasitology). 
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     Trypanosome parasites enter the mammalian host when an infected tsetse fly 
bites the host. In the mammalian host, the bloodstream form (BF) T. brucei 
expresses a dense layer of ~10 million surface coat protein molecules called 
variant surface glycoproteins (VSG) (figure 1-2). These VSGs are rod shaped 
molecules anchored to the membrane through a glycosylphosphatidylinositol  
(GPI) anchor, and they cover the entire cell surface including the flagellum 
(Ferguson, 1999, Schwede and Carrington, 2010). The parasite remains 
extracellular and survives in the bloodstream of the host by evading its immune 
response through periodically changing VSGs, a phenomenon termed antigenic 
variation (McCulloch, 2004, Pays et al. 2004). These proliferative BF T. brucei 
are morphologically slender and long; and eventually differentiated to a short and 
stumpy form (Matthews et al. 2004). This serves two purposes: (1) the 
parasitemia levels is controlled ensuring prolonged host survival and (2) the 
stumpy form T. brucei cells uniformly arrest in the G1 phase, which allows them 
to have coordinated morphological changes upon re-entry into the tsetse fly 
(Matthews, 2005). 
     Upon re-entry into the tsetse fly, the stumpy form metamorphoses into a more 
proliferative form called procyclic form (PF). At this stage all VSG genes are 
silenced (Kooter and Borst, 1984, Kooter et al. 1987) and a different but a less 
dense surface coat of procyclic acidic repetitive protein (PARP, also known as 
Procyclin) is expressed (Roditi et al. 1989, Dorn et al. 1991, pays et al. 1993). 
Procyclins, unlike VSGs, are resistant to tsetse fly gut proteases, allowing 
parasite to survive in the gut of the insect host (Gruszynski et al. 2006). PF cells 
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proliferate in the mid-gut of tsetse fly and eventually migrate towards the salivary 
glands of the fly. They attach to the fly’s salivary glands by elaboration of the 
flagellar membrane and become quiescent. This quiescent metacyclic form T. 
brucei expresses a surface coat consisting of metacyclic VSGs (mVSGs). 
Metacyclic form cells remain in the lumen of the salivary gland and are 
transferred to a new mammalian host when the tsetse fly takes a bite of the host. 
After infection mVSGs are si lenced in the mammalian host and BF VSGs are 
expressed. Expressing metacyclic VSG is important for parasite survival and 
proliferation after T. brucei cells are transferred back into the mammalian host 
(Vickerman, 1985).  
     Hence, the regulation of the expression of the life cycle stage-specific coat 
protein as well as the silencing of the other surface coat is crucial for T. brucei 
survival and pathogenesis. Elucidating the mechanism of this regulation is 
important for understanding the pathogenesis of this parasite. 
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Genome of T. brucei 
                   
 
 
 
Figure 1-3: Schematic representation of chromosomes of T. brucei. Sequencing 
of intermediate chromosome is not yet complete, and hence the representation is 
partially hypothetical (Ersfeld, 2011). 
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     The T. brucei genome consists of 11 pairs of megabase chromosomes, ~5 
intermediate chromosomes, and ~100 minichromosomes (figure 1 -3). 
Intermediate chromosomes, and minichromosomes are usually haploid. The 
sizes of diploid megabase chromosomes vary greatly, ranging from 5.5 Mbp 
(chromosome XI) to 0.9 Mbp (chromosome I) (Berriman et al. 2005, Melville et al. 
1998, Melville et al. 2000). Megabase chromosomes can be  divided into two 
large regions: (1) The chromosome internal core region consisting of 
housekeeping genes transcribed by RNA polymerase II and (2) the subtelomeric 
region consisting of VSG expression sites where VSG genes are transcribed by 
RNA polymerase I (Berriman et al. 2002, Hertz-Fowler et al. 2008). 
Heterogeneity in the size of  megabase chromosomes is mostly due to the 
subtelomeric chromosomal regions (Callejas et al. 2006). Not every megabase 
chromosome and every telomere has the VSG expression site at the 
subtelomeric region, resulting in these chromosomes being partially hemizygous 
(Melville et al.1999). 
     There are approximately 9,000 predicted genes in the T. brucei genome 
(Berriman et al. 2005). ~1,500 genes among them are VSG genes and they are 
usually organized in large subtelomeric arrays (figure 1 -3, megabase 
chromosomes) (Barry et al.  2005, Berrimen et al. 2005). Many of these genes 
are VSG pseudogenes that are used by the parasite for assembling functional 
mosaic genes through DNA recombination (Marcello and Barry, 2007). T. brucei 
genes lacks introns and are transcribed in polycistronic transcription units (Mair 
et al. 2000). 
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     There are ~5 intermediate chromosomes ranging in size from 200 to 900 Kbp 
in each cell (Van der Ploeg et al. 1984a). They consist of non-repetitive DNA 
cores, subtelomeric 177 bp repeats, and telomeric repeats (Wickstead et al. 
2004). Few of the Intermediate chromosomes can also carry subtelomeric VSG 
expression sites (Van der Ploeg et al. 1984b). Similar to the megabase 
chromosome, not every intermediate chromosome carries ESs at their 
subtelomeric loci. 
     The T. brucei genome consists of ~100 minichromosomes ranging in size 
from 30 to 150 kbp; this comprises approximately 10% of the nuclear DNA 
(Gibson and Borst, 1986, Van der Ploeg et al. 1984a). Minichromosomes consist 
of palindromic 177 bp repeats in the core and non-repetitive elements including 
VSG genes towards the telomeric ends (Weiden et al. 1991, Zomerdijk et al. 
1992, Alsford et al. 2001, Wickstead et al. 2004). It is thought that the VSGs on 
minichromosomes are never expressed. They serve as an important VSG 
reservoir for VSG switching (Borst, 1986). 
Surface molecules of T. brucei and their expression 
     T. brucei expresses different major surface coat proteins at various stages of 
its life cycle. In the mammalian host, it expresses the bloodstream form VSGs. In 
the mid-gut of the insect host, it expresses procyclins and all bloodstream form 
VSGs are silent. After reaching the salivary glands of the fly, it changes its 
surface coat and expresses metacyclic VSGs. All these coat proteins are 
expressed from different sites (some being in specialized expression sites) on 
chromosomes, and their expression is tightly regulated. 
 15 
             
 
 
Figure 1-4: Loci of VSGs and procyclin expression sites in T. brucei. 
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     In the bloodstream form, VSGs are exclusively expressed from the 
subtelomeric bloodstream form VSG expression sites (ESs) (de Lange and Borst 
1982). In total there are 15 different ESs present on the megabase and 
intermediate chromosomes in the T. brucei 427 strain (Hertz-Fowler et al. 2008). 
Along with VSG, ESs also consist of other genes known as Expression Site-
Associated Genes (ESAGs) (Pays et al. 2001) and a stretch of repeats with TAA-
rich sequence known as 70-bp repeats. VSG is located at the end of the ES and 
next to the telomeres. These expression sites are polycistronically transcribed by 
RNA polymerase I, and the promoter is located 40-60 kb upstream of the VSG 
gene (Gunzl et al. 2003, Hertz-Fowler et al. 2008). Only one ES promoter is fully 
active, resulting in a single type of VSG being expressed and present on the 
surface of the trypanosome cell. The silent archives of VSGs are present in long 
tandem arrays on the megabase chromosomes or as a single gene on the 
minichromosomes. These VSGs can only be expressed after they are 
recombined into the active ES (Horn and Barry 2005). 
     When T. brucei cells are in the metacyclic form, metacyclic VSGs (mVSGs) 
are expressed from metacyclic VSG expression sites (MESs) located on a few of 
the megabase chromosomes. MESs are monocistronic transcription units located 
at subtelomeres with the promoter being located ~5 kb upstream of the telomeres 
(Lenardo et al. 1984, Cornelissan et al. 1985, Alarcon et al. 1994). MESs are 
also transcribed by RNA polymerase I (Ginger et al. 2002). The VSG genes in 
these sites are rarely replaced. The parasite population injected into the 
mammalian host expresses many different mVSGs; however, each cell 
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expresses only one type of mVSG (Tetley et al. 1987). This diversity in the 
population allows the parasite to easily establish successful infection in the 
mammalian host (Barry et al. 1998).  
     Unlike VSGs, procyclin is expressed from a chromosomal-internal locus. 
Procyclin genes are organized in tandem arrays of two or three copies on two 
pairs of megabase chromosomes (Mowatt and Clayton, 1987, Koenig et al. 
1989). In total there are four types of loci expressing procyclins (Ruepp et al. 
1997). Three of these loci express proteins with extensive glutamic acid-proline 
dipeptide repeats (EP repeats) and can be distinguished by a presence or an 
absence of glycosylation sites, while the fourth type of locus encodes proteins 
with pentapeptide repeat (GPEET) and no glycosylation site (Roditi et al. 1998). 
Similar to VSGs and mVSGSs, procyclins are also transcribed by RNA 
polymerase I (Gunzl et al. 2003). However, in contrast to ESs and MESs, 
procyclins can be simultaneously expressed from two or more loci (Mowatt and 
Clayton, 1987, Mowatt and Clayton, 1988). 
     In the mammalian host, T. brucei is able to evade the attack from the host 
immune system through regular switching of VSG through a phenomenon called 
antigenic variation. Antigenic variation allows the parasite to establish persistent 
infection in the host.  
Antigenic variation in T. brucei and its regulation  
     Antigenic variation comprises of two main aspects: 
(1) VSG switching – This involves periodic switching of the expressed VSG and 
changing the surface coat to an immunologically distinct VSG. 
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(2) Monoallelic VSG expression – VSGs are exclusively expressed from only one 
of the 15 ESs while the rest are kept silent. This monoallelic expression ensures 
effective VSG switching and provides the parasite with an inexhaustible reservoir 
of surface molecules when challenged by the host’s immune system. 
     T. brucei megabase chromosomes carry a large array of VSG genes located 
at the subtelomeres. Minichromosomes also carry VSGs at their subtelomeric 
loci. All these silent VSGs serve as a reservoir for antigenic variation (Marcello 
and Barry, 2007). Activation of these VSGs occurs primarily through 
recombination into the ESs located on the megabase chromosomes. There are 
fundamentally two main mechanisms used during VSG switching: (a) a 
transcriptional switch and (b) recombination (reviewed in Horn and McCulloch, 
2010 and Rudenko, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 19 
 
 
 
 
 
 
Figure 1-5: Mechanism of VSG switching in T. brucei. Two main mechanisms of 
VSG switching are schematically depicted. Different color rectangular boxes 
depict different VSGs (figure adapted from Horn and McCulloch, 2010). 
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     As seen in figure 1-5, during transcriptional switching, a new ES is expressed 
and the originally active ES is silenced. Another mechanism involves DNA 
recombination, which primarily occurs through a gene conversion process (Barry 
and McCulloch, 2001).  During the duplicative VSG gene conversion process, a 
silent VSG, usually from a silent ES, is duplicated and copied into the active ES 
by replacing the old VSG gene (which is lost).  Another mechanism is ES gene 
conversion, where an entire ES is copied into the active ES resulting in its 
duplication and loss of the previously active ES. Switching can also occur 
through crossovers where VSG crossover occurs between two telomeric ends 
carrying VSG genes, resulting in a new VSG gene (present on minichromosomes 
or a silent ES) inserted into the active ES. Such crossovers may or may not 
include telomeric sequences. Finally, a less frequent process can generate a 
novel mosaic VSG gene in the active ES. This is achieved by copying the 
sequence from multiple VSGs genes that are normally nonfunctional (Kamper 
and Barbet, 1992). Such a mechanism is thought to be important for maintaining 
a persistent late-stage infection. 
     Many factors regulating VSG switching have been identified. DNA damage 
repair factors BRCA2, RAD51, and its paralogue RAD51-3 have been shown to 
affect the VSG switching frequency. Knockout cells for these factors displayed 
lower switching frequencies (McCulloch and Barry, 1999, Proudfoot and 
McCulloch, 2005, Hartley and McCulloch, 2008, Dobson et al. 2011). On the 
contrary, deletion of the factors, such as TOPO3α topoisomerase and RMI1 
(usually involved in DNA recombination) led to an increased VSG switching 
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frequencies (Kim and Cross, 2010, Kim and Cross, 2011). The cohesin subunit 
SCC1 was shown to be required for faithful inheritance of the active VSG to the 
daughter cell and its depletion led to an increase in the VSG switching frequency 
(Landeira et al. 2009). Depletion of the DNA replication factor ORC1 (origin 
recognition complex) displayed an elevated VSG switching frequency 
(Benmerzouga et al. 2013). Finally, telomeres play an important role in regulating 
the VSG switching. Telomerase reverse trancriptase (TERT) null cells carrying 
extremely short telomeres had a higher VSG switching frequency, where most 
VSG switchers arose through gene conversion events (Hovel-Miner et al. 2012). 
Also, the depletion of telomeric proteins, such as TbTRF (Jehi et al., reviewed 
and currently in revision), TbRAP1 (Nanavaty and Li, unpublished data), and 
TbTIF2 (Jehi et al. 2014) affect the VSG switching frequencies. 
     For a successful VSG switching, it is extremely important to have a tightly 
regulated monoallelic VSG expression.  
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Figure 1-6: Monoallelic expression of VSG in T. brucei. Multiple ESs carrying 
different VSGs are depicted.  
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     Only one ES is fully active at any time in a T. brucei cell (Cross, 1975).  
Although transcription initiates at all ES promoters, only one promoter is fully 
active, resulting in a single type of VSG being expressed. Multiple mechanisms 
have been identified that play roles in regulating monoallelic VSG expression: (1) 
restricted transcription elongation, (2) a unique subnuclear locus for VSG 
transcription, (3) chromatin remodeling, (4) replication machinery, and (5) 
telomeric si lencing. 
     Transcription initiates at multiple ES promoters, but transcription elongation 
quickly attenuates in all but one ES, resulting in only one ES being fully 
transcribed. This is proposed to happen due to  selective recruitment of the RNA 
elongation/processing machinery (Vanhamme et al. 2000). Another interesting 
feature observed in T. brucei is the presence of an extranucleolar polymerase I 
containing focus. It has been determined that only the active ES is associated 
with this extranucleolar focus called ES body (ESB) (Navarro and Gull, 2001). An 
ESB is required for stable inheritance of the active VSG, thus suggesting its role 
in the monoallelic expression (Landeira et al. 2009). 
     The chromatin structure has been shown to play an important role in 
regulating ES transcription. It was determined that silent ESs have regularly 
spaced nucleosomes while the active ES is highly devoid of nucleosomes 
(Figueiredo and Cross, 2010, Stanne and Rudenko, 2010). However, it still 
needs to be determined whether such nucleosome occupancy in the active ES is 
a cause or a consequence of RNA polymerase I transcription. Many chromatin-
remodeling factors have been identified that affect ES promoter activities. The 
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depletion of histone H3 (Alsford and Horn, 2012), linker histone H1 (Povelones et 
al. 2012), and histone chaperones, such as FACT (Denninger et al. 2010), NLP 
(Narayanan et al. 2011), and ASF1A or CAF-1b (Alsford and Horn, 2012) led to 
the derepression of the silent ES promoter without affecting VSG silencing. 
Similar effects on the ES promoter were also observed upon the depletion of 
chromatin remodeler ISWI (Stanne et al. 2011). Depletion of SIR2rp1 (homolog 
of yeast Sir2) (Alsford et al. 2007), MYST-family histone acetyltransferase HAT1 
(Kawahara et al. 2008), and histone deacetylase DAC1 or DAC3 (Wang et al. 
2010) led to the derepression of telomere proximal reporter genes without 
affecting VSG silencing. Interestingly, depletion of the histone methyltransferase 
DOT1B led to an ~10 fold derepression of the silent VSGs suggesting that it is 
required for monoallelic VSG transcription (Figueiredo et al. 2008).  
     The DNA replication machinery is suggested to have a link with antigenic 
variation in T. brucei. The depletion of ORC1 (origin recognition complex) led to a 
4-12 fold derepression of the silent VSGs (Benmerzouga et al. 2013). The 
knockdown of MCM-BP (MCM binding protein, a component of replication 
complex) also led to a 12-30-fold derepression of silent VSGs (Kim et al. 2013). 
However, the detailed mechanisms are unknown. 
     Finally and most importantly, telomeres have been shown to play important 
roles in maintaining VSG silencing. TbRAP1, a telomeric protein, is known to be 
important for maintaining VSG silencing. Depletion of TbRAP1 led to a 10-100-
fold derepression of all the silent VSGs tested (Yang et al. 2009). Such high 
derepression is not observed when other factors were examined, suggesting that 
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telomeres are crucial in VSG expression regulation. Our lab focuses on 
characterizing and elucidating functions of telomere in antigenic variation of T. 
brucei. 
Telomeres and the telomere complex 
     Telomeres are the ends of linear chromosomes. They contain telomeric DNA 
and telomere-associated proteins. Telomeric DNA consist of G-rich repetitive 
sequences, such as TG2-3(TG)1-6 in budding yeast, TTACAG2-5 in fission yeast, 
TTTAGGG in plants and, TTAGGG in humans (Shampay et al. 1984, Sugawara 
et al. 1986, Moyzis et al. 1988, McKnight et al. 1997). Most of the telomere DNA 
is duplex except for a single-stranded 3’-overhang present at the end of 
telomeres known as G-overhang. Protein-free DNA ends are susceptible to 
degradation by nucleases and illegitimate repair by DNA damage repair 
machineries, which leads to genome instability. Telomeric proteins form a 
protective cap and ensure chromosome stability and genome integrity. Linear 
DNA molecules require additional mechanisms to complete the replication of 
their extreme termini. Attrition of sequences from the ends of chromosomes 
occurs after every round of semi-conservative DNA replication. This is known as 
the end replication problem. Without alternative mechanism such attrition would 
lead to loss of genetic information and prevent cells from multiplying. This end 
replication problem is solved by telomerase (Greider and Blackburn 1985). 
Telomerase is a ribonucleoprotein complex with a reverse transcriptase activity 
that can synthesize telomeric DNA de novo, and solve the telomere end 
replication problem. 
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Figure 1-7: Telomere complexes in different organisms. Core components of 
telomere complex identified so far along with telomerase in budding yeast, 
mammals, and T. brucei are depicted. 
 
 
 27 
      Telomeric DNA in budding yeast consists of a G-rich imperfect repeat 
sequence, such as TG2-3(TG)1-6 (Shampay et al. 1984). The distal end of 
telomeres contains G-rich 3’ single-stranded overhang called G-overhang 
(McElligott and Wellinger, 1997, Klobutcher et al. 1981, Shampay et al. 1984, 
Moyzis et al. 1988). ScRAP1 is a component of the budding yeast telomere 
complex and is the predominant duplex telomere DNA binding factor (Konig et al. 
1996). ScRAP1 interacts with two groups of telomeric proteins. One group 
consisting of ScRif1 and ScRif2 is primari ly involved in telomere length regulation 
(Hardy et al. 1992, Wotton and Shore, 1997). The other group consists of Sir3 
and Sir4 and is primarily involved in heterochromatin formation/maintenance and 
silencing of subtelomeric gene transcription (Moretti et al. 1994, Cockell et al. 
1995). Sir3 and Sir4 recruits Sir2, which deacetylates histones on neighboring 
nucleosomes and provides further binding sites for Sir3 and Sir4, thereby 
allowing propagation of heterochromatic structure (Rusche et al. 2002). Cdc13 
binds to the single-stranded G-overhang along with two other factors called Stn1 
and Ten1, and mutations in this complex lead to abnormally elongated or 
shortened telomeres (Nugent et al. 1996, Grandin et al. 1997, Grandin et al. 
2001). The Ku heterodimer, consisting of yku70 and yku80 subunits, binds to the 
distal end of the telomeres and is known to be important for regulating telomere 
length and silencing (Boulton and Jackson 1998, Gravel et al. 1998, Polotnianka 
et al. 1998). Finally, telomeres in budding yeast are maintained by telomerase, 
consisting of Tlc1 (the RNA subunit of telomerase), Est2 (the catalytic protein 
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subunit of telomerase), Est1, and Est3 (Singer and Gottschling 1994, Zhou et al. 
2000,Timothy et al. 2000). 
     The human telomeric DNA consists of TTAGGG repeats (Moyzis et al. 1988). 
The core telomere protein complex in humans is known as the Shelterin and 
consists of six subunits. TRF1 and TRF2 bind directly to the duplex telomeric 
DNA as homodimers (Broccoli  et al. 1997). Overexpression of a dominant 
negative mutant of TRF1 leads to removal of TRF1 from the telomere and 
abnormally elongated telomeres. Overexpression of a dominant negative mutant 
of TRF2 leads to removal of TRF2 from the telomere and chromosome end 
fusions (Van Steensel and de Lange 1997, Van Steensel et al. 1998). It has been 
shown that human telomeres fold back and the single stranded telomere G-
overhang invade the double stranded telomeric DNA region to form a lasso-like 
structure, known as the T-loop (Griffith et al. 1999). TRF2 is required for the 
formation and/or maintenance of the T-loop (Dokasani et al. 2013). TIN2 is 
localized to telomeres through interaction with both TRF1 and TRF2, and its 
truncation leads to abnormally elongated telomeres (Kim et al. 1999). RAP1 was 
identified as a TRF2-interacting factor, and overexpression of RAP1 or some 
domain deletion mutants leads to elongation of telomeres (Li et al. 2000, Li and 
de Lange 2003). POT1 is another component of Shelterin and binds to the 
single-stranded telomeric DNA (Lei et al. 2002, Loayza and de Lange 2004, Lei 
et al. 2004). POT1 protects telomere ends from nucleolytic degradation and also 
regulates telomerase-dependent telomere elongation (Loayza and de Lange 
2003, Liu et al. 2004, Hockemeyer et al. 2005, Yang et al. 2005). Recent work 
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also showed that POT1 protects the telomere by preventing RPA-mediated 
activation of the ATR signaling pathway (Denchi and de Lange 2007). TPP1 
interacts with POT1 and is required for the telomere localization of POT1 (Liu et 
al. 2004). TPP1 binds to POT1 and increases its affinity for telomeric ssDNA. It 
also interacts with the telomerase for its recruitment to telomeres (Xin et al. 2007, 
Wang et al. 2007). The Ku heterodimer is known to bind DNA ends in a 
sequence independent manner and is a key player in the Non-homologous end 
joining pathway (NHEJ). At telomeres, the Ku70/Ku80 heterodimer is known to 
interact with TRF1 or TRF2 and prevent end joining (Hsu and Gilley 2000, Song 
et al. 2000). The telomerase consists of a protein subunit called TERT and its 
RNA component called TERC (Nakamura et al. 1997). However, these are just 
minimal components and additional accessory factors are required for its function 
in vivo. Other telomerase-associated factors include hEST1A, hEST1B, and 
dyskerin (Mitchell et al. 1999, Reichenbach et al. 2003, Snow et al. 2003).  
     The T. brucei telomere sequence is the same as the one for the vertebrate 
telomere and consists of TTAGGG repeats (Blackburn and Challoner 1984). The 
T. brucei telomere can be more than 10 kb long and comprises 10% of the total 
DNA (Dreesen and Cross 2008). Similar to human telomeres, but comparatively 
much smaller (~1 kb), t-loops have been observed in T. brucei (Munoz-Jordan et 
al. 2001). At the end of the telomeres there is a short single stranded 3’ G-rich 
overhang. TbTRF is a component of the core telomere complex, and it directly 
binds to the duplex telomere DNA (Li et al. 2005). TbTRF is required for telomere 
end protection, and its depletion leads to loss of the telomere G-overhang 
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structure (Li et al. 2005). TbRAP1 was identified as a TbTRF-interacting factor 
and it plays an important role in regulating VSG silencing at T. brucei telomeres 
(Yang et al. 2009). TbTIF2 (TRF interacting factor) was recently identified as a 
component of the telomere complex, and it is required for maintaining 
subtelomere/telomere integrity and stability. Depletion of TbTIF2 leads to an 
increased VSG switching frequency (Jehi et al. 2014). TbTRF and TbRAP1 also 
play roles in regulating VSG switching in T. brucei (Jehi et al., reviewed and 
currently in revision, Nanavaty and Li, unpublished data). Ku80 has been 
characterized in T. brucei, and it is required for telomere length maintenance as 
its deletion leads to telomere shortening (Conway et al. 2002, Janzen et al. 
2004). The telomerase complex in T. brucei consists of a protein subunit called 
TbTERT and an RNA component called TbTR (Cano et al. 1999, Dreesen et al. 
2005, Sandhu et al. 2013, Gupta et al. 2013). Deletion of TbTERT and TbTR 
leads to the shortening of telomeres. This shortening of telomeres led to an 
increased VSG switching frequency (Dreesen and Cross, 2006, Hovel-Miner et 
al. 2012, Sandhu et al. 2013).  
     Recent studies have shown that the T. brucei telomeres and its integral 
components play a key role in regulating antigenic variation (VSG si lencing and 
VSG switching). Hence, it is crucial to understand the telomere biology and 
elucidate its role in pathogenesis of T. brucei. 
Telomere transcription and heterochromatin formation 
     Long non-coding RNAs are involved in epigenetic regulation of gene 
expression by either forming euchromatic or heterochromatic structures. 
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Chromatin associated long non-coding RNAs, such as XIST and rox regulate 
dosage compensation in mammals and Drosophila melanogaster, respectively 
(Deng and Meller, 2006, Payer and Lee, 2008).  Air or Kcnq1ot1 are long non-
coding RNAs involved in genomic imprinting (Pauler et al. 2007, Pandey et al. 
2008). Hence, it is increasingly evident that long non-coding RNAs play important 
roles in epigenetic regulation of gene transcription. 
     Contrary to popular belief that telomeres are transcriptionally silent due to 
their repressive chromatin state, it has been established that telomeres are 
transcriptionally active and produce long non-coding RNA molecules called 
TERRA (telomere repeat containing RNA) (Azzalin et al. 2007, Schoeftner and 
Blasco, 2008). TERRA ranges in size from 100 bp to 9 kb in mammals and is 
transcribed from the C-rich strand giving rise to UUAGGG repeats  (Azzalin et al. 
2007, Schoeftner and Blasco, 2008). TERRA forms discrete nuclear foci and is 
associated with telomeres in vivo (Azzalin et al. 2007). It is known to interact with 
the telomeric proteins TRF1 and TRF2 (Deng et al. 2009). 
      Not all TERRA foci are colocalized with telomeres. Interestingly, in mouse 
embryonic fibroblasts, an intense TERRA focus co-localizes with XIST RNA that 
coat inactive X chromosomes (Schoeftner and Blasco, 2008).  Also, TERRA 
associates with mouse sex chromosomes in a development specific manner. 
Upon development, it is only associated with telomeres of heterochromatinzed 
(inactive) sex chromosome of each sex (Ogawa et al. 2008). This suggests that 
the possible role of TERRA is to establish/maintain heterochromatin at inactive 
sex chromosomes. 
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     Open chromatin structure favors transcription of TERRA. TERRA levels are 
increased when human cells are treated with an inhibitor of Class I and II histone 
deacetylases (Azzalin et al. 2007). Mouse cell lines deficient in histone 
methyltransferases Suv3-9h and Suv4-20h also displayed elevated levels of 
TERRA (Schoeftner and Blasco 2008). On the contrary, the knock-out of 
telomerase RNA component in mouse cells led to shortened telomere sand 
decreased levels of TERRA (Schoeftner and Blasco 2008). These shortened 
telomeres also had an open chromatin structures with decreased levels of 
telomeric histone methylation and increased histone acetylation (Benetti et al. 
2007). In addition, overexpression of TRF2 in mouse cells led to  the telomere 
shortening with an open chromatin structure but with decreased levels of TERRA 
(Benetti et al. 2008). Hence, TERRA levels are intricately balanced in vivo, and 
the telomere length can affect TERRA levels. 
     Not much is known about functions of TERRA. SiRNA mediated depletion of 
TERRA affected cell viability, telomere aberrations, decreased recruitment of 
ORC to telomeres, and decreased H3K9 trimethylation at telomeres in human 
cells (Deng et al. 2009). TERRA is known to facilitate ORC recruitment to 
telomeres via binding to TRF2 (Deng et al. 2009). These results collectively 
suggest that TERRA may play a role in forming the heterochromatin structure at 
telomeres. 
     TERRA is also proposed to negatively regulate telomerase-mediated telomere 
elongation (Schoeftner and Blasco 2008). Telomerase-positive cells display 
higher methylation of TERRA promoters and lower level of TERRA compared to 
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telomerase-negative cell lines (Ng et al. 2009). Also, high-grade tumors have 
diminished levels of TERRA compared to low-grade tumors (Schoeftner and 
Blasco 2008). During embryonic development of mouse, high telomerase activity 
is related to lower levels of TERRA (Schoeftner and Blasco, 2008). Finally, 
TERRA was shown to efficiently inhibit telomerase in vitro by base pairing with 
the RNA component of telomerase (Schoeftner and Blasco, 2008). On the 
contrary, a recent study in budding yeast showed that TERRA nucleates 
telomerase molecules and recruits them specifically to short telomeres for their 
elongation (Cusanelli  et al. 2013). Thus, more research needs to be done in 
order to determine the role of TERRA in regulating telomerase activity. 
     It is critical to regulate TERRA levels in the cell. The impairment of non-sense-
mediated RNA decay machinery in human cells or the deletion of 5’-3’ 
exonuclease Rat1p in budding yeast interferes with the decay of TERRA 
molecules and leads to its eventual accumulation (Azzalin et al. 2007, Luke et al. 
2008). These elevated levels of TERRA led to the dramatic shortening of 
telomere tracts by rapid truncations (Azzalin et al. 2007, Luke et al. 2008). 
Forced transcription of yeast telomeres led to the shortening of its telomeric 
tracts (Sandell et al. 1994). Using transcriptionally induced telomeres, it was 
proven that high levels of TERRA lead to telomere shortening in a DNA-
replication dependent manner and also cellular senescence in the absence of 
telomere maintenance mechanisms (Maicher et al. 2012). TERRA forms RNA-
DNA hybrids with telomeric DNA and their accumulation promotes telomeric 
recombination (Balk et al. 2013). Collectively, these results suggest that it is 
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extremely important to regulate TERRA levels in cells as it can lead to an early 
senescence and a deleterious effect. However, deregulating TERRA transcription 
can be beneficial when fighting against pathogens such as T. brucei. 
     TERRA has been identified in T. brucei; however, nothing is known about its 
function or regulation (Rudenko and Ploeg 1989). It ranges in size from ~200 bp 
to 9 kb and is transcribed by polymerase insensitive to α-aminitin treatment 
(Rudenko and Ploeg 1989). From the results mentioned above, it is likely that 
TERRA plays a role in forming a heterochromatic structure at telomeres and also 
regulates telomere length and recombination in T. brucei. Hence, it will be 
imperative to determine the functions of TERRA in regulating VSG silencing at T. 
brucei telomeres. Due to its role in suppressing telomere recombination, it can be 
hypothesized that TERRA may additionally regulate VSG switching in T. brucei.  
 
Significance of the study 
     The T. brucei undergoes antigenic variation and evades host immune 
responses. Genes encoding its surface antigen are located at subtelomeric loci , 
and it is proven that telomeres play important roles in the regulation of VSG 
expression. Importantly, telomeric proteins of T. brucei, although functionally 
conserved, have very low sequence homology with the human telomeric 
proteins. This makes telomeric proteins potential drug targets for therapeutic 
purposes, as they are essential for survival of the parasite. Understanding the 
functions of telomeres in regulating antigenic variation will provide means to 
disrupt its regulation. Disruption of antigenic variation will facilitate the host’s 
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immune system to combat T. brucei infection. In addition, since telomere proteins 
are essential for the survival of the parasite; targeting these telomere proteins will 
have deleterious effects. 
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CHAPTER II 
 
MATERIAL AND METHODS 
 
 
 
Growth analysis 
     Uninduced and induced cells were grown in parallel to compare their growth. 
Cells were counted at regular intervals and population doublings was calculated. 
Population doubling = log2 (total number of cell, n/total number cells, (n-1)) + PD 
(n-1), where n is the hour or day when cells are counted and n-1 is the immediate 
time-point preceding it. 
Western blot analysis 
 
     Cells were lysed in 2X laemmli buffer (0.1 M Tris-Cl, pH 6.8, 6% SDS, 20% 
glycerol, 0.004% bromophenol blue) and boiled at 100ºC for ten minutes in order 
to collect total cell lysate (Laemmli 1970). Samples were separated on 6-10% 
Tris-Glycine polyacrylamide gel at 100 V for ~2 hours. After separation, proteins 
were transferred onto 0.45 µm nitrocellulose membrane (GE healthcare life 
sciences) by electrophoresis at 70 V for 2 hours at 4ºC. The membrane was 
stained with Ponseau dye (2% w/v Ponseau S in 30% w/v Tri-chloroacetic acid)
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for about a minute and rinsed with Ponseau destaining buffer (2.3 liters of ddH20 
+ 4ml of concentrated HCl) to ensure proper transfer of proteins. The membrane 
was blocked with 10% milk/ 0.5% Tween20/ 1x PBS (phosphate -buffer saline) at 
room temperature for ~1 hour. The membrane was rinsed twice for ~5 minutes 
each using 0.1% milk/0.1% Tween 20/ 1x PBS. The membrane was hybridized 
overnight in a plastic bag using appropriate primary antibody and dilution, in 
5%milk/ 0.1% Tween 20/ 1x PBS. Next day, the membrane was washed twice for 
~5 minutes using 0.1% milk/ 0.1% Tween 20/ 1x PBS and hybridized with 
appropriate secondary antibody in 5%milk/ 0.1% Tween 20/ 1x PBS at room 
temperature for one hour. Followed by hybridization membrane was washed 4 
times for ~5 minutes each using 0.1% milk/ 0.1% Tween 20/ 1x PBS. Final wash 
was given for 5 minutes using 1x PBS. Membrane was rinsed with water and 
incubated with Amersham ECL western blotting reagent (GE Healthcare Life 
Sciences) for ~2 minutes. The blot was exposed to X-ray films for various lengths 
of time and the films were developed.  
     For detection of endogenous TbRAP1 protein, rabbit polyclonal antibodies 
597 or 598 were used (Yang et al. 2009). Rabbit polyclonal antibodies 1260 or 
1261 were used to detect TbTRF (Li et al. 2005). TAT-1 (gift from Dr. keith Gull) 
was used to detect tubulin. A commercially available goat antibody against EF-2 
(elongation factor 2) (Santa Cruz Biotechnology Inc.) was used. Rabbit anti-
VSG2 (CRD-depleted) antibody was used to detect VSG2 (Figueiredo et al. 
2008). BB2 antibody (MSKCC, AB core facility) was used to detect Ty1-TbRAP1. 
Rabbit GFP antibody was used to detect GFP tagged TbTRF, TbKU80, and 
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hygromycin-GFP-TK. Commercially available HA antibody (F-7) (Santa Cruz 
Biotechnology Inc.) was used to detect F2H (Flag-HA-HA) tagged TbRAP1 and 
TbTIF2. Rabbit polyclonal antibody was used to detect histone H3 (AbCam). 
Histone H2A was detected using a rabbit polyclonal antibody (Millipore 
Corporation). 
Southern blot analysis 
     Genomic DNA was isolated either using DNAzol (Life Science Inc.) or the 
DNA spooling method (de Lange et al. 1990). The DNA concentration was 
measured using NanoDrop 2000 (Thermo Fisher Scientific Inc.). 2-5 µg of 
digested genomic DNA (using appropriate restriction enzymes) were separated 
on a 0.7% agarose gel prepared in 0.5xTAE at 100 V until the orange G dye 
reaches the bottom of the gel. The gel was scanned on Typhoon FLA 9140 (GE 
Healthcare Life Sciences) by placing a ruler next to it. DNA was depurinated 
(0.25 M HCL) for 30 minutes followed by denaturation (1.5  M NaCl; 0.5 M NaOH) 
for one hour (buffer was changed after 30 minutes). Finally the DNA was 
neutralized (1 M Tris 7.4; 1.5 M NaCl) for one hour and blotted onto hybond 
nylon membrane (GE healthcare life sciences) in 20x SSC (3 M NaCl, 0.3 M 
sodium citrate). After overnight blotting, the membrane was cross-linked 
(Stratalinker UV crosslinker) and pre-hybridized for ~1 hour in CHURCH mix (0.5 
M NaPi pH 7.2, 4 mM EDTA pH 8.0, 7% SDS, 1% BSA) at 65ºC. Hybridization 
was done at 65ºC overnight using the CHURCH mix and appropriate 
radiolabeled probe. The blot was washed three times using CHURCH wash (40 
mM NaPi pH 7.2, 1 mM EDTA pH 8.0, 1% SDS) for ~15 minutes each at 65ºC, 
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wrapped, and exposed to a phosphorimager screen (GE Healthcare Life 
Sciences). 
Probe labeling 
     For labeling of the probe, a desired DNA fragment of around 600-800 bp was 
generated. 200 ng of this DNA fragment was mixed with 5 ng of random hexamer 
and the total volume was brought up to 39 µl with double distilled water. The 
mixture was incubated at 100ºC for 5 minutes and immediately moved on ice 
after boiling. 5 µl of 10X nucleotide mixture (containing dATP, dGTP, dTTP) 
without dCTP was added to the tube. Klenow polymerase (New England Biolabs) 
and 5 µl of 32P-alpha-dCTP (3000 Ci/mmol) were added. The reaction was 
incubated at room temperature for 90 minutes followed by adding 50 µl of TNES 
(10 mM Tris pH7.4, 10 mM EDTA, 100 mM NaCl, 1%SDS) buffer. The probe was 
purified on a 3 ml of G-50 beads column and eluted using TNES buffer. After 
monitoring with a Geiger counter, the probe was heated at 100ºC for 5 minutes 
and added to 10-25 ml of CHURCH mix. This mixture was filtered using a 0.22 
µm syringe filter and added directly onto the blot. 
     End labeling of oligonucleotide probe was done for telomere in-gel 
hybridization. 50 ng of TELC4 oligo ((CCCTAA)4) or TELG4 oligo ((TTAGGG)4) 
was mixed with 32P-gamma-ATP, Kinase buffer, and Polynucleotide kinase (New 
England Biolabs). The reaction was incubated at 37ºC for 45 minutes followed by 
adding 80 µl of TES (Tris-HCl/EDTA/SDS) buffer to the mixture. The probe was 
purified using a 3 ml Sepharose G-25 column and elution with TNES buffer. The 
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purified probe was mixed with 25 ml of CHURCH mix, filtered through a 0.22 µm 
syringe fi lter, and added to the blot for hybridization. 
RNA collection 
     Total RNA was isolated from T. brucei cells using RNAstat (TEL-TEST, Inc). 
Briefly, 140 million cells were harvested by centrifugation at 580 g for 10 minutes 
at 4ºC. The pellet was resuspended and evenly homogenized in 1 ml of RNAstat 
reagent. After incubation at room temperature for 5 minutes, 200  µl of chloroform 
was added to the tube and mixed vigorously by vortexing for 15-30 seconds. 
After another 5 min incubation, the sample was centrifuged at 15,682 g for 15 
minutes at 4ºC to collect the aqueous phase. 600 µl of isopropanol was added to 
the aqueous phase and mixed thoroughly. Samples were stored at -20ºC. When 
ready to use, samples were centrifuged at 15,682g for 15 minutes at 4ºC. The 
RNA pellet was washed with 70% ethanol, air-dried, and dissolved using ddH2O. 
Reverse transcription and quantitative Real time PCR 
     RNA samples were cleaned using QIAGEN RNeasy kit and treated with 
DNase (QIAGEN). Reverse transcription was performed using M-MLV (Promega) 
according to the manufacturer’s protocol. Quantitative RT-PCR was carried out 
using Bio-Rad iTaq SYBR Green supermix with ROX according to the 
manufacturer’s protocol. The amount of DNA was quantified using DNA Engine 
Opticon 2 (Bio-Rad). The following formula was used to calculate normalized 
increase in mRNA levels: (mRNAV, n/mRNAV, 0)/(mRNAT, n/ mRNAT, o), where 
mRNAV, n represents mRNA level for particular VSG at n hour after induction and 
mRNAV, 0 represents mRNA levels at 0 hour. mRNAT, n and mRNAT, o represent 
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the mRNA levels for β-tubulin at 0 hour (pre-induction) and n hours (post-
induction). 
Flow cytometry 
     ~20 million cells were harvested by centrifugation at 208 g for 10 minutes at 
4ºC. Cells were washed twice with 1xPBS/2 mM EDTA for PF cells or with 
1xTDB (5 mM KCl, 80 mM NaCl, 1 mM MgSO4, 20 mM Na2HPO4, 2 mM 
NaH2PO4, 20 mM glucose pH 7.4), with 2 mM EDTA for BF cells. Cells were 
resuspended in 200 µl of 1xPBS/2mM EDTA (for PF cells) or in 1xTDB/2mM 
EDTA (for BF cells). Cells were fixed by adding 2  ml of ice-cold 70% ethanol drop 
wise while vortexing. After fixing, cells were stored for at least overnight at 4ºC. 
Storage never exceeded more than one week. For performing FACS analysis, 
cells were harvested by centrifugation at 208 g for 10 minutes at 4ºC. The cell 
pellet was resuspended in 0.5 ml of staining solution (1xPBS, 2mM EDTA, 200 
µg/ml RNAse A and 50 µg/ml propidium iodide). Cells were collected in a tube by 
passing them through a cell-strainer cap and incubated in dark at 37ºC for 30 
minutes. FACS was performed on BD FACSCanto II cytometer (BD Biosciences) 
using the BD FACS DIVA software (BD Biosciences). Data were analyzed using 
the FlowJo software. 
Chromatin Immunoprecipitation (ChIP) 
     Dynabead protein G beads (Life Sciences Inc.) were prepared for the 
immunoprecipitation. 50 µl of beads were washed and resuspended in 200 µl of 
antibody binding and washing buffer (1xPBS, 0.02% Tween 20) with appropriate 
antibody. Pre-immune serum of equal amount was used for a negative control. 
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Beads were kept for antibody coupling at 4ºC on a rotor. 2x108 cells were 
harvested by centrifugation at 580 g for 10 minutes at 4ºC. Cells were 
resuspended in 40 ml 1xTDB with proper mixing. Cells were fixed for precisely 20 
minutes by adding 4 ml of freshly prepared 11% formaldehyde solution (final 
concentration 1%). After fixing, 2.75 ml of 2M glycine was added to quench 
formaldehyde. Cells were centrifuged at 5,000 g for 15 minutes at 4ºC. After 
discarding supernatant cells were washed with cold 1xPBS. Cells were lysed 
using lysis buffer containing appropriate protease inhibitors and sonicated using 
sonic dismembrator (Thermo Fisher Scientific Inc.) at out put ~6 (Scale 4 -5) for 4 
cycles with 30 second on/ 30 second off for each cycle. After taking out sample 
to check sonication efficiency, 50 µl of 10% Triton-X100 was added to the tubes 
and centrifuged at 15,682 g for 10 minutes at 4ºC. After centrifugation the 
supernatant was carefully transferred to a fresh tube. 50 µl of sample was taken 
out for Input from each tube. Beads were prepared for binding by placing them 
on magnetic rack and removing the supernatant. The remaining lysate was 
equally divided among the control tube (pre-immune serum) and the IP 
(containing antibody) tube. Tubes were rotated at 4ºC for three hours. After 
incubation, beads were thoroughly washed three times using 1xPBS and 
samples were eluted using elution buffer (50 mM Tris-HCl, pH8.0, 10 mM EDTA 
and 1% Sodium-dodecyl-sulphate). All samples (including input sample) were 
reverse crosslinked using 5 µl of 5 M Nacl at 65ºC overnight. DNA was extracted 
by phenol chloroform and purified using the Qiaquick spin PCR purification kit 
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(Qiagen). Quantitative PCR was performed using appropriate dilutions o f the 
DNA. 
     10 µg of 598 antibody (rabbit polyclonal) was used for testing differential 
binding of TbRAP1 to active and silent VSGs. 10 µg of 598 pre-immune serum 
was used for a negative control. 5 µg of 1260 or 1261 antibody (rabbit polyclonal) 
was used for testing differential binding of TbTRF to the active and silent VSGs. 
     Pull-down of specific DNA was calculated as percentage of input. The 
following formula was used for calculation after performing quantitative PCR. 
        % of input = (1 + Efficiency) 
ΔCT 
/ (dilution factor) * 100 
     where ΔCT (sample) = ΔCT (untreated sample) - ΔCT (treated sample) 
     In this case, treated samples were either preimmune control or IP sample. 
Untreated sample represents input. 
Formaldehyde assisted isolation of regulatory elements (FAIRE) analysis 
     FAIRE analysis was performed according to Giresi et al. 2009. Briefly, 2x108 
cells were fixed using 1 ml of 37% formaldehyde for 20 minutes at room 
temperature. Cells were lysed using lysis buffer and sonicated for 4 cycles (30 
seconds on/ 30 seconds off) using Bioruptor®300 (Diagenode Inc.) at high 
output. Sonication sample (25µl) (to check efficiency of sonication) and input 
sample (50µl) were taken out after sonication. DNA was extracted from 
remaining lysate by performing phenol chloroform extraction. Input sample and 
sonication sample were kept for reverse crosslinking overnight at 65ºC after 
adding 125 mM NaCl and treated with RNAse A and Proteinase K before 
extracting DNA. DNA from all samples was precipitated and purified using 
 44 
Qiaquick spin PCR purification kit (Qiagen). The amount of DNA extracted was 
measured by quantitative PCR using iTaq SYBR Green Supermix with ROX (Bio-
rad) in an Opticon II (Bio-rad). The amount of FAIRE-extracted DNA was 
normalized to that of the input DNA. 
VSG cloning 
     RNA was collected from 50x106 cells using RNAstat 60 (Tel-Test Inc). RNA 
samples were treated with DNaseI (Qiagen) and purified using RNeasy column 
(Qiagen). Reverse transcription was performed using polydT primers. PCR was 
performed using cDNA as the template. Forward primer was designed to 
recognize spliced leader sequence (present on each mature mRNA) and 
backward primer was designed to recognize C-terminal region of VSG (which is 
similar in all VSGs). PCR products were purified and sent for sequencing. 
Sequences were compared with the T. brucei genome using BLAST to determine 
the VSGs expressed in each cell line. 
Statistical analysis 
     P-values of unpaired t-tests were calculated using the GraphPad Prism 
software. 
Micrococcal nuclease (MNase) digestion  
     5x107 cells were collected and washed with 1xTDB (BF cells) or 1x PBS (PF 
cells). Cells were permeabilized using 40 mM digitonin. All samples were treated 
with 1 unit of Micrococcal nuclease (Worthington Biochemicals) for 1, 2.5 or 5 
minutes. EDTA and EGTA (final concentration of 10 mM each) were added to 
terminate the reaction. DNA was subsequently extracted by phenol-chloroform. 
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Equal amount of DNA (for untreated and treated samples) was loaded and 
separated by agarose gel electrophoresis. EtBr-stained gel was scanned using 
Typhoon FLA 9140 (GE healthcare life sciences). After scanning, DNA was 
treated as described for southern blot analysis and blotted onto the Hybond nylon 
membrane (GE healthcare life sciences). After UV cross-linking, the blot was 
hybridized with the appropriate radiolabeled probe at 65ºC overnight. After 
hybridization, the blot was washed three times with CHURCH wash for 15 minute 
each and exposed to a phosphorimager screen (GE Healthcare Life Sciences). 
Telomere southern blot analysis 
     Genomic DNA was isolated using the DNA spooling method (de Lange et al. 
1990). An appropriate amount of genomic DNA was digested overnight at 37ºC 
by using frequent cutting enzymes such as AluI and MboI. The DNA 
concentration was measured. A 0.7% agarose gel with 20x20 cm dimensions 
was prepared by using 0.5xTAE. 1-2 µg ( for telomere blots) or ~12 µg (for single 
copy genes) of digested genomic DNA was loaded per lane along with an 
appropriate DNA marker. Initially, the gel was run for 1 hour at 30 volts followed 
by overnight at 50 volts. In total, the gel was run for ~1,000-1,100 V•hrs. The 
EtBr-stained gel was scanned using Typhoon FLA 9140 (GE healthcare life 
sciences) by placing a ruler next to it. The DNA was depurinated, denatured, 
neutralized, and blotted onto a Hybond nylon membrane (GE Healthcare Life 
Sciences) in 20xSSC (3 M NaCl, 0.3 M sodium citrate) overnight. The blot was 
UV cross-linked (Stratalinker UV crosslinker) and hybridized with the appropriate 
radiolabeled probe. 
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Pulsed field gel electrophoresis 
     To prepare DNA plugs, ~150x106 cells were harvested and washed with 
1xTDB (BF cells) or 1xPBS (PF cells). After centrifugation, cell pellets were 
resuspended in L-buffer (0.01 M Tris-HCl pH 7.6, 0.02 M NaCl, 0.1 M EDTA pH 
8.0) to obtain a final concentration of 4x108 cells/ml and incubated at 50ºC for 10 
minutes. Equal volume of 1.6% of low melting point agarose (Agarose type VII, 
Sigma Aldrich) in L-buffer (50ºC) was added to the cells. Cells were mixed and 
loaded into disposable molds at a concentration of ~1x107 cells per plug. Plugs 
were allowed to solidify at room temperature, subsequently, plugs were 
incubated in L-buffer with 1% Sarkosyl and 1 mg/ml Proteinase K at 50ºC for 48 
hours. After 48 hours, the plugs were washed twice with L-buffer followed by 
incubation in L buffer with Proteinase K for another 48 hours at 50ºC. DNA plugs 
were finally washed and stored in L-buffer at 4ºC.  
     A 1.2 % agarose gel was prepared using 0.5xTris-borate-EDTA (TBE). DNA 
plugs were loaded on the gel with the appropriate marker (H. wingei 
chromosomal DNA). Intact chromosomes were separated in a CHEF DR II (Bio-
Rad) using the following conditions: initial pulse 1,500 seconds, ending pulse 700 
seconds, voltage 2.5 volts/cm, at 14ºC for 120 hours. Subsequently, the gel was 
stained for 1 hour in 0.5xTBE containing 1 µg/ml of Ethidium Bromide and 
destained in ddH2O for 30 minutes. The EtBr-stained gel was scanned using 
Typhoon FLA 9140. DNA was depurinated, denatured, and neutralized using 
southern blot analysis conditions. DNA was blotted onto the Hybond nylon 
membrane in 20X SSC followed by UV cross-linking. The blot was hybridized 
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with appropriate radiolabeled probe at 65ºC overnight, washed, and exposed to a 
PhosphorImager screen (GE healthcare life sciences). 
G-overhang analysis 
     Pulsed field gel electrophoresis followed by in-gel hybridization was 
performed to quantify the telomere G-overhang signal. The same DNA sample 
was run in duplicates and after electrophoresis the gel was dried overnight in a 
gel dryer (Bio-rad). The DNA-containing gel was prehybridized at 50ºC for 30 
minutes in a CHRUCH mix. TELC4 oligo ((CCCTAA)4) and TELG4 oligo 
((TTAGGG)4) were end-labeled by Polynucleotide kinase with ATP (γ -32 P). One 
gel was hybridized with the TELC4 oligo to detect the G-strand overhang and the 
other gel with the TELG4 oligo to detect the C-stand overhang. The latter serves 
as a negative control. Both gels were hybridized overnight at 50ºC in CHURCH 
mix. After hybridization, gels were washed three times for 30 minutes each with 
4xSSC (0.6 M NaCl and 0.06 M sodium citratre) at 50ºC followed by a final wash 
in 4xSSC with 0.1%SDS for 30 minutes at 50ºC. Gels were wrapped in plastic 
wrap and exposed to PhosphorImager screens. After overnight exposure, signals 
were quantified using Typhoon FLA 9140. Subsequently, both gels were 
denatured (1.5 M NaCl and 0.5 M NaOH) for 30 minutes and neutralized for 30 
minutes (3 M NaCl and 0.5 M Tris-HCl, pH 7.0). After rinsing with ddH2O, the 
gels were prehybridized in CHURCH mix at 55ºC for 1 hour. Hybridization was 
done using the same TELC4 and TELG4 probes at 55ºC for overnight. Gels were 
washed the same as described above and exposed to PhosphorImager screens 
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for 2 hours. Signals were quantified using Typhoon FLA 9140. This signal was 
used as a loading control. 
     The following formula was used to calculate the telomere G-overhang signal: 
     G-overhang signal for any given sample = (Native TelC4 signal)/ (Denatured 
TelC4 signal)  
     The change in the G-overhang signal was calculated by normalizing G-
overhang levels at different time points (induced samples) with that at the zero 
time point (uninduced samples). 
In vitro transcription and translation of TbRAP1 
     The TbRAP1 ORF containing the Kozak sequence was cloned after the T3 
promoter in the pBlueScript SK vector. pSK-TbRAP1 (Kozak) was linearized 
using PvuI and purified using the Qiaquick spin PCR purification kit (Qiagen).  
1µg of digested and purified plasmid was used as the template to for in vitro 
transcription using the mMESSAGE mMACHINE® T3 transcription kit (Thermo 
Fisher Scientific Inc.) according to the manufacturer’s protocol. After completing 
transcription, the product was treated with DNaseI and RNA was precipitated 
using Lithium chloride. The resulting RNA pellet was washed once with cold 70% 
ethanol and resuspended in ddH2O. RNA was electrophoresed in a 
formaldehyde gel to determine the quality and the yield of transcribed RNA. 
     1 µg of the transcript was used for in vitro translation using the TNT® T7/T3 
Coupled Reticulocyte Lysate System (Promega) with S35 labeled Methionine  
according to the manufacturer’s protocol. Lysate containing translated TbRAP1 
was separated on a 10% polyacrylamide gel, which was subsequently fixed in 
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5% methanol and 7% acetic acid for 30 minutes followed by drying for 30 
minutes at 80ºC using a Gel dryer (Bio-Rad). The dried gel was exposed to a 
PhosphorImager screen overnight. 
Electrophoretic mobility shift assay (EMSA) 
     The (TTAGGG)12 probe was prepared as previously discussed (Zhong et al. 
1992). Purified GST-TbTRF was available in the lab (Li et al. 2005). TbRAP1 was 
obtained by performing in vitro transcription and translation as described above 
(lysate containing TbRAP1). Proteins were incubated with 80% glycerol, 1 µg/µl 
of sheared E. coli DNA, 200 mM Glycine pH 7.6, 100 ng/µl β-casein, 10 mM 
dithiothreitol, 1 ng/µl of probe, and cold competitor (non radiolabeled  (TTAGGG)5 
probe) for 20 minutes at room temperature. Antibody was added when necessary 
and incubated for another 20 minutes at room temperature. All samples were 
loaded onto a 0.6% agarose gel and separated in 0.1x Tris-borate-EDTA. Gel 
was dried at 80ºC for 2 hours by placing a DE-81 membrane underneath. After 
drying, the gel was exposed overnight to a PhosphorImager screen (GE 
Healthcare Life Sciences). 
Cloning of TbTRFH domain mutants 
     The N-terminal half of the TbTRFH domain upstream of the helix to be deleted 
along with the N-terminal region of TbTRF was PCR-amplified using primers 
containing the EcoRI and HindIII sites. The TbTRFH region downstream of the 
helix to be deleted to the end of the TbTRF was PCR-amplified using primers 
containing the HindIII and BamHI sites. The wild type TbTRF gene previously 
cloned in the pBTM116 vector (lex A-fusion bait vector) was used as the template 
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in the PCR reactions. Hence, the two fragments flanking the helix to be deleted 
were generated by PCR. After digestion and purification, the two fragments were 
simultaneously ligated with the pBTM116 vector that was digested with EcoRI 
and BamHI to obtain the lexA-fused TbTRF with the helix-deletion mutation. This 
procedure was repeated to delete each helix in the TbTRFH domain. For helix 1 
deletion, the N-terminal region upstream of helix is very short. Hence annealed 
oligo pairs with appropriate restriction sites instead of the PCR product was used 
for ligation.  
     All seven helix mutants were subsequently cloned into the pACT2 (GAD) 
vector. Specifically, each mutant was PCR-amplified using primers having the 
BamHI and XhoI restriction sites and cloned into pACT2 vector.  
Yeast transformation 
     Single colony from a freshly streaked L40 cells was inoculated in YPD 
medium for overnight at 30ºC with rotation. OD600 was measured to determine 
the cell concentration. The overnight yeast culture was used to inoculate 
appropriate amount of YPD medium (10 ml/transformation) so that the OD600 of 
the new culture was ~0.1. The new yeast culture was grown till OD600 reaches 
~0.5. Yeast cells were harvested by centrifugation at 6,446 g for 5 minutes and 
the cell pellet was resuspended in 10 ml sterile water. Cells were centrifuged at 
6,446g for 5 minutes again, and the cell pellet was resuspended in freshly 
prepared lithium solution (1xTBE pH7.5/1x lithium acetate (0.1M, pH7.5)). For 
each transformation 5 µg of plasmid DNA was fully mixed with 200 µl of yeast 
cells and 1.2 ml of freshly prepared Polyethylene glycol solution (40% PEG,/1x 
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Tris-EDTA buffer pH 7.5/1x lithium acetate). The DNA/yeast cell mixure was 
rotated at 100 rpm at 30ºC for 30 minutes. Cells were heat shocked for precisely 
15 minutes at 42ºC and centrifuged for 15 seconds to obtain the cell pellet. Cells 
were resuspended in 200 µl of 1x Tris-EDTA buffer and plated on Tryptophan 
and Leucine dropout plates. Plates were incubated at 30ºC for ~3-4 days to 
obtain yeast transformants. 
Yeast two-hybrid analysis 
 pBTM116-based LexA binding domain (LexABD)-fused protein and pACT2-
based Gal4 activation domain (GAD)-fused protein were co-expressed in yeast 
L40 transformants. The interaction between LexABD and GAD fusion proteins 
was represented as the LacZ reporter gene expression. β-galactosidase activity 
was measured using ONPG (o-nitro-phenyl-β-D-galactopyranoside) as the 
substrate . Single colonies of yeast transformants were inoculated in Tryptophan 
and Leucine dropout medium and allowed to grow for ~18-20 hours at 30ºC with 
constant rotation. OD600 was measured to determine the cell concentration of 
the overnight yeast culture. Yeast cells were centrifuged and the cell pellet was 
washed with 1 ml ddH2O then resuspended in 200 µl Z buffer (60mM 
Na2HPO4•7H2O, 40mM NaH2PO4.H2O, 10mM KCl and 1mM MgSO4•7H2O). 100 
µl of this cell suspension was transferred to a fresh Eppendorf tube along with 
two tubes containing only z buffer (for blank purpose). Cells were quickly frozen 
using liquid nitrogen and subsequently thawed by incubating at 37ºC. 900 µl of z 
buffer containing β-mercaptoethanol and 200 µl of z buffer containing 4 mg/ml 
ONPG was added to the cells and immediately incubated at 30ºC. 500 µl of 1 M 
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Na2CO3 was added to stop the reaction after the sample turned yellow. The time 
required for each sample to turn yellow was noted. At the end of experiment, 
cells were pelleted and the supernatant was used to measure OD 420. 
     The final β-glactosidase activity was calculated using the following formula: 
Unit = 1000*OD420/(OD600 * time * dilution factor/10) 
Dilution factor = Volume of cells used (4 ml in this case)/volume of Z buffer used 
to resuspend the cell pellet (200 µl in this case) 
Northern blot analysis 
     A 1.5% agarose gel containing formaldehyde was prepared in MOPS buffer 
(0.4 M MOPS, 0.1 M NaOAc and 0.01 M EDTA). 2-5 µg (to detect VSGs and 
other transcripts) or 10 µg (to detect TERRA transcript) of RNA was mixed with 
premix (1.5 µl 10xMOPS, 2.6 µl 37% formaldehyde, 7.5 µl Formamide, 3 µl 5x 
loading buffer and Ethidium bromide). 5 µg of RNA marker was also mixed with 
premix. Samples were mixed and incubated at 65ºC for 10 minutes. After 
heating, samples were immediately loaded onto the gel. Gel was run at ~5V/cm 
(50 volts in this case) using 1xMOPS buffer. The EtBr stained gel was scanned 
using a Typhoon FLA 9140 on the completion of running and washed in ddH2O 
for one hour by gentle rotation. The gel was blotted onto a nylon hybond 
membrane (GE healthcare life sciences) for overnight in 20x SSC (3 M NaCl, 0.3 
M sodium citrate). UV crosslinking was performed and the blot was prehybridized 
at 55ºC for one hour using the CHURCH mix. Hybridization was performed 
overnight at 55ºC using the appropriate radiolabeled probe. The blot was washed 
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three times for 15 minutes each at 55ºC using the CHURCH wash, wrapped, and 
exposed overnight to a Phosphorimager screen (GE healthcare life sciences). 
     To detect the TERRA transcript, hybridization was performed at 55ºC 
overnight and the blot was washed twice for 15 minutes each at 65ºC using 
0.1xSSC (15 mM NaCl, 1.5mM sodium citrate)/0.1% SDS followed by exposure 
to a phosphorimager screen overnight. 
RNA Immunoprecipitation (RNA IP) 
          Dynabead protein G beads (Thermo Fisher Scientific Inc.) were prepared 
for the immunoprecipitation. 50 µl of beads were washed and resuspended in 
200 µl of antibody binding and washing buffer (1xPBS/0.02% Tween 20).  An 
appropriate antibody was added to the beads and the mixture was kept for 
antibody coupling at 4ºC on a rotor. 2x108 cells were harvested and washed once 
with 1xTDB. The cell pellet was resuspended in 1 ml NET-5 buffer (40 mM Tris-
HCl, pH 7.5, 420 mM NaCl, 0.5% Nonidet P-40, 2 mg/ml aprotinin A, 1 mg/ml 
leupeptin, 1mg/ml pepstatin A and 10 units of RNAsin). Cells were lysed by 
repeated freezing/thawing technique by freezing them in -80ºC. Repeated 
freezing and thawing was done three times and lysate was cleared by 
centrifugation at 1,5682 g for 10 minutes at 4ºC. The lysate was transferred to a 
fresh tube.100 µl of input sample was taken out and the rest of the lysate was 
equally divided between the control IP (no antibody) and the desired IP. Tubes 
were rotated at 4ºC for three hours. After incubation beads were thoroughly 
washed thrice using 1xPBS and samples were eluted using elution buffer  (50 mM 
Tris-HCl, pH8.0, 10 mM EDTA and 1% SDS). RNA was extracted from all 
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samples including the input sample by phenol/chloroform. 50 µl of 5 M 
ammonium acetate, 15 µl of 7.5 M lithium chloride, 1 µl of 20 mg/ml glycogen 
and 850 µl of 100% ethanol was added to 300 µl of aqueous phase for 
precipitating RNA. Samples were stored overnight at -20ºC. All the samples were 
treated with DNaseI before performing a RNA slot blot experiment.  
RNA slot blot  
     The slot blot manifold was treated with 0.1 M NaOH before assembly and 
rinsed with distilled water. The Hybond nylon membrane was pre -treated with 
10xSSC for 10 minutes before assembly into the manifold. Each slot of manifold 
was filled with 10xSSC. RNA samples were treated with DNaseI at room 
temperature for precisely 20 minutes. At the completion of incubation, 3 volumes 
of denaturing solution (500 µl formamide, 162 µl of 37% formaldehyde, 100 µl of 
MOPS buffer) was added to the RNA samples and samples were incubated at 
65ºC for 15 minutes. At the end of incubation all the samples were kept on ice 
and 2volumes of ice-cold 20xSSC was added. Samples were allowed to pass 
through manifold. 1 ml of 10xSSC was allowed to filter through manifold after 
loading the samples. The apparatus was disassembled, the blot was allowed to 
dry and UV-crosslinked (Stratalinker UV cross-linker). 
     Blots were pre-hybridized for one hour at 55ºC using the CHURCH mix. 
Hybridization was done at 55ºC overnight using an appropriate radiolabeled 
probe. Blots were washed twice for 15 minutes each at 65ºC using 0.1X SSC and 
0.1% SDS and exposed overnight onto a PhosphorImager screen (GE 
Healthcare Life Sciences).                                            .
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CHAPTER III 
TbRAP1-MEDIATED VSG SILENCING IN T. BRUCEI 
 
INTRODUCTION 
     RAP1 (Repressor/Activator Protein 1) is one of the intrinsic and well-
characterized components of the telomere complex in mammalian cells, budding 
yeast, fission yeast, and T. brucei (Conrad et al. 1990, Li et al. 2000, Kanoh and 
Ishikawa 2001, Yang et al. 2009). It plays various roles in telomere end 
protection, telomere length regulation, and telomeric silencing.  
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Figure 3-1: The domain structure of RAP1 in various organisms (Kabir et al. 
2010). (A) A diagram depicting the conserved protein motifs of RAP1 in 
mammals and yeasts. Its TRF2 like interacting partners are depicted as well. The 
empty cyan box in S. pombe indicates that it has a sequence similarity with S. 
cerevisiae myb-fold; however, the structure has not yet been determined. It is not 
known whether S. pombe RAP1 contains RCT domain. (B) Conserved motifs of 
TbRAP1 along with its protein interacting partner TbTRF. 
 
 
 57 
     ScRAP1 directly binds to the telomeric DNA through its myb and myb-like 
domains (Konig et al. 1996), while hRAP1 and SpRAP1 do not seem to directly 
bind to the telomeric DNA in vivo. Instead, they depend on TRF2 and TAZ1 for 
their recruitment to telomeres, respectively (Li et al. 2000, Kanoh and Ishikawa 
2001). Recently, an in vitro study using EM analysis showed that hRAP1 could 
bind to the telomeric DNA sequence (Arat and Griffith 2012). However, the proof 
of DNA binding in vivo is still lacking. The TbRAP1 domain structure is very 
similar to that of ScRAP1 and hRAP1. However, it is still not clear whether 
TbRAP1 can interact with telomeric DNA by itself or solely depends on TbTRF 
for its recruitment. The RCT (RAP1 C-terminus) domain present in RAP1 is 
thought to be required for protein-protein interaction (Kabir et al. 2010), while the 
functions of the RAP1 BRCT domain are unknown.  
     Genes present on the subtelomeric region are often si lenced due to the 
heterochromatic nature of telomeres. This phenomenon is known as telomere 
position effect (TPE) or telomeric silencing. So far, TPE has been identified in 
Drosophila melanogaster, yeast, human, mouse, T. brucei, and Plasmodium 
falciparum (Hazelrigg et al. 1984, Gottschling et al. 1990, Horn and Cross 1995, 
Baur et al. 2001, Frietas-Junior et al. 2005, Duraisingh et al. 2005, Pedram et al. 
2006). RAP1 is known to play an important role in TPE and in expression of 
subtelomerically located genes.      
     In S. pombe, the deletion of SpRAP1 led to a loss of telomere silencing as 
well as a loss in telomere clustering towards spindle pole body, and increased 
telomere length (Kanoh and Ishikawa 2001). In human cells a telomere position 
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effect has been identified. However, the proteins involved in TPE are currently 
unknown (Baur et al. 2001).  
     ScRAP1 plays an important role in TPE. It recruits Sir3/Sir4 to the telomere to 
regulate telomeric silencing and heterochromatin formation/maintenance (Moretti 
et al. 1994, Cockell et al. 1995), and the mechanism is well characterized. Sir3 
and Sir4 together recruit Sir2, an NAD+-dependent histone deacetylase that can 
remove the acetyl group from histone H3 at K9 and K14 residues, and from 
histone H4 at K16 (Moazed et al. 1997, Bourn et al. 1998, Imai et al. 2000, 
Moretti  et al. 2001). Sir3 in turn recognizes the unacetylated H4K16 (Hect et al. 
1995). Therefore, binding of Sir3 and Sir4 recruits Sir2, which deacetylates 
neighboring histone tails and allows the subsequent binding of Sir3 and Sir4 to 
neighboring nucleosomes, allowing the propagation of the heterochromatin 
structure from telomere to subtelomeric region (Rusche et al. 2002). The loss of 
the RCT domain of ScRAP1 leads to de-repression of subtelomeric genes, 
indicating that ScRAP1 is required for proper telomeric silencing (Kyrion et al. 
1993). In T. brucei, homologs of Sir3 and Sir4 are not known. However, 
homologs of Sir2 have been identified (Garcia-salcedo et al. 2003). TbSir2rp1 
(the only homolog located in the nucleus) is required for silencing a reporter gene 
targeted to a subtelomeric locus but not VSG (Alsford et al. 2007).  
     The proper regulation of VSG silencing is of the utmost importance for 
parasite survival and pathogenesis. TbRAP1 (Tb11.03.0760) was identified as a 
TbTRF-interacting protein in a yeast 2-hybrid screen using TbTRF as bait (Yang 
et al. 2009). TbRAP1 is an essential protein. It was confirmed using ChIP, CO-
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ImmunoPrecipitation (CO-IP), and Immunofluorescence (IF) that TbRAP1 
localizes to the telomere. Most importantly, TbRAP1 is required for VSG silencing 
in BF form T. brucei (Yang et al. 2009). Upon depletion of TbRAP1, multiple 
VSGs were expressed as confirmed by qRT-PCR and western blot analysis. IF 
confirmed that more than one silent VSGs were expressed on the surface of 
TbRAP1-depleted T. brucei cells. However, the observed VSG de-repression 
was not at the same level as the fully activated VSG, suggesting that TbRAP1 
independent mechanisms are also involved in ES expression regulation. 
Telomere proximal genes were more strongly de-repressed compared to 
telomere distal genes upon depletion of TbRAP1. Thus, finding confirmed that in 
T. brucei TbRAP1 plays an important role in VSG silencing. However, the 
mechanism of TbRAP1-mediated silencing is not fully understood.  
     In PF cells, T. brucei growing in the mid-gut of tsetse fly, all VSGs are si lent, 
and a different surface protein called procyclin is expressed. Metacyclic VSGs 
(mVSGs) expressed during the metacyclic stage (in the salivary glands of fly) are 
silent in both BF and PF cells. We hypothesized that TbRAP1 may also be 
required in silencing ES-linked VSGs in PF cells as well as mVSGs in both BF 
and PF cells. 
 
RESULTS 
TbRAP1 is essential for PF T. brucei survival 
     In order to study the role of TbRAP1 in PF cells, various independent clones 
carrying inducible TbRAP1 RNAi vector were established. The TbRAP1 RNAi 
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vector was inserted in the rDNA spacer of 29-13 cells. 29-13 (PF) cells express 
the tet repressor and the T7 polymerase, which allow inducible expression of a 
double stranded TbRAP1 RNAi fragment (Wirtz et al. 1999). The RNAi construct 
contains the TbRAP1 sequence encoding its C-terminal domain. RNAi is induced 
upon adding doxycycline. We obtained a pool (PRi-Pool) of transfected cells as 
well as various independent clones (PRi-B2, PRi-C1 and PRi-C2) by limiting 
dilution. Upon adding doxycycline (2µg/ml), depletion of TbRAP1 was achieved 
and growth arrest was observed (Figure 3-2).  
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Figure 3-2: Depletion of TbRAP1 in the PF cells. (A) Growth curve analysis for 
the PRi-pool and control cells carrying empty vector under induced (+Dox) or 
uninduced (-Dox) conditions. Y-axis depicts population doubling calculated as 
average from six independent experiments. Error bars represent standard 
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deviation. (B) Western blot analysis to detect knockdown of TbRAP1 in PRi-pool 
and empty vector cells. Whole cell lysate was collected before (Day 0) and after 
induction (Day 2 & 3) to detect TbRAP1 and TbTRF using antibodies against 
endogenous proteins. Tubulin was used as a loading control. (C), (D) and (E) 
Growth curves of independent TbRAP1 RNAi clones (PRi-C1, PRi-C2, and PRi-
B2, respectively). Population doubling was calculated as an average from three 
independent experiments. Error bars represent standard deviation. (F) Whole cell 
lysate was collected before and after induction of clone PRi-C2 to detect 
TbRAP1. EF-2 (elongation factor 2) was used as a loading control. (G) 
Complementation of TbRAP1 by ectopically expressing F2H-TbRAP1 in PRi-pool 
cells. Western blot analysis depicts ectopically tagged TbRAP1 (running slightly 
higher at day 2 & 3) as well as endogenous TbRAP1 before and after induction. 
(H) Growth curve of PRi-pool/F2H-TbRAP1 cells after adding doxycycline. The 
population doubling was plotted for a single growth analysis. 
      
     Upon depletion of TbRAP1, we observed a severe growth defect by day 2 in 
PRi-Pool cells (figure 3-2 A). Control cells carrying empty vector did not have any 
growth defects. Western analysis confirmed that the TbRAP1 protein was 
significantly depleted by day 2 of induction. Depletion of TbRAP1 did not have 
any effect on protein levels of another telomeric protein, TbTRF (figure 3-2 B). 
TbRAP1 and TbTRF protein levels were unaffected in control cells upon 
induction with the same amount of doxycycline. We obtained several 
independent clones that had various degrees of growth defects after depletion of 
TbRAP1. PRi-C2 had the strongest growth arrest (figure 3-2 D). Western 
analysis of cell lysate collected from PRi-C2 showed that a significant amount of 
TbRAP1 was depleted within 24 hours of induction (figure 3-2 F). In order to 
avoid phenotypic variations associated with the clonal cell lines, we decided to 
use PRi-Pool cells for further studies and key phenotypes were also verified in 
PRi-C2 clone. Complementation of TbRAP1 knockdown was achieved by 
expressing an ectopic F2H (Flag-HA-HA) tagged allele of TbRAP1. Expression of 
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both vectors (ectopic F2H-TbRAP1 and TbRAP1 RNAi) was under the control of 
tet operator and is induced simultaneously upon adding doxycycline. After 
multiple independent transfections and screening several clones, we were able to 
achieve partial complementation as seen in western analysis (Figure 3-2 G) and 
growth analysis (Figure 3-2 H). Ectopically tagged TbRAP1 was expressed upon 
induction (as seen by slightly higher mobility running band), however by day 3 
the protein levels were a little lower than at day 2. Similarly, normal growth was 
restored at day 2 but was a little delayed by day 3. This finding suggests that the 
complementation was partial and that by day 3 the RNAi was able to deplete 
even ectopically expressed TbRAP1, possibly due to a stronger expression of the 
TbRAP1 double stranded RNA than the ectopic wild-type TbRAP1 allele. 
     Next, flow cytometry analysis was performed to examine the cell cycle profile 
of PRi-pool cells after depletion of TbRAP1. Cells were collected before and after 
depletion of TbRAP1 and subjected to propidium iodide staining to measure the 
DNA content. We observed a mild increase in G2/M and sub G1 population with 
a decrease in G1 population upon depletion of TbRAP1 (figure 3-3 C). These 
results are very similar to those observed previously in BF cells upon TbRAP1 
depletion (Yang et al. 2009).   
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Figure 3-3: Flow cytometry analysis of PRi-pool cells. (A) Results from two 
independent analyses are shown. Cells were collected before (Day 0) and after 
(Day1, Day2 and Day3) depletion of TbRAP1. (B) Gating schematics of 
uninduced PRi-Pool cells in flow cytometry analysis. Sub-G1 population contains 
DNA content less than 2C and represents cells experiencing DNA degradation. 
PI, propidium iodide intensity. (C) Quantification of cell population at various cell 
cycle stages of PRi-pool cells before (Day 0) and after (Day 1, 2 & 3) depletion of 
TbRAP1. P values were calculated to compare day 1, 2, and 3 with day 0 using 
unpaired t-test. *, 0.01<P≤ 0.05; **, 0.001<P≤ 0.01. 
 
TbRAP1 is required for silencing ES-linked VSGs in PF cells. 
      
     We wanted to test whether TbRAP1 plays similar roles in regulating VSG 
silencing in PF cells as it does in BF cells. Total RNA was collected before and 
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after depletion of TbRAP1 to compare steady state mRNA levels of various ES-
linked VSG. 
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Figure 3-4: ES-linked VSGs are de-repressed in PF cells upon depletion of 
TbRAP1. qRT-PCR analysis was performed to measure steady state mRNA 
levels of  ES-linked VSGs and control genes before (day 0) and after depletion 
(day 2 & 3) of TbRAP1 in PRi-pool cells (A) and control cells (B). Day 0 value 
was set to 1 but not shown. Fold change in mRNA level was calculated for day 2 
& 3 (after depletion) by normalizing against day 0 (before depletion). All samples 
were normalized with tubulin as an internal loading control. Fold changes in 
mRNA levels are shown for three independent experiments. (C) Western 
analysis to determine levels of various proteins in PRi-pool cells (left) and 
PF/TbTRF RNAi cells (right). Whole cell lysate was collected before (day 0) and 
after (day 1, 2, & 3) adding doxycycline. (D) qRT-PCR analysis to measure 
steady state mRNA levels of ES-linked VSGs and control gene in PRi-C2 cells. 
Day 0 value was set to 1 but is not shown. Fold change was calculated by 
normalizing after TbRAP1 depletion value by before TbRAP1 depletion. 
 
     Steady-state mRNA levels were estimated for several ES-linked VSGs and 
control genes before and after depletion of TbRAP1 in PRi-Pool cells by qRT-
PCR analysis. 35% of TbRAP1 protein was left by day 1 after induction of RNAi 
vector, however, by day 2 only 10% of protein was left. Hence we decided to 
collect RNA samples at day 2 and 3 following induction. Upon depletion of 
TbRAP1 in PRi-pool cells, mRNA levels of all tested VSGs (VSG 2, 3, 6, 11, and 
16) increased by several ten- to several hundred-fold (figure 3-4 A). No 
significant changes in mRNA levels were observed in control cells (figure 3-4 B). 
We also tested the expression of RNA Pol II-transcribed TbPGI (a glycolytic 
protein), TbRPS15 (a ribosomal protein), and the RNA Pol I-transcribed rRNA. 
Expression of these genes was unaffected upon depletion of TbRAP1, 
suggesting that TbRAP1’s effect on VSGs is specific. Western analysis 
confirmed depletion of TbRAP1 and expression of VSG2 protein by day 2 
following induction (figure 3-4 C). Levels of TbTRF (TbRAP1-interacting partner 
and another telomeric protein) remained unchanged upon depletion of TbRAP1. 
Induction of TbTRF RNAi in PF cells leads to growth arrest by day 2 (Li et al. 
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2005). We did not detect any VSG2 expression upon depletion of TbTRF (figure 
3-4 C right), suggesting that VSG derepression is not a consequence of cell 
growth arrest and that TbRAP1 is required for VSG silencing in PF T. brucei 
cells. We also tested steady state mRNA levels of two representative VSGs in 
the PRi-C2 clone to further confirm this phenotype. Several hundred-fold of 
derepression was observed for both tested VSGs while rRNA expression was 
unaffected (figure 3-4 D). In addition to ES-linked VSGs, VSGs are also present 
on subtelomeric regions of minichromosomes. Minichromosomes mostly contain 
177 bp repeats and terminal telomere repeats. The VSGs located on 
minichromosomes lack upstream promoters. 
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Figure 3-5: Detection of VSG671 on minichromosomes. Southern blot analysis 
was performed to test the presence of VSG671 on minichromosomes in BF (Ri-
CT and Ri-BRCT) and PF (PRi-pool) RAP1 RNAi cells. Pulsed field gel 
electrophoresis was performed followed by hybridization with VSG671 probe 
(right panel). The EtBr stained-gel is depicted on the left. Arrow indicates 
minichromosome species. 
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     DNA plugs were made from BF and PF TbRAP1 RNAi cells. Pulsed field gel 
electrophoresis was performed using these plugs under conditions that separate 
intact T. brucei chromosomes (Li et al. 2005). VSG671 was detected on 
minichromosomes in all three TbRAP1 RNAi cell lines (figure 3-5). We 
subsequently tested whether VSG671 is derepressed upon depletion of TbRAP1 
in PRi-pool cells. No VSG671 mRNA was detected in the northern blot analysis 
(data not shown) after knockdown of TbRAP1, suggesting that derepression of 
VSG requires functional upstream promoter. 
TbRAP1 is required for silencing mVSGs in PF cells. 
     Metacyclic VSGs (mVSGs) are major surface proteins expressed in the 
metacyclic form of T. brucei in salivary glands of the tsetse fly. The mVSGs are 
expressed from subtelomerically located monocistronic expression sites. The 
mVSGs are silent in both PF and BF forms. However, their silencing mechanisms 
are not understood. Five mVSG genes (mVSG 397, 531, 639, 653, and 1954) 
were identified in our lab strain (Kolev et al. 2012). We wanted to determine 
whether TbRAP1 plays a role in silencing mVSGs in PF and BF T. brucei cells. 
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Figure 3-6: Silencing of mVSGs in PF cells. (A) Steady state levels of mVSG 
mRNA was measured before (day 0) and after (day 2, 3) depletion of TbRAP1 in 
PRi-pool (A) and control cells (B) using qRT-PCR analysis. Fold change is 
calculated for day 2 & 3 compared to that of day 0 value, which is set to 1 but not 
shown. Values for three independent induction experiments are shown.  
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     Upon depletion of TbRAP1 in PF cells, steady state levels of all tested 
mVSGs increased from several to several 10-fold. In control, no change in 
steady-state mRNA levels of mVSGs was detected. These results indicated that 
TbRAP1 not only plays a role in silencing ES-linked VSGs but also is required for 
silencing mVSGs in PF cells. 
TbRAP1 is required for silencing mVSGs in BF cells. 
     We wanted to test whether TbRAP1 is also required for silencing mVSGs in 
BF T. brucei cells. Two BF TbRAP1 RNAi cell lines were generated. One cell line 
had expressed the pZJMβ-based RNAi construct (Wang et al. 2000) containing 
the BRCT domain of TbRAP1 (Ri-BRCT) while the other the RCT domain (Ri-CT) 
inserted into the rDNA spacer region. Since these cell lines were not previously 
characterized, we decided to confirm critical phenotypes of TbRAP1 depletion in 
these cell lines first. 
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Figure 3-7: Depletion of TbRAP1 in the BF cells. (A) A representative growth 
curve of the two TbRAP1 RNAi strains (Ri-CT & Ri-BRCT). The population 
doubling was calculated in the presence (+) or absence (-) of doxycycline (Dox). 
(B) & (C) qRT-PCR analysis to determine steady state levels of ES-linked VSGs 
in Ri-CT & Ri-BRCT cell lines respectively. Values were calculated before (0 hr) 
and after (24 hr) depletion of TbRAP1. Fold change in mRNA levels was 
calculated compared to day 0. Results for 5 (Ri-CT) and 3 (Ri-BRCT) 
independent experiments are shown. (D) Flow cytometry analysis for the Ri -CT 
cell line. Results from two independent analyses are shown. Cells were analyzed 
before (0 hr) and after (18, 24, & 36 hr) depletion of TbRAP1. (E) Gating 
schematics of uninduced BF cells. The Sub-G1 population refers to cells having 
DNA content less than 2C, which often experienced DNA degradation. (F) 
Quantification of the cell population at various cell cycle stages of the Ri-CT cells 
before (0 hr) and after (18, 24, & 36 hr) depletion of TbRAP1. P values were 
calculated to compare 18, 24 & 36 hr values with 0 hr value using unpaired t-test. 
*, 0.01<P≤ 0.05; **, 0.001<P≤ 0.01. 
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     Upon depletion of TbRAP1 growth arrest was observed in both strains by 30 
hours (figure 3-7 A). Steady state mRNA levels of various ES-linked VSGs were 
tested before and after induction. As previously published (Yang et al. 2009),  an 
increase in VSG mRNA levels from several ten- to several hundred-fold was 
observed after depleting TbRAP1 from both strains (figure 3-7 B & C). FACS 
analysis showed a slight decrease in the proliferation of cells in G1 phase and, 
an increase in G2/M and sub G1 phase.  
     After it was proved that these newly established TbRAP1 RNAi strains give 
similar phenotypes as previously published, we decided to use them for further 
experimentation. The role of TbRAP1 in si lencing mVSGs in BF cells was tested 
by collecting total RNA before (0 hr) and after (24 hr and 36 hr) depletion of 
TbRAP1. By 24 hr only 6% TbRAP1 was left in the Ri-CT cells while 26% was 
left in the Ri-BRCT cells. The RNA collected was then subjected to reverse 
transcription and steady state mRNA levels of various mVSGs were determined 
using specific primers in qRT-PCR analysis. Derepression of mVSGs was 
observed from several to over 1000-fold upon depletion of TbRAP1 (figure 3-8 A 
& B). No change in mVSG mRNA levels was observed in control cells (figure 3-8 
C). Expression of control genes such as rRNA and TbPGI remain unaffected 
upon depletion of TbRAP1. Thus, these results proved that TbRAP1 is required 
for ES-linked as well as metacyclic VSG silencing in BF cells. 
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Figure 3-8: Silencing of mVSGs in BF cells. qRT-PCR analysis to measure 
steady state mRNA levels of mVSGs in (A) Ri-CT, (B) Ri-BRCT & (C) control 
cells before (0 hr) and after (24 hr and 36 hr) depletion of TbRAP1. Fold change 
in mRNA level was calculated after depletion compared to that of 0 hr whose 
value is set to 1 and not shown. Values for three independent experiments are 
shown. 
 
Comparison of TbRAP1-mediated ES-linked VSG silencing at different life 
cycle stages 
 
     Our results suggest that TbRAP1 is required for silencing ES-linked VSGs in 
both PF and BF cells.  However, it seems that derepression of ES-linked VSGs in 
PF is much stronger than that in BF. From our previous studies in BF cells (Yang 
et al. 2009), we know that VSG 3, 6, and 11 were derepressed up to 8-, 23- and 
41-fold respectively upon depletion of TbRAP1. Whereas in PF cells, upon 
depletion of TbRAP1, the same VSGs were de-repressed up to 270-, 220-, and 
260- fold respectively (figure 3-4 A). 
     In order to better quantify these differences, we decided to perform a 
comprehensive qRT-PCR analysis. We wanted to test and compare individual 
ES-linked VSG mRNA level under different conditions: i) at the silent state in 
WT/PF and WT/BF cells, ii) at the derepressed state in PF and BF TbRAP1 RNAi 
cells, and at iii) the fully acti ve state in BF cells. Total RNA was collected and 
subjected to reverse transcription followed by qRT-PCR analysis. VSG 2, 3, and 
9 were tested owing to availability of all the necessary cell lines in our laboratory.  
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Figure 3-9: Strength of TbRAP1 mediated VSG silencing at PF and BF stages. 
(A) Schematic representation of the status of ES-linked VSGs in various 
scenarios. (B) Quantification of qRT-PCR analysis for relative mRNA levels of the 
same VSG in various backgrounds. All the values were normalized to that of the 
PF WT silent state, whose value was arbitrarily set to 1. The average value was 
calculated from five independent experiments. Error bars represent standard 
deviation. VSG derepression was analyzed at day 0 & day 2.5 in PRi-pool cells. 
Derepression of VSG 3 and 9 in BF cells were analyzed at 0 hr & 36 hr in cells 
originally expressing VSG2 (Ri-2 cells). While derepression of VSG2 was 
analyzed at the same time points in cells originally expressing VSG9 (Ri-9 cells). 
For fully active state, three BF WT cells were used: i) VSG2 expresser (SM cells) 
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(Wirtz et al. 1999), ii) VSG9 expresser (PVS3-2/OD1-1 cells) (Yang et al. 2009) 
and iii) VSG3 expresser (SM-derived cell lines). 
 
     Several conclusions were obtained from qRT-PCR analysis. 1) Steady state 
mRNA levels of VSG were 28-, 16- and 9-fold higher in the WT BF cells 
compared to the WT PF cells (figure 3-9 B PF/WT and BF/WT silent) 
respectively. It is known that VSG mRNAs are less stable in PF cells than in BF 
cells where they are prevented from degradation (Berberof et al. 1995). Hence, 
this could contribute to our observation. 2) TbRAP1 is required for ES-linked 
VSG silencing in both the PF and BF cells since VSG derepression was 
observed upon its depletion. 3) This derepression observed due to depletion of 
TbRAP1 is significantly stronger in PF than in BF cells. VSG mRNA levels were 
elevated on an average 333-, 527-, and 217-fold, respectively, in PF. In BF cells, 
proven derepression was on an average 22-, 133-, and 30-fold, respectively 
(figure 3-9 B, PF/TbRAP1 RNAi -/+Dox, BF/TbRAP1 RNAi  -/+Dox). P values 
were all <0.02 when comparing derepression of VSG 2, 3, and 9 in BF to that in 
PF cells. Thus TbRAP1-mediated VSG silencing is stronger in PF cells than that 
in BF cells. We observed that VSG mRNA level is ~3 fold lower for the uninduced 
PRi-pool cells (PF/TbRAP1 RNAi –Dox) compared to PF WT cells, while 
theoretically it should be the same. This observation could be due to variations 
between different cell populations. 
     In yeast, longer telomere results in stronger telomeric si lencing (Kyrion et al. 
1993). It is possible that different strength of TbRAP1-mediated VSG silencing in 
the PF and BF could be due to different telomere length. However, the PF and 
BF strains used in this study have similar length of telomeres (on average ~15 
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kb) suggesting that telomere length is not the contributing factor. Another 
possibility is that TbRAP1 might not be equally depleted in PF and BF cells,  
resulting in different levels of VSG derepression in both forms. To rule out this 
possibility, we tested and compared TbRAP1 protein levels within all the TbRAP1 
RNAi cell lines used for this study. 
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Figure 3-10: Depletion of TbRAP1 in PF and BF cells.  (A-C) Representative 
western blot analysis to determine depletion of TbRAP1. Whole cell lysate was 
collected before (0 hr) and after depletion of TbRAP1 in Ri-2 (A), Ri-9 (B), Ri-CT, 
Ri-BRCT and PRi-pool cells (C). Tubulin and EF-2 were used as loading control. 
Numbers below blots indicate the average relative amount of TbRAP1 protein 
levels. These numbers were calculated from 2 (Ri-2 and Ri-9) or 3 (Ri-CT, Ri-
BRCT, and PRi-pool) independent experiments. (D) Northern analysis to 
determine the relative mRNA levels of TbRAP1 in BF and PF cells. rRNA is 
shown as loading control. Numbers indicate relative ratio of TbRAP1 mRNA 
level. (E) Western blot analysis to determine relative protein levels of TbRAP1 in 
the BF and PF cells. Tubulin was used as a loading control. 
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     RNA samples were collected at 36 hr (for Ri-2 and Ri-9 cells), and at 60 hr 
(for PRi-pool cells). From figure 3-10 A-C, it is evident that comparative residual 
amount of TbRAP1 was left in all the cell lines at respective time points. On an 
average, 4% TbRAP1 was left in Ri-2 cells, 14-11% in Ri-9 cells, and 16% was 
left in PRi-pool cells. Thus, it is unlikely that differential derepression of ES-linked 
VSGs in PF and BF cells is due to different levels of TbRAP1 depletion. We 
further confirmed that TbRAP1 mRNA and protein levels are equal in both life 
cycle stages (figure 3-10 D and E). Collectively, these results suggest that, 
indeed, TbRAP1-mediated silencing is stronger in PF compared to that in BF. 
Such differential strength of silencing was not observed for mVSGs between both 
forms. 
TbRAP1 depletion led to more open chromatin structure in PF cells.  
     Next, we wanted to test whether TbRAP1-mediated VSG silencing involves 
chromatin remodeling. In order to test this, FAIRE (formaldehyde assisted 
isolation of regulatory elements) was performed (Giresi et al. 2009). In FAIRE, 
cells are cross-linked, lysed, and sonicated followed by the phenol-chloroform 
extraction. Protein-free DNA fragments are enriched in the aqueous phase, while 
protein-bound DNA is retained at interphase. DNA from aqueous phase is 
subsequently isolated. PCR analysis can then be done to estimate enrichment of 
protein-free DNA fragments of interest. We were interested in testing whether 
chromatin of subtelomeric ES-linked VSGs is more opened up (hence devoid of 
bound protein) upon depletion of TbRAP1. FAIRE was performed to isolate 
protein-free DNA before and after depletion of TbRAP1. Quantitative PCR using 
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primers specific for various VSGs was performed to calculate the amount 
extracted. Fold change was calculated by dividing values obtained post-TbRAP1 
depletion by those obtained before depletion. 
    
 
Figure 3-11: Depletion of TbRAP1 led to a more loosened chromatin structure in 
the PF cells. FAIRE was performed before (day 0) and after (day 2.5) depletion 
of TbRAP1 in (A) PRi-pool cells and (B) control cells. Quantitative PCR was done 
using primers specific to the indicated gene loci. Fold change was calculated 
from at least three independent experiments. Error bars represent standard 
deviation. In PRi-pool cells, P-values were calculated by comparing ES-linked 
VSG changes with the change of chromosome internal genes. Significant 
differences (P<0.05) are indicated with asterisks. P-values were also calculated 
for each gene between PRi-pool cells and the control cells shown by asterisks 
between corresponding columns from two histograms. Control genes are 
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indicated with the last four digits of their ID. Tb927.2.2430, Tb927.2.2440, 
Tb09.211.1510. *, 0.01<P≤ 0.05; **, 0.001<P≤ 0.01, ***, P≤ 0.001 
 
      
     FAIRE was performed in TbRAP1 depleted PRi-pool cells. Upon depletion of 
TbRAP1 8- to 19-fold increase in the enrichment of ES-linked VSGs was 
observed compared to that in the control cells. An increase in the enrichment of 
mVSG DNA of 4- to 7-fold was also observed. These differences were 
significantly higher compared to that in control cells. In order to determine that 
this effect of TbRAP1 depletion is telomere specific, we also tested enrichment of 
DNA at several random chromosome-internal genes. A 3- to 4-fold increase in 
FAIRE-extracted DNA was observed at these loci, which are modest yet 
significantly higher than that in control cells. However, the enrichment at ES-
linked loci (8- to 9-fold) was significantly higher compared to the chromosomal 
internal loci (3- to 4-fold), suggesting that TbRAP1 has a more prominent effect 
on chromatin structure at subtelomeric loci. The BES promoter lies 40-60 kb 
upstream of the telomeres. TbRAP1 depletion led to ~3-fold enrichment in FAIRE 
extracted DNA, which is similar to that of the chromosome internal loci.  
     It is possible that this change in chromatin structure could be due to an 
elevated transcription, rather than directly due to the loss of TbRAP1. In order to 
test this possibility, the chromatin structure change o f VSG671 locus was 
examined before and after depletion of TbRAP1. VSG671 is located on a 
minichromosome and lacks an upstream promoter. Hence, it is not derepressed 
upon TbRAP1 knockdown. An approximately 5-fold increase in FAIRE-extracted 
DNA was observed for VSG671, which is significantly higher compared to that in 
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control cells as well as chromosome internal loci, suggesting that the change in 
chromatin compaction upon TbRAP1 depletion is not due to elevated 
transcription.  
     Subsequently, FAIRE analysis was also performed in BF cells to test whether 
TbRAP1 has a similar effect on chromatin structure as that observed in the PF 
cells. 
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Figure 3-12: FAIRE analysis in BF cells. FAIRE was performed before (0 hr) and 
after (24 hr in Ri-CT, Ri-BRCT and control cells; 36 hr in Ri-2 and Ri-9 cells) 
depletion of TbRAP1. Quantitative PCR was done using primers specific to 
indicated gene loci. Fold change was calculated from at least three independent 
experiments. Error bars represent standard deviation. Control genes used are 
Tb11.0330, Tb927.2.2430, Tb927.2.2440, and Tb09.211.1510. 
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     FAIRE was performed in four independent TbRAP1 RNAi cell lines (Ri-CT, Ri-
BRCT, Ri-2 and Ri-9) as well as empty vector control cells. Fold change in 
FAIRE-extracted DNA was calculated for ES-linked VSGs, mVSGS, a 
minichromosome VSG (VSG671), ES promoter region and control genes. A 
moderate increase of 2- to 3-fold was observed for ES-linked VSGs, mVSGs, 
and a minichromosome VSG, which was not significantly different from that 
observed in the control cells. Also, a very small change of 1- to 3-fold was 
observed for the ES promoter and chromosome internal loci, which was similar to 
that observed in the control cells. P-values were calculated to compare ES-linked 
VSGs with chromosome internal loci within TbRAP1 RNAi cells and to compare 
all loci between TbRAP1 RNAi and control cells. All calculated P-values were 
>0.05, indicating that the changes in chromatin structure observed in BF cells are 
not significant. Thus, unlike PF cells, TbRAP1 depletion in BF cells does not lead 
to significant changes in chromatin structure. 
     This difference in observed phenotype was not due to different degrees of 
TbRAP1 depletion. This observation was confirmed by performing western blot 
analysis. At the time points when FAIRE was performed, protein levels of 
TbRAP1 were around 4% for Ri-2 (figure 3-10 A), 10% for Ri-9 (figure 3-10 B), 
6% for Ri-CT, 26% for Ri-BRCT, and 16% for the PRi-pool cells of wild-type level 
(figure 3-10 C). This finding indicates that TbRAP1 was depleted in PF and BF 
cells at similar levels. 
    In order to confirm that TbRAP1 depletion has different effects on chromatin 
structure in PF and BF cells, we performed a Micrococcal nuclease (MNase) 
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digestion assay. Ranjodh Sandhu, another graduate student from our lab, did this 
part of work. MNase digestion was performed to test accessibility of chromatin 
before and after depletion of TbRAP1. TbRAP1 RNAi cells in the PF and BF 
cells, as well as the control cells were treated with a fixed amount of Mnase for 
increasing length of time before and after depletion of TbRAP1. Genomic DNA 
was then isolated and separated on an agarose gel. We subsequently performed 
Southern blot analysis by blotting DNA samples on nylon membranes followed by 
hybridization with probes specific to different loci.  
 
 88 
 
 89 
Figure 3-13: A micrococcal nuclease digestion to determine the chromatin 
structure changes. MNase assay was performed before and after depletion of 
TbRAP1 in (A) PRi-pool cells (day 0 and day 2.5) (B) PF/Vector cells (day 0 and 
day 2.5) (C) Ri-BRCT (0 hr and 24 hr) (D) BF/Vector cells (0 hr and 24 hr). In 
each panel, the left panel shows an Ethidium Bromide-stained gel while the right 
panel shows the hybridization result with VSG18 specific probe. Solid black dots 
and arrowheads represent the limiting mobility of genomic DNA in the agarose 
gel and Southern results, respectively. Asterisks indicate mono-, di-, tri-, and 
tetra-nucleosomes. 
 
     PRi-pool cells were treated with a fixed amount of MNase for increasing 
length of time. After 2.5-5 min, a portion of chromatin was digested into mono-, 
di-, tri- and tetra-nucleosomes. However, when TbRAP1 was depleted, this 
digestion was much more rapid and by 5 minutes most of the chromatin was 
found in the mono-nucleosomal fraction (figure 3-13 A, compare lane 4 with lane 
8 on the left).  Control cells did not show any change in chromatin digestion upon 
adding doxycycline (figure 3-13 B, compare lane 5 with lane 10 on the left). This 
suggests that after depletion of TbRAP1, the chromatin is more opened up and 
accessible to MNase digestion. Changes observed in chromatin digestion in the 
Ethidium Bromide- (EtBr)-stained gel suggested that TbRAP1 depletion had a 
mild global effect. In order to test effects of TbRAP1 knockdown on a specific 
locus, the MNase digested DNA was blotted from the agarose gel onto a nylon 
membrane and hybridized with the VSG18 specific probe. In PRi-pool cells after 
TbRAP1 depletion, the entire VSG18 signal was lost by 2.5 minutes of digestion 
compared to before depletion (figure 3-13 A, compare lane 3 with lane 7 in right 
panel). The VSG18-specific signal remained unaffected upon adding doxycycline 
in control cells (figure 3-13 B, compare lane 5 with lane 10 in right panel).  Thus it 
was proven that TbRAP1 regulates VSG silencing in PF cells via chromatin 
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remodeling. We further performed a MNase assay for other ES-linked VSGs, 
mVSGs, and telomere DNA (Pandya et al. 2013). All of them gave similar results. 
TbRAP1 depletion had a very mild effect on chromatin change at the ES 
promoter region. This was similar to the result of FAIRE analysis. The change in 
chromatin structure was also confirmed in PRi-C2 (independent PF/TbRAP1 
RNAi clone). 
     Interestingly, TbRAP1 depletion had no affect on chromatin structure in BF 
when analyzed by MNase digestion.  No change in the chromatin digestion was 
observed in EtBr-stained gels, before or after depletion of TbRAP1 in Ri-BRCT 
cells (figure 3-13 C, compare lane 4 with lane 7 in the left panel). The digestion 
pattern was almost the same as that observed in control cells (figure 3-13 D, 
compare lane 4 with lane 8 in the left panel). We also tested the effect of 
TbRAP1 depletion at the VSG18 locus. No visible difference in the digestion 
pattern was seen between uninduced and induced cells (figure 3 -13 C, compare 
lane 4 with lane 7 in the right panel, figure 3-13 D, compare lane 4 with lane 8 in 
the right panel). This phenotype was further confirmed for other ES-linked VSGs, 
mVSGs, and telomere repeats. No significant change in chromatin structure was 
detected, suggesting that TbRAP1 does not affect chromatin structure 
significantly in BF cells.  
 
TbRAP1 preferentially localizes to silent ES-marked telomeres (preliminary 
studies) 
      
     We wanted to test whether TbRAP1 carries out silencing of VSGs in a cis-
acting manner. Our previous observations indicated that the TbRAP1-mediated 
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silencing effect is position-dependent, i.e. it is stronger at telomere-proximal loci 
than at telomere-distal loci (Yang et al. 2009). We wanted to test whether 
TbRAP1-mediated silencing depends on the amount of TbRAP1 protein 
associated with the local chromatin. If this is true, we expect that more TbRAP1 
protein is associated with the silent ES than the active ES-marked telomere in 
wild-type BF cells. 
     To test this hypothesis, we performed a TbRAP1 chromatin 
immunoprecipitation (ChIP) experiment. The amount of the active ES-linked VSG 
DNA and a silent ES-linked VSG DNA co-immunoprecipitated with TbRAP1 was 
estimated by quantitative PCR. The experiment was performed in two different 
ways. First, the same VSG was examined in different BF cell lines, where the 
VSG is either fully active or silent. Second, the active VSG and silent VSGs 
within the same cell line were examined to determine whether different amount 
TbRAP1 binds to them. Immunoprecipitation was performed using an antibody 
against the endogenous TbRAP1. 
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Figure 3-14: TbRAP1 preferentially binds to the silent ES-marked telomere. (A) 
ChIP was performed in different BF cells lines where either VSG9 is active 
(PVS3-2/OD1-1) or silent (SM and SM-derived cell line). Similar analysis was 
also done in BF cell lines where a different VSG, VSG2, is either active (SM) or 
silent (PVS3-2/OD1-1). After ChIP, quantitative PCR was performed using 
primers specific to VSG9 and VSG2 and the enrichment of the ES-linked VSG 
DNA was calculated as percent of input. Protein G beads with pre-immune serum 
 93 
were used as a negative control. Three VSG9 and two VSG2 independent 
experiments are shown. As a control, enrichment of TbRAP1 at three 
chromosome internally located gene was also estimaed in the same way. For 
control genes, average values were calculated from four independent 
experiments, and error bars represent standard deviation. Control genes are 
listed using the last 4 digits of their gene ID. Tb2430: Tb927.2.2430; Tb2440: 
Tb927.2.2440; Tb1510: Tb09.211.1510. (B) TbRAP1 ChIP was performed in 
VSG9-expressors or VSG2-expressors and enrichment of various ES-linked 
VSGs (active and silent) was calculated as percentage of input. Protein G beads 
without any antibody was used as the negative control. 
 
      A TbRAP1 ChIP was performed to follow the same VSG gene across multiple 
BF cell lines in which this VSG is either fully active or silent. We discovered that 
enrichment of the VSG DNA in the ChIP product is always lower in cells where it 
is fully active than in cells where it is silent. For example, enrichment of VSG9 
DNA in VSG9-expressors is always lower than that in two independent cell lines 
where VSG9 is silent (figure 3-14 A). Similarly, enrichment of VSG2 is always 
lower in VSG2-expressors compared to that in cells where VSG2 is silent (figure 
3-14 A). A ChIP experiment was also done to test binding of TbRAP1 to active 
and silent ES-marked telomeres within the same cell line. Similar results were 
obtained with this approach. We found that enrichment of VSG9 (active) was less 
compared to VSG 2, 14, 18, and 6 (silent) in VSG9-expressors (figure 3-14 B). 
Also, enrichment of VSG2 (active) was less compared to VSG 9, 3, 6, 14, and 18 
(silent) in VSG2-expressors.  
     As a control, we randomly selected three chromosome internally located 
genes, Tb927.2.2430, Tb927.2.2440, and Tb09.211.1510, and estimated the 
amount of their DNA co-immunoprecipitated with TbRAP1 in the ChIP 
experiment. As shown in figure 3-14 A, a very low amount of these DNAs were 
detected in the TbRAP1 ChIP product. The amount of precipitated control gene 
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DNA is similar to that of the active VSGs, suggesting that TbRAP1 does not 
interact with the active VSGs at a significant extent. 
     It is not yet clear whether TbRAP1 possesses any direct DNA binding ability. 
The current prevailing hypothesis is that, like hRAP1, TbRAP1 depends on its 
interacting partner TbTRF to be recruited to telomeres. TbRAP1 was found to 
preferentially bind to si lent ES-marked telomeres. We wanted to test whether 
TbTRF mediates this preferential binding of TbRAP1. If this is true, then TbTRF 
will also binds preferentially more to silent ES-marked telomeres. In order to test 
this possibility TbTRF ChIP was performed using an antibody against TbTRF. 
The amount of the active ES-linked VSG DNA and a silent ES-linked VSG DNA 
co-immunoprecipitated with TbTRF was estimated by quantitative PCR. ChIP 
was performed in VSG2-expressors (VSG2 active). Enrichment of VSG2 DNA as 
well as of VSG 13, 14, and 16 (silent VSGs) was estimated. Pull-down was also 
calculated for two control genes (Tb927.2.2430 and Tb927.2.2440) that are 
present at the chromosome internal regions.  
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Figure 3-15: TbTRF binding to subtelomeric VSGs. TbTRF ChIP was performed 
in VSG2-expressors and enrichment of various ES-linked VSGs (active and 
silent) was calculated as percentage of input. Protein G beads without any 
antibody was used as a negative control. Average values were calculated from 
three independent experiments, and error bars represent standard deviation. 
Control genes are listed using the last 4 digits of their gene ID. Tb2430: 
Tb927.2.2430; Tb2440: Tb927.2.2440. 
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     TbTRF ChIP was performed in VSG2-expressors (VSG2 active). As seen in 
figure 3-14, no significant difference in pull-down of active (VSG2) and silent 
VSGs (VSG 13, 14, and 18) was observed, suggesting that TbTRF does not 
differentially bind to silent ES-marked telomeres. Also, binding at all VSGs was 
almost equal to that seen for control genes (Tb2430 and Tb2440), suggesting 
that TbTRF does not bind to VSGs in significant way and the binding observed is 
sequence non-specific. This result suggests that unlike TbRAP1, probably 
TbTRF does not spread towards the subtelomeric region. From our previously 
published IF data we know that all TbTRF foci co-localizes with telomeres. 
However, not all TbRAP1 foci co-localizes with TbTRF, suggesting that TbRAP1 
might be associated with non-telomeric chromatin (Li et al. 2005 and Yang et al. 
2009). 
      TbRAP1 ChIP will have to be repeated to determine whether TbRAP1, 
preferentially associates with silent ES due to several reasons: i) There is a lot of 
variation in pull-down for the same VSG within different experiments , ii) In a few 
cases there is not a significant difference between pull-down of the active VSG 
and a silent VSG (figure 3-15 B, VSG9 and VSG2 in VSG9-exprssors). Owing to 
such differences it is hard to obtain a statistically significant value, although a 
clear trend does exist. More experiments may provide a clearer result.  
DISCUSSION 
     In this study, we discovered that TbRAP1 is required for maintaining ES-
linked VSG silencing in PF cells as well as in BF cells. Depletion of TbRAP1 led 
to an increase in steady-state levels of VSG mRNA from several ten- to several 
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hundred-fold. TbRAP1 is also required for si lencing mVSGs in both PF and BF 
cells. The strength of TbRAP1-mediated ES-linked VSG silencing is stronger in 
PF compared to that in BF. Interestingly, steady-state mRNA levels of ES-linked 
VSGs are lower in PF cells than in BF cells (silent VSGs), possibly due to 
differential regulation of VSG mRNA stability by VSG 3’ UTR in PF and BF cells 
(Berberof et al. 1995). However, regardless of the steady-state levels of VSGs, 
the changes detected in mRNA levels upon depletion of TbRAP1 are solely due 
to the silencing effect of TbRAP1. Upon depleting TbRAP1, VSG derepression 
observed in PF cells was increased compared to that in the BF cells (Yang et al. 
2009), indicating a stronger silencing by TbRAP1 in PF cells. This comparative 
analysis was performed for only three VSGs due to limited strain availability. 
However, a comparison between previously published data and current data 
suggests that derepression for most of the ES-linked VSGs were higher in PF 
cells. Nevertheless, during derepression, every ES-linked VSG behaved 
differently and hence it is possible that for some VSG the derepression level 
might be similar in PF and BF cells. 
     The telomeric and subtelomeric chromatin structure was affected significantly 
upon depletion of TbRAP1 in PF cells but not in BF cells, indicating that TbRAP1-
mediated VSG silencing in PF occurs through chromatin remodeling. Many 
previous studies have implied the role of chromatin modulation in regulation of 
ES-expression in BF forms. It is known that the active ES is highly devoid of 
nucleosomes compared to the silent ES in BF cells (Figueiredo and Cross 2010, 
Stanne and Rudenko 2010). Also, several chromatin-remodeling factors, such as 
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ISWI (Hughes et al. 2007, Stanne et al. 2011), DAC3 (Wang et al. 2010), Spt16 
(Denninger et al. 2010), and Dot1b (Figueiredo et al. 2008) have been proven to 
be important for regulating activity of the ES promoter. We now find that TbRAP1 
also plays an important role in regulation of ES-linked VSGs, mVSGs, and 
minichromosomes VSGs via chromatin remodeling in PF cells. 
     Depletion of TbRAP1 led to a change in chromatin structure at all tested 
subtelomeric VSG loci. The chromatin structure change was also observed for 
VSG671, which is located on a minichromosome. No change in the mRNA levels 
was observed for VSG671 upon depletion of TbRAP1, possibly due to lack of an 
upstream promoter. Therefore, opening up of chromatin structure at the VSG671 
locus after knocking down TbRAP1 suggests that the change was not due to 
elevated transcription but was rather primarily due to TbRAP1 depletion. ES-
linked VSGs and mVSGs on the other hand possess upstream promoters and 
hence it is possible that the changes in chromatin structure may be one of the 
reasons for their derepression. FAIRE values obtained for ES-linked VSGs were 
higher compared to that obtained for the VSG671 locus (P<0.05) (figure 3-11 A). 
Since all ES-linked VSGs were highly derepressed it is possible that the elevated 
transcription may result in an even more opened chromatin structure.  
     FAIRE and MNase data proved that TbRAP1 had a mild global effect on 
chromatin structure as small changes were seen at chromosome internal loci as 
well as at the ES promoter regions upon TbRAP1 depletion. In budding yeast, 
RAP1 is known to bind at non-telomeric sites and function as transcription 
regulator of multiple genes (Shore D 1994, Yarragudi et al. 2007, Teo et al. 2010, 
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Martinez et al. 2010, Yang et al. 2011). In yeast depletion of Abf1 and RAP1 led 
to altered nucleosome occupancy at more than a thousand loci, resulting in a 
genome-wide effect (Ganapathi et al. 2011). Thus, it is possible that similar to its 
yeast and human homologs, TbRAP1 determines the chromatin structure at a  
global level. However, its effect on subtelomeric loci is much more significant and 
robust. 
     “To our surprise, we did not detect significant chromatin structure changes in 
BF cells on TbRAP1 depletion. Our observations suggest that the significantly 
more severe chromatin structure change and the significantly stronger gene de-
repression at ESs in PF cells than those in BF cells are linked. Currently, we 
favor several possible explanations (not necessarily mutually exclusive) for the 
different phenotypes observed in BF and PF cells. First, the BES chromatin may 
have different structures in BF and PF cells, and TbRAP1 may be the 
responsible factor for this difference. An earlier work (Navarro et al. 1999) found 
that T7 polymerase-mediated transcription from a chromosomally integrated T7 
promoter is repressed along the entire length of the BES in PF cells, but not in 
BF cells. Therefore, the chromatin structure at the silent BES appears to be more 
tightly packed in PF cells. It is possible that TbRAP1 is the factor that maintains a 
more closed BES structure in PF cells. Second, as BF cells undergo antigenic 
variation and si lent BESs need to be ready to switch to the active state, their 
silent state is likely metastable, similar to what is often observed for telomeric 
silencing in yeast (Gottschling et al 1990). Therefore, the BES may switch 
between the open and closed states more frequently in BF cells than in PF cells. 
In this case, TbRAP1 may still be involved in determination of chromatin 
structures in BF cells, but our techniques are not sensitive enough to detect a 
significant change owing to the fast switching status of the BES. Another 
possibility is that more factors are involved in modulating BES chromatin 
structure and BES silencing independent of TbRAP1 at the BF stage. Therefore, 
depletion of TbRAP1 in BF cells may still affect the chromatin structure, but a 
lesser degree of change or no quantifiable differences can be detected. Glover 
and Horn showed that an rRNA promoter- driven reporter gene targeted 5 kb 
from the telomere in a silent BES was expressed in PF cells, but not in BF cells 
(Glover et al. 2006), suggesting that additional factors are involved in silencing 
BESs in BF cells. A recent study suggested that depletion of histone H1 led to a 
chromatin opening at multiple genomic loci only in BF cells, but not in PF cells 
(Povelones et al. 2012), which is also consistent with this hypothesis.” (Pandya et 
al. 2013) 
    A unique DNA base modification, β-D-glucosyl-hydroxymethyluracil (base J) 
has been identified in T. brucei (Gommers-Ampt et al. 1993). Base J is present in 
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BF but absent in PF (Van Leeuwen et al. 1998a) and is highly enriched at 
telomeres (Van Leeuwen et al. 1998b). In T. cruzi, loss of base J led to elevated 
transcription of Pol II transcribed gene, with decrease in nucleosome abundance 
and increased histone acetylation (Ekanayake and Sabatini 2011). This suggests 
that base J can regulate chromatin structure. It is possible that lack of chromatin 
structure change observed in BF cells upon depletion of TbRAP1 could be due to 
base J. In the future, depletion of base J in TbRAP1 knockdown background can 
be performed to test whether there is any change in chromatin structure and any 
additional elevation of VSG derepression. 
     TbRAP1 was found to preferentially locate with the silent ES-marked 
telomere. This suggests that TbRAP1 functions in a cis-acting manner and it 
physically binds to silent VSGs to maintain their regulation. The amount of 
TbRAP1 associated with the active VSG was not significantly different from that 
at the chromosome internal genes. This finding is in co-ordinance with the fact 
that the active VSG is highly transcribed in T. brucei. TbRAP1-mediated VSG 
silencing was found to be stronger in PF cells compared to that in the BF cells. In 
the future, it would be interesting to perform ChIP and compare the relative 
binding of TbRAP1 at VSGs in BF and PF cells. We hypothesize that; the amount 
of TbRAP1 bound to ES-telomeres in PF cells would be more compared to that in 
the BF cells. 
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CHAPTER IV 
 
ROLE OF TbRAP1 IN TELOMERE BIOLOGY 
 
 
 
INTRODUCTION 
 
     Chromosome ends need to be protected from being detected as double 
strand breaks from DNA damage repair machineries such as non-homologous 
end joining (NHEJ) and homology-directed repair (HDR). Telomeric proteins play 
a key role in the protection of the telomeres from being detected as DNA breaks 
and thereby preventing deleterious consequences. Another key role of telomere 
proteins is maintaining telomere length via regulating the access of telomerase to 
the telomeres. 
     ScRAP1 is known to regulate the telomere length (Conrad et al. 1990, Lustig 
et al. 1990, Kyrion et al. 1992, Liu et al. 1994, Marcand et al 1997). The 
temperature sensitive alleles of ScRAP1 with a C-terminal truncation had several 
phenotypes including dramatically elongated telomeres that are prone to rapid 
deletions (Kyrion et al. 1992). The C-terminal domain of ScRAP1 is known to 
interact with Rif1 and Rif2. Rif1 and Rif2, along with ScRAP1, contribute to 
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telomere length homeostasis (Hardy et al. 1992, Wotton and Shore, 1997).  The 
overexpression of ScRAP1 also led to reduced chromosome stability (Conrad et 
al. 1990). A “protein counting” model has been proposed in budding yeast, where 
a threshold number of RAP1 molecules bound to the telomere, prevents its 
further elongation by inhibiting the telomerase (Marcand et al. 1997). Mutation of 
SpRAP1 in fission yeast leads to telomere elongation (Kanoh and Ishikawa 
2001). It also regulates telomeric clustering since upon its mutation very few 
telomeres cluster towards the spindle pole body at the horsetail stage (Kanoh 
and Ishikawa 2001). Overexpressing hRAP1 or its domain-deletion mutation in 
telomerase positive cell lines leads to telomere elongation, suggesting that like its 
yeast homologs, hRAP1, also regulates telomere length (Li and De Lange 2000, 
Li and De Lange 2003). Thus, it is evident that in budding yeast, fission yeast, 
and humans, RAP1 has an important function in telomere length regulation. 
     The depletion of RAP1 also leads to the activation of various DNA damage 
repair pathways in yeast and human. The conditional knock-out of ScRAP1 
resulted in telomere fusions which were mediated by the NHEJ pathway (Pardo 
and Marcand 2005). The C-terminal truncation of ScRAP1 culminated in rapid 
chromosome loss and elevated rates of chromosome nondisjunction (Kyrion et 
al. 1992). In budding yeast, non-dividing cells depend on yKu and RAP1 for 
telomere capping. G0 cells lacking RAP1 had telomere degradations , suggesting 
that RAP1 prevents nuclease activities at telomeres in resting cells (Momchil et 
al. 2010). Surprisingly, compared to the shorter telomeres, little or no DNA 
damage response was elicited at long telomeres having multiple RAP1-binding 
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sites upon induction of double strand breaks, suggesting that yeast RAP1 plays a 
role in telomere end concealment (Negrini et al. 2007). In Kluyveromyces lactis 
disruption of RAP1 binding by altering telomeric sequences results in elevated 
telomere recombination leading to the formation of t-circles (free circular 
telomeric DNA molecules) (Cesare et al. 2008). hRAP1 was also implicated in  
preventing NHEJ, as RAP1 artificially tethered to telomeres was able to inhibit 
telomere end fusions (Bae et al. 2007, Sarthy et al. 2009). Additional evidence 
came from in vitro analysis using telomeric oligos; the results showed that 
TRF2/RAP1 prevented ligase IV dependent end joining (Bombarde et al. 2010). 
In contrast, mouse RAP1 was implicated in preventing homology directed repair 
and was not required for preventing telomere fusions (Sfeir et al. 2010, Martinez 
et al. 2010). These results were confirmed using two independent approaches, 
where either the RAP1 gene was deleted or by using a TRF2 mutant allele that 
fails to recruit RAP1 to telomeres (Sfeir et al. 2010, Martinez et al. 2010). 
Regardless of the observed differences, it is evident that RAP1 is required for 
preventing activation of the DNA damage repair pathways at the telomere.  
     TbRAP1 was identified as a TbTRF interacting factor and was confirmed to be 
an intrinsic telomeric factor (Yang et al. 2009). A role of TbRAP1 in the 
transcriptional gene silencing was identified. However, not much is known about 
the function of TbRAP1 in telomere end protection. The lack of recognizable 
homologues of DNA ligase IV in T. brucei suggested that NHEJ is either absent 
or diverged (Burton et al. 2007). However, repair through homologous 
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recombination have been identified and studied in T. brucei (Alsford and Horn 
2007, Barnes and McCulloch 2007, Glover et al. 2008, Glover et al 2010).  
     Recent work from our lab found that TbRAP1 depletion in BF cells leads to an 
elevated rate of VSG switching through gene conversion mechanism 
(recombination based mechanism) (Nanavaty and Li, unpublished data). This 
finding suggests that TbRAP1 has a role in preventing telomere recombination. 
Unlike its yeast homologs, the depletion of TbRAP1 did not affect telomere length 
dramatically in BF cells within two days (Li, unpublished data). However, a 
decrease in the telomere G-overhang (single-stranded 3’ overhang at the end of 
telomeres) signal was obtained after the knockdown of TbRAP1 in BF cells, 
suggesting that it is required for protecting the G-overhang structure. The 
characterization of the role of TbRAP1 in the telomere terminal structure at the 
PF stage is lacking. Also, it is not clear whether TbRAP1 carries out all of these 
functions via direct DNA binding. Hence, we wanted to test whether TbRAP1 has 
any DNA binding activity and whether it plays any role in telomere end protection 
in PF T. brucei cells. 
RESULTS 
The DNA-binding activity of TbRAP1 
     It is not known whether TbRAP1 can directly bind to the telomeric DNA in T. 
brucei, similar to ScRAP1. In order to test this possibility, electrophoretic mobility 
shift assay (EMSA) was performed. The TbRAP1 gene with a Kozak sequence 
was cloned into the pBlueScript vector driven by a T3 promoter. The TbRAP1 
protein was obtained by performing in vitro transcription (mMESSAGE 
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mMACHINE® T3 transcription kit, Thermo Fisher Scientific Inc.) and translation 
(TNT® T7/T3 Coupled Reticulocyte Lysate System, Promega). GST-TbTRF 
purified from E. coli was used as a positive control (Li et al. 2005). 
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Figure 4-1: EMSA to test DNA-binding activity of TbRAP1. (A) TbRAP1 was 
obtained by performing in vitro transcription and translation. The left panel shows 
EtBr-stained RNA gel.  A band of precise 2.6 kb for the TbRAP1 transcript was 
obtained. The right panel shows a polyacrylamide gel with S35  labeled TbRAP1 
protein obtained by in vitro translation. (B) An EMSA assay was performed using 
GST-TbTRF, TbRAP1 (lysate containing translated protein) and no mRNA 
(lysate without TbRAP1). P32 labeled (TTAGGG)12 probe was used. The 
competitor used was nonradioactive (TTAGGG)5 probe. 100 ng of GST-TbTRF 
was used. 2 µl and 5 µl of lysate with (labeled as TbRAP1) or without TbRAP1 
(labeled as no mRNA) protein were used. 3.45 µg of competitor was used. 
Asterisks indicate the free probe. 
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     In vitro transcription was performed to obtain TbRAP1 mRNA, as seen in 
figure 4-1 A. After confirming the correct size, mRNA was purified and further 
used for in vitro translation. Translation was performed in the presence of 
radioactive S35 to confirm successful translation of TbRAP1. The translated 
product was seperated on a polyacrylamide gel, which was dried and exposed to 
a phosphorimager screen. A faint band of ~150 kDa corresponding to TbRAP1 
was obtained, indicating that TbRAP1 was not translated at a very abundant 
level. We further used the translation product for EMSA. No mRNA sample was 
used as a control. S35 was also added to no mRNA sample for better comparison. 
A recombinant partially purified GST-TbTRF is known to directly bind TTAGGG 
repeats in vitro and was used as a positive control (Li et al. 2005). As previously 
published, GST-TbTRF binds the duplex TTAGGG repeat (figure 4-1 B lane 2), 
and the GST-TbTRF/telomere DNA complex can be competed by adding non-
radioactive TTAGGG duplex DNA probe, indicating that the binding is specific 
(figure 4-1 B lane 3). Mixing in vitro translated TbRAP1 with the duplex telomere 
DNA probe resulted in several bands on the polyacrylamide gel (figure 4-1 B lane 
4 and 5 depicted by solid black dot). However, these bands did not disappear 
upon adding cold competitors (figure 4-1 B lane 6 and 7), suggesting that the 
observed bands my not be complexes formed specifically between TbRAP1 and 
the double stranded TTAGGG repeats. Since in vitro translated TbRAP1 is 
radiolabeled, it is possible that one observed band in the polyacrylamide gel was 
free TbRAP1 protein. Hence, we decided to perform another binding assay by 
using unlabeled TbRAP1 protein. 
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Figure 4-2: EMSA by using unlabeled TbRAP1 protein. (A) EMSA was performed 
by using GST-TbTRF, unlabeled TbRAP1 and unlabeled empty mRNA. P32 
labeled (TTAGGG)12 probe was used to test the binding. The competitor used 
was nonradioactive (TTAGGG)5 probe. 100 ng GST-TbTRF was used. 5 µl of 
lysate with (labeled as TbRAP1) or without TbRAP1 (labeled as no mRNA) 
protein was used. 3.45 µg of competitor was used. (B) EMSA was performed 
using S35 labeled TbRAP1 or no mRNA sample. The bold arrow represents free 
radiolabeled TbRAP1 protein. 
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     Using unlabeled or labeled TbRAP1 containing lysate, EMSA was performed. 
As seen in figure 4-2 A, a shift was observed for GST-TbTRF that was competed 
out using competitor, thus suggesting specific binding of TbTRF to TTAGGG 
repeats. Interestingly, we did not observe the shifted bands on gel upon using 
unlabeled TbRAP1 protein, which we previously observed. However, a smear 
was seen on the gel probably due to interference from the lysate (which is known 
to contain huge amount of globin proteins). Interestingly, the bands reappeared 
on the gel when EMSA was performed using radiolabeled TbRAP1 (figure 4-2 B, 
bold arrow). This suggests that, the bands observed on the gel were due to free 
radiolabeled TbRAP1 protein. Thus it seems that TbRAP1 does not possess 
DNA binding activity. However, due to interference of lysate with free probe 
migration and due to very low levels of TbRAP1 translation, it is difficult to reach 
any clear conclusions at this point.  
TbRAP1 and telomere length regulation  
     In BF cells, it is known that the telomere length is not affected upon TbRAP1 
depletion within two days. Southern blot analysis was performed to determine if 
TbRAP1 plays any role in telomere length regulation in PF cells. Genomic DNA 
was collected before and after depletion of TbRAP1 and digested with the 
frequent DNA cutters, AluI and MboI. After digestion, chromosome internal 
genomic DNA was digested into small fragments leaving only the telomeric tracts 
intact. The digested genomic DNA was then separated on an agarose gel where 
most chromosome internal DNA fragments were run off the gel. The larger sized 
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telomeric DNA fragments were subsequently blotted onto a nylon membrane 
followed by hybridization with a telomere specific probe.  
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Figure 4-3: Telomere Southern blot in PRi-pool cells. Protocol for performing the 
telomere Southern blot is described on the left. On the right the result of 
hybridization with a telomere specific probe is shown. Genomic DNA was 
collected before (day 0) and after (day 2 and 3) depletion of TbRAP1 in PRi-pool 
cells (PF cells). The parent cell line not carrying the RNAi vector was used as a 
control.  
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     As seen from figure 4-3, no change in the telomere length was observed upon 
depleting TbRAP1 in PF cells within 3 days. The telomere length in T. brucei 
ranges from 2-12 kb. Telomere fragments of 3 kb to more than 12kb were 
observed for PRi-pool cells when the bulk telomeres were detected by a 
TTAGGG repeat probe. No apparent change in size of the telomere fragments 
was observed, indicating that TbRAP1 depletion does not affect telomere length 
in PF cells. However, if TbRAP1’s effect on telomere length is subtle then it will 
be hard to capture in the bulk telomere Southern blot. Hence, we decided to 
follow a single telomere and analyze its length before and after depletion of 
TbRAP1, by performing terminal restriction fragment (TRF) analysis. T. brucei 
telomeres are marked with unique VSG genes at subtelomeric loci, which allows 
us to measure length change at individual telomeres. Genomic DNA was 
digested with restriction enzymes that cut specifically upstream of a particular 
VSG gene, releasing a terminal restriction fragment containing the VSG gene 
and its downstream telomere. This TRF can be visualized on a Southern blot by 
hybridization with the VSG specific probe. 
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Figure 4-4: Terminal restriction fragment analysis to measure telomere length in 
PRi-pool cells. Genomic DNA was collected before (day 0) and after (day 2 and 
3) depletion of TbRAP1 and digested with EcoRI. Southern blot analysis was 
performed and blots were hybridized with (A) VSG2 and (B) VSG9 specific 
probes. Left panel shows EtBr-stained gel, while right panel shows the hybridized 
Southern blot. Arrowheads indicate telomeric fragments containing VSG2 and 
VSG9. 
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     Two VSG-marked telomeres were tested. As seen in figure 4-4 A, the size of 
the VSG2 TRF remained unchanged, suggesting that the telomere length is not 
affected upon depletion of TbRAP1 within a short frame of time. Similar analysis 
was done for telomere associated with VSG9. Unlike VSG2, which is a single 
copy gene, VSG9 have two copies in the genome and two DNA bands were 
observed on the gel. Although the loading of genomic DNA was unequal between 
different samples (figure 4-4 B left panel), no change in the size of the VSG9-
containing fragments was observed (arrowheads in figure 4-4 B right panel). We 
also tested the VSG11-marked telomere and similar results were obtained (data 
not shown). Thus from the bulk telomere southern blot (figure 4-3) and terminal 
restriction fragment analysis (figure 4-4) it was evident that TbRAP1 does not 
affect telomere size in PF cells within three days. 
G-overhang structure analysis 
     Since telomere length was not affected upon depletion of TbRAP1, we wanted 
to test whether the telomere G-overhang structure is affected. T. brucei 
telomeres end in a 3’ overhang (containing TG repeats). The telomere complex 
protects the G- overhang in mammals (de Lange 2005).  
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Figure 4-5: In-gel hybridization analysis of the telomere G-overhang in PRi-pool 
cells. (A) DNA plugs were prepared before (day 0) and after (day 2 and 3) 
depletion of TbRAP1. Plugs were also prepared from the parent cell line  without 
any RNAi construct. Intact chromosomes were separated by pulsed filed gel 
electrophoresis as seen in EtBr-stained gel (left panel). The gel was dried and 
hybridized with an end-labeled (CCCTAA)4 oligo probe either before (middle 
panel) or after (right panel) denaturation of the gel. Arrowheads indicate the 
signal from the minichromosomes. (B) An average of quantification of the G-
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overhang signal calculated from two independent experiments. The relative G-
overhang signal was calculated for either day 2 or day 3 by dividing their signals 
to that of the day 0 signal. 
      
     DNA plugs were prepared from induced and uninduced PRi-pool cells. A 
parent cell line devoid of any RNAi construct was used as a control. Intact 
chromosomes were separated using Pulse Field Gel Electrophoresis (PFGE). 
The T. brucei genome consists of ~100 minichromosomes. Under our 
electrophoresis conditions, they all migrate at the same position. The telomere G-
overhang signal is therefore most prominent at minichromosomes and is used for 
calculation (arrowheads in figure 4-5 A). To detect the G-overhang signal, the 
native gel was first hybridized with the (CCCTAA)4 probe and the signal was 
quantified (figure 4-5 A middle panel). The same gel was subsequently 
denatured and hybridized with the same probe and the signal quantified again 
(figure 4-5 A right panel). The G-overhang signal is therefore calculated by 
dividing the amount of the native hybridization signal by that of the hybridization 
signal after denaturation. After obtaining the G-overhang signal for each sample, 
relative G-overhang levels were calculated by dividing values of day 2 and day 3 
with the value of day 0. As seen in figure 4-5 B, a 20% reduction in G-overhang 
signal was seen by day 2 upon inducing RNAi against TbRAP1. By day 3, only 
~30% of the G-overhang signal was left. Thus, we concluded that TbRAP1 is 
required for protecting the telomere G-overhang structure in PF cells. 
DISCUSSION 
     EMSA analysis suggested that TbRAP1 does not bind to the telomeric DNA 
directly. However, the experiment encountered certain technical difficulties. The 
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Rabbit Reticulocyte Lysate system used for translation contains a huge amount 
of globin protein. These proteins present in the binding reaction interfered with 
the migration of the probe, making it difficult to interpret the results. Also, the in 
vitro translated TbRAP1 was in a very low amount. In the future, translation can 
be done using a baculovirus expression system to obtain higher amounts of 
translated protein. The full length GST-TbRAP1 is not soluble when expressed in 
E. coli. Instead of full-length recombinant protein, only the C-terminal half of 
TbRAP1 can be expressed in E. coli with reasonable solubility. We are currently 
working on solving the NMR structures of TbRAP1 myb and myb-like domains in 
collaboration with Dr. Yanxiang Zhao at Hong Kong Polytechnic University. This 
will help reveal whether TbRAP1 has any sequence-specific DNA binding 
activities. 
     Telomere length seems to be unaffected upon depleting TbRAP1 in PF cells, 
at least within a short frame of time. TbRAP1 knockdown leads to growth arrest 
within 72 hours in the PF cells and within 24 hours in the BF cells. The decrease 
in telomere size due to the absence of telomerase activity is 3-6 bp/population 
doubling (Dreesen et al. 2005). It is possible that we do not observe telomere 
length change due to a limited time window before the cells arrest upon TbRAP1 
depletion. In the future, viable point mutants of TbRAP1 can be used to further 
analyze its role in telomere length maintenance. Overexpression of hRAP1 led to 
telomere elongation (Li and De Lange 2000, Li and De Lange 2003). TbRAP1 
can presumably be overexpressed in order to study its role in telomere 
maintenance, although attempted overexpression of TbRAP1 led to massive 
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degradation of the ectopic TbRAP1 allele (data not shown). If TbRAP1 does not 
have any telomere DNA binding activity, it will depend on TbTRF to be recruited 
to the telomere. Establishing TbTRF mutants with weakened interaction with 
TbRAP1 (described in chapter V) can also be helpful in elucidating TbRAP1’s 
function in telomere length regulation. 
     TbRAP1 depletion affects G-overhang structure in PF cells. A 70% loss of G-
overhang signal was observed by day 3 of TbRAP1 RNAi induction, suggesting 
that TbRAP1 is required for the chromosomal end protection. Deprotection of 
telomeres in mammalian cells leads to DNA damage responses and results in 
activation of ATM/p53 dependent apoptosis or senescence-like cell cycle arrest 
(Van steensel et al. 1998, Karlseder et al. 1999, Takai et al. 2003). Since we 
observed growth arrest upon TbRAP1 depletion, it is possible that this 
deprotection at telomeres (loss of G-overhang) might elicit a DNA damage 
response. 
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CHAPTER V 
 
FUNCTIONAL ANALYSIS OF TbTRF  
 
 
 
INTRODUCTION 
 
TbTRF functions in telomere end protection 
 
     TbTRF (Tb10.389.0680) was identified as a component of the telomere 
complex, and it directly binds to the telomeric DNA in T. brucei (Li et al. 2005). 
TbTRF is an essential protein, and cells stop proliferating after TbTRF depletion 
within 24 (in BF cells) or 48 hours (in PF cells). TbTRF depletion in T. brucei did 
not affect ES-linked VSG si lencing (Yang et al. 2009, Pandya et al. 2013). 
However, TbTRF is required for the protection of the telomere G-overhang 
structure (Li et al. 2005). Due to this acute growth arrest upon knockdown of 
TbTRF, it is difficult to define all of the functions of TbTRF at the telomere. 
Hence, identification of viable mutants of TbTRF would be very useful for 
characterization of all its roles at telomeres.  
     TbTRF contains a C-terminal myb domain that is required for DNA binding 
and a TRF homology (TRFH) domain towards the N-terminus that is essential for 
homodimerization (Li et al. 2005).                                             .     
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The TbTRFH domain also interacts with TbRAP1 (Yang et al. 2009) and TbTIF2 
(Jehi et al. 2014), suggesting its role in recruitment of other telomeric proteins. 
Hence, the TbTRFH domain is critical for several functions at the telomeres. 
     Similarly, in mammalian cells, TRF1 forms a homodimer via its TRFH domain 
and binds to telomere DNA through its C-terminal myb domain (Bianchi et al. 
1997). The TRFH domain of TRF1 is required for recruiting another telomere 
protein, TIN2, to the telomeres (Kim et al. 1999, Houghtalin et al. 2004). It was 
discovered that the TRFH domain of TRF1 is not only required for protein-protein 
interaction and for recruitment of telomere proteins, but it is also required for 
stabilizing the telomere structure. Disruption of this domain led to an abnormal 
telomere structure, such as broken or lost telomeres (Okamoto and Shinkai 
2009). We are, therefore, interested in obtaining viable mutants of TbTRFH 
domain that would allow us to dissect its role in protein-protein interaction as well 
as its function in maintaining telomere structure integrity. 
      Dr. Bibo Li predicted the secondary structure of TbTRFH domain by using 
PHD (service to predict the secondary structure of protein based on the 
sequence information) and 3D-PSSM (software to predict the 3D structure of a 
protein by matching it with existing database of available 3D structures of other 
proteins). It was predicted that TbTRFH contains seven α-helices. This is very 
similar to the secondary structure of mammalian TRFH domain of TRF1 and 
TRF2, which consists of 9 α-helices (Fairall et al. 2001). 
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 Figure 5-1: The domain structure of TbTRF. TbTRF contains two domains: (i) a 
TbTRFH (homodimerization) domain and (ii) a myb domain (DNA binding 
domain). Software prediction suggested that the TbTRFH domain consists of 
seven helices. The amino acid sequence of the TRFH domain is marked in 
orange. The seven predicted helices are marked in blue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 122 
     Deleting large fragments of the TbTRFH domain can lead to abrogation of its 
homodimerization function, which is essential for the TbTRF’s telomere DNA 
binding activity; normally, at least two myb repeats are required for DNA 
recognition. Hence, we decided to perform subtle mutations by disrupting 
individual helices to study the effects of mutants on TbTRF homodimerization 
and protein-protein interaction. Our goal was to identify mutants that cannot 
interact with the wild type TbTRF or other telomere proteins but can form 
homodimers. Such mutants, when expressed in vivo, will be able to bind 
telomeric DNA but will probably be defective in other protein-protein interactions. 
This will give us information regarding functions of TbTRF in telomere protein 
complex formation. 
Roles of TRF in chromatin modulation  
     Apart from its role in telomere end protection, there has been evidence that  
TRF also plays an important role in chromatin compaction and remodeling. The 
overexpression of TRF2 in mice led to decreased heterochromatin marks at 
telomeres and subtelomeres, a decrease in abundance of core nucleosomes, 
and an increase in nucleosomal spacing at the telomeres (Benetti et al. 2008, 
Galati  et al. 2012). In another instance, an in vitro biophysical analysis of TRF2 
and telomeric nucleosome fibers determined that TRF2 could promote folding of 
these fibers and also increase their compaction, thus suggesting its role in 
chromatin remodeling (Baker et al. 2009, Baker et al. 2011, Poulet et al. 2012). 
Interestingly, in vitro analysis suggested that TRF1 can form a ternary complex 
with the telomeric DNA bound nucleosomes and can alter its structure, 
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suggesting that TRF1 can modulate chromatin structure at telomeres (Galati et 
al. 2006). Also, it is known that TRF2 interacts with TERRA (telomeric transcript), 
which further facilitates ORC recruitment and heterochromatin formation at 
telomeres (Deng et al. 2009). Thus, it is evident that along with RAP1, TRF also 
plays a role in chromatin modulation at telomeres.  
      Knockdown of TbTRF does not lead to ES-linked VSG derepression (Li et al. 
2005). However, it is possible that TbTRF may play a secondary role in VSG 
silencing by inducing chromatin compaction. Our goal was to test whether TbTRF 
possess any chromatin remodeling activity at T. brucei telomeres. 
 
RESULTS 
Establishing TbTRFH domain mutants 
     We wanted to identify interaction-deficient mutants by performing yeast 2-
hybrid analysis. The TbTRF gene containing a single helix (in TbTRFH domain) 
deleted at a time was amplified and cloned in the lexA vector. 
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Figure 5-2: Strategy of making TbTRFH deletion mutants. pBTM116 (LexA) 
vector containing wild type TbTRF was used for PCR amplification (top). Mutants 
with individual helices deleted were cloned in pBTM116 vector (bottom). H 
represents HindIII sites. Black bar represents PCR products generated for each 
helix. 
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     As shown in figure 5-2, fragments upstream and downstream of the helix to 
be deleted were generated using PCR amplification. Both fragments were then 
simultaneously ligated into vector to obtain LexA-fused mutant TbTRF. Thus the 
TbTRF gene was obtained containing a single helix deleted in the TbTRFH 
domain. This protocol was repeated for each helix.  
 
Analyzing TbTRFH mutant interactions 
     All the mutants were further transformed in the yeast L40 reporter strain along 
with the wild-type GAD-fused TbTRF protein. After transformation, a liquid ONPG 
assay was performed to test interactions between mutants with wild-type TbTRF 
protein. β-galactosidase activity were measured in order to estimate the lacZ 
reporter gene expression level. Interaction of wild type LexA-fused TbTRF with 
GAD-fused TbTRF was used as a positive control while the interaction between 
two empty vectors was used as a negative control. 
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Table 2: Interaction of TbTRFH mutants with the wild-type TbTRF protein. β-
galactosidase activities were measured by performing liquid assay containing 
ONPG as the substrate. Values were calculated for interactions between each 
mutant and the wild type full-length TbTRF protein, as well as with the empty 
vector. Each value is calculated from nine independent experiments +/- standard 
deviations. LEX ABD, Lex A binding domain; GAD, Gal4 activation domain.  
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As seen in Table 2, deletion of helix 1, 2, 3, and 7 did not affect their interaction 
swith the wild type TbTRF protein, suggesting that these helices are not required 
for homodimerization of TbTRF. Deletion of helix 4, 5, and 6 affected interaction 
with the wild type TbTRF to different degrees. Helix 5 deletion seems to have 
weakened interaction with TbTRF compared to full-length protein. Expression of 
helix 4 deletion mutant was decreased compared to other mutants and hence 
that could possibly lead to a dramatically decreased interaction with the wild type 
TbTRF (data not shown). 
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Table 3: TbTRFH mutant-mutant self-interaction. β-galactosidase activity units 
were measured by performing liquid assay containing ONPG as the substrate. 
Values were calculated for interaction of each mutant with itself as well as with 
the empty vector. Each value is calculated from nine independent experiments 
+/- standard deviations. LEX ABD, Lex A binding domain; GAD, Gal4 activation 
domain. 
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     Next, we wanted to test mutant-mutant self-interaction. Each TbTRF mutant 
was amplified from the pBTM116 vector using primers having BamHI and XhoI 
restriction sites and cloned into the pACT2 (GAD-fused) vector. Hence, we 
obtained each mutant fused with LexA and GAD. These mutants were co-
transformed in the L40 yeast strain. Liquid ONPG assay was performed to test 
their interaction. Interaction of LexA-fused wild type TbTRF with GAD-fused wild 
type TbTRF was used as a positive control, while interaction between two empty 
vectors was used as a negative control. As seen in table 2, helix 4, 5, 6, and 7 
mutants had a significantly decreased self-interaction activity while helix 1, 2, and 
3 mutants were dispensable for self-interaction. Again, the loss of interaction 
observed for helix 4 could be due to its low expression level in yeast. From both 
yeast 2-hybrid experiments it is evident that helix 4, 5, 6, and 7 are required for 
homodimerization of TbTRF.  
Function of TbTRF in chromatin remodeling 
     Initially, it was established that depletion of TbTRF does not affect ES-linked 
VSG silencing in PF (unpublished data) and BF cells (Yang et al. 2009). From 
our studies, it is evident that TbRAP1 is a major regulator of VSG silencing and 
that it regulates this silencing via chromatin remodeling in PF forms. It is possible 
that TbTRF may also play an important role in VSG silencing. However, due to 
acute growth arrest upon its depletion the phenotype might not be evident. 
Mammalian TRF1 and TRF2 possess the ability to compact telomeric chromatin 
and form higher order chromatin structure. Hence, it was logical to test TbTRF’s 
function in chromatin modulation. In order to investigate this, FAIRE analysis was 
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performed in TbTRF RNAi cells in PF and BF cells. By performing quantitative 
PCR using specific primers, changes in chromatin structure of ES-linked VSGs 
were determined. 
 
 
Figure 5-3: FAIRE analysis in TbTRF RNAi cells. FAIRE was performed in (A) 
PF/TbTRF RNAi cells, (B) PF/Vector control cells, (C) BF/TbTRF RNAi cells and 
(D) BF/Vector control cells. Samples were collected before (0 hr in PF and BF 
cells) and after (48 hr in PF and 24 hr in BF cells) depletion of TbTRF. 
Quantitative PCR was done using primers specific to indicated gene loci. Fold 
change was calculated from four independent experiments and standard 
deviation was calculated. Control genes are indicated with the last four digits of 
their ID. Tb927.2.2430, Tb927.2.2440, Tb09.211.1510.  
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     Upon depletion of TbTRF in PF cell, a 5-7 fold of increased enrichment of ES-
linked VSGs (VSG 2, 14 and 18) was observed (figure 5-3 A). This difference 
was significantly different than observed in the vector control cells (P<0.05, figure 
5-3 B). Enrichment of three chromosomal internal genes was also tested as a 
control. Increase in enrichment of VSG2 and VSG18 was significantly different 
from that of Tb927.2.2440 (P<0.05), suggesting that TbTRF has a mild but 
significant effect on the chromatin structure of the ES-linked VSGs. Also, 
changes observed at chromosome internal genes after depletion of TbTRF were 
significantly different compared to that in the vector control cells , indicating that 
TbTRF depletion might have a mild effect on global chromatin structure (figure 5-
3 A and B). 
     Strikingly, depletion of TbTRF had no effect on chromatin structure of ES-
linked VSGs in BF cells. The increase in enrichment after depletion of TbTRF in 
BF cells was not significantly different than that in the vector control cells (figure 
5-3 C and D). Thus, TbTRF only affects chromatin structure of ES-linked VSGs in 
PF cells but not in the BF cells. 
      We subsequently wanted to test whether TbTRF depletion had any effect on 
regulation of mVSGs. Derepression of mVSGs upon depletion of TbTRF in PF 
cells was tested before analyzing changes in chromatin structure. 
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Figure 5-4: Quantitative RT-PCR and FAIRE analysis of mVSGs in PF TbTRF 
RNAi cells. Fold change in steady state mRNA levels of mVSGs upon induction 
were tested in (A) PF/TbTRF RNAi cells and (B) PF/Vector cells. Samples were 
collected before (day 0) and after (day 2 and 3) adding doxycycline. Fold change 
in steady state mRNA levels for day 2 and 3 were calculated by normalizing 
against day 0 value (not shown). Values for three independent experiments are 
depicted. FAIRE analysis was performed to determine change in the chromatin 
structure of mVSGs in (C) PF/TbTRF RNAi cells and (D) PF/Vector cells. 
Samples were collected before (day 0) and after (day 2 for TbTRF RNAi, day 3 
for vector control) induction. Quantitative PCR was performed using specific 
primers for indicated loci in order to calculate the fold change. Fold change was 
calculated by dividing values obtained post depletion with that of the values 
obtained pre-depletion. Values were calculated from four independent 
experiments. Bar represents standard deviation. 
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     After depletion of TbTRF in PF cells, steady state levels of mVSGs mRNA 
were measured. No derepression of mVSGs was observed in PF/TbTRF RNAi 
cells compared to the vector control cells (figure 5 -4 A and B). Hence it is 
established from current studies and previously published data that TbTRF does 
not play a role in ES-linked VSG or mVSG silencing. However, derepression 
analysis of mVSGs upon depletion of TbTRF in BF form still remains to be 
tested. FAIRE analysis was performed to determine whether there are any 
changes in chromatin structure of mVSGs upon depletion of TbTRF in PF cells. 
Quantitative PCR was performed to measure relative enrichment of mVSG 
specific DNA after depletion of TbTRF. A 10-16 fold enrichment of mVSGs DNA 
was observed after knockdown of TbTRF in PF cells (figure 5-4 C). This 
enrichment was significantly different from the chromosome internal gene used 
as a control (Tb927.2.2440) as well as from the vector control cells (figure 5-4 D). 
Thus, TbTRF influences telomere/subtelomere chromatin structure and its 
depletion lead to opening up of the chromatin structure at ES-linked VSGs and 
mVSGs in PF cells. 
DISCUSSION 
     Due to acute growth arrest upon depletion of TbTRF, it was difficult to reveal 
all the functions of TbTRF, especially in telomere structure maintenance and 
protection. Therefore, establishing viable mutants of TbTRF was pivotal. TbTRFH 
domain is deemed to be important for its role in TbTRF self-dimerization as well 
as in interaction with other telomeric proteins, such as TbRAP1 and TbTIF2. Our 
goal was to establish several helix deletion mutants of TbTRFH domain that 
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would affect TbTRF homodimerization or its interaction with other telomere 
proteins. Seven deletion mutants were generated and their interaction with wild-
type TbTRF as well as self-interaction was tested in vitro by yeast 2-hybrid 
analysis. It was established that Helix 4, 5, 6, and 7 are important for 
homodimerization of TbTRF while helix 1, 2 and 3 are dispensable. These results 
were very exciting since it suggested that not all helices are required for TbTRF 
homodimerization and few may be utilized for interaction with other proteins. 
Yeast 2-hybrid analysis can be further performed to test interaction of TbTRFH 
mutants with TbRAP1 and TbTIF2 to determine which helices are involved in 
these interactions. It is possible that a similar set of helices might also interact 
with other telomeric proteins. If that is the case, then how does TbTRF regulate 
the formation of telomere complex? Do they compete with each other for binding 
at telomeres? These will be a few interesting questions to answer. If distinct 
helices are used for different interactions then separation of function mutants can 
be obtained. These mutants will be very valuable in elucidating role of TbTRF as 
well as other telomeric proteins in telomere end regulation. So far the mode of 
recruitment of TbRAP1 and TbTIF2 to the telomeres is unknown. Mutants 
defective in binding to TbRAP1 and TbTIF2 can be utilized to test their binding to 
telomeres. 
     Mutants that are able to self-dimerize can be knocked-in to replace the unique 
wild-type TbTRF allele in a TbTRF single-allele knockout background. As long as 
the mutants are capable of performing essential functions of TbTRF, the cells 
should be viable. These mutants can be further used to study the role of TbTRF 
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in recruiting other telomeric proteins and also its role in telomere structure 
maintenance.  
     Helix 4 deletion had a dramatic effect on expression of TbTRF protein in 
yeast. It is possible that its deletion could affect proper folding of TbTRF protein. 
Hence, point mutations can be made in this helix to study the role of helix 4 in 
homodimerization. Since helix 1, 2, and 3 are dispensable for the 
homodimerization of TbTRF, simultaneous deletions of more than one helix can 
also be made to further analyze critical functions of TbTRF. 
     Telomeric proteins are known to be involved in telomere heterochromatic 
structure formation/maintenance. Our aim was to determine whether TbTRF had 
any role in VSG silencing by chromatin compaction. TbTRF depletion does not 
lead to ES-linked VSG derepression in PF and BF cells (Yang et al. 2009). Our 
studies further established that TbTRF is not required for mVSG silencing in PF 
cells. Interestingly, depletion of TbTRF does affect chromatin structure of ES-
linked VSGs and mVSGs in PF cells. In contrast, similar to TbRAP1, no effect on 
chromatin structure was observed in BF cells after depletion of TbTRF. 
Monoallelic VSG expression is of crucial importance in BF cells. Hence, it is 
possible that additional mechanisms other than telomeric proteins may play 
important roles in VSG silencing. Elucidating these mechanisms can further shed 
light on chromatin structure differences in PF and BF cells.  
     TbTRF is a DNA binding protein. It seems that TbTRF holds the telomeric 
complex together and maintains its integrity. This observation explains the acute 
growth arrest observed upon its depletion compared to TbRAP1 (Yang et al. 
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2009, Pandya et al. 2013) and TbTIF2 (Jehi et al., 2014). For VSG derepression 
to occur, a certain level of functional transcriptional machinery is required. It is 
possible that the whole telomere complex may fall apart upon TbTRF depletion, 
stalling all the machineries in cell. In the future, domain mutants of TbTRF can be 
used to study its function in VSG regulation. 
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CHAPTER VI 
CHARACTERIZATION OF TRYPANOSOMA BRUCEI TELOMERIC 
TRANSCRIPT: TERRA 
 
 
INTRODUCTION 
     Telomeres were long considered transcriptionally si lent due to their repressive 
chromatin structure This dogma was overcome with the discovery of telomeric 
transcription called TERRA: telomeric repeat containing RNA. Telomere 
transcription was first identified in birds, trypanosomes, and diptera (Morcillo et 
al. 1988, Rudenko & Ploeg 1989, Solovei et al. 1994). Till this date TERRA has 
been identified in humans, rodents, budding yeast, fission yeast, and zebra fish 
(Azzalin et al. 2007, Luke et al. 2008, Schoeftner and Blasco 2008, Greenwood 
and Cooper 2011). 
     In mammals, TERRA is transcribed from the C-rich strand, giving rise to 
UUAGGG repeats with sizes ranging from 100 bp-9 kb (Azzalin et al. 2007). In 
trypanosomes TERRA is also transcribed from the C-rich strand ranging from 
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0.5-4 kb (Rudenko and ploeg 1989). In budding yeast its size is usually <500 bp. 
Along with TERRA, budding yeast also expresses molecules called ARRET that 
are antisense to the subtelomere and do not contain any detectable telomeric 
repeats (Luke et al. 2008). On the other hand, the transcriptome of fission yeast 
is much more complicated and contains multiple transcripts namely TERRA, 
ARRET, ARIA, and αARRET (Bah et al. 2012). 
     TERRA is transcribed by RNA polymerase II in humans, mouse, and budding 
yeast (Schoeftner and Blasco, 2008, Luke et al. 2008). In trypanosomes, 
however, it is established that TERRA transcription is not sensitive to α-amanitin, 
suggesting that it is transcribed by RNA polymerase I (Rudenko and Ploeg 
1989). A portion of TERRA is poly-adenylated in human, yeast, and 
trypanosomes (Rudenko and Ploeg 1989, Azzalin and Lingner 2008, Luke et al. 
2008). In humans, a CpG island consisting of “61-29-37” repeats located in the 
subtelomeric region is the promoter for TERRA transcription, and TERRA is 
found mostly in the nucleus co-localizing with telomeres  (Azzalin et al. 2007, 
Schoeftner and Blasco 2008, Nergadze et al. 2009).  
     Not only does TERRA co-localizes physically with telomeres, but also it 
interacts with telomeric proteins, such as TRF1, TRF2, and ORC subunits in vivo 
in mammalian cells. TERRA interaction with several heterochromatin associated 
factors including heterochromatin protein 1 (HP1) and H3K9 methyltransferases 
has also been established (Deng et al. 2009). Telomeric proteins are known to 
play a role in regulation of TERRA levels. In budding yeast, Rap1/Sir and 
Rap1/Rif complexes regulate TERRA transcription, and TERRA levels are 
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upregulated upon introducing Rap1 mutant that fai ls to recruit Sir proteins 
(Iglesias et al. 2011). In fission yeast, deletions of Taz1 or Rap1 lead to 
upregulation of TERRA transcription (Greenwood and Cooper 2011). Thus , it is 
clear that telomeric proteins are important in regulation of TERRA expression.  
     Functions of TERRA are not well characterized. Depletion of TERRA RNA 
using siRNA led to loss of cell viability and formation of telomere dysfunction 
induced foci (TIFs) in mammalian cells (Deng et al. 2009). Interestingly, depletion 
of TERRA also affected telomere heterochromatin with reduced recruitment of 
ORC and decreased amount of H3K9 trimethylation (Deng et al. 2009). This 
observation suggests that TERRA might have a role in regulating telomere 
heterochromatin. However, further studies are needed in order to rule out 
possible secondary effects from siRNA.  
     T. brucei telomeres are unique in terms of the presence of VSG genes at 
subtelomeres. From our studies with TbRAP1, we determined that de-repression 
of silent VSGs is linked to chromatin compaction. Thus, it is possible that TERRA 
may be involved in VSG silencing regulation via chromatin remodeling. This 
hypothesis makes TERRA an excellent candidate to study regulation of antigenic 
variation in T. brucei. Mammalian telomeres are gene-less, making them 
unsuitable for studying telomere position effect, while many T. brucei telomeres 
are marked with natural subtelomeric VSG genes. Hence, T. brucei is an 
excellent model system to study functions of TERRA in telomere position effect. 
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RESULTS  
Characterization of TERRA in wild-type PF and BF cells 
      TERRA has been previously detected in T. brucei BF and PF cells (Rudenko 
and Ploeg 1989). However data were shown only for PF cells. It was established 
that the C-rich telomeric strand is transcribed, giving rise to the UUAGGG repeat 
transcript and that this transcription is unidirectional, running 5’ to 3’ from 
chromosome internal region towards the telomere. However, T. brucei 
subtelomeric regions are quite plastic due to antigenic variation. The same strain 
used in the previous study has been cultured in vitro for a long period of time. It’s 
therefore possible that some detailed subtelomeric sequences have changed, 
which might lead to variations from previously reported data on TERRA. Hence, 
we decided to determine TERRA in wild-type BF (SM) and PF (WT427) cells. 
Northern blot analysis was performed to detect TERRA size distribution as well 
as the directionality of its transcription (Figure: 5-1 A). The northern blot was 
hybridized with either the radioactively labeled (*CCCTAA)133 or (*TTAGGG)133 
probe. 
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FIGURE 6-1: TERRA in wild-type T. brucei cells. (A) Directionality of TERRA 
transcription. The C-rich strand is transcribed when transcription proceeds from 
chromosome internal region towards the telomere, giving rise to UUAGGG 
transcript. However, if the transcription proceeds from telomere towards 
chromosome internal region, then the G-rich strand will be transcribed, giving rise 
to CCCUAA transcript. (B) Northern blot analysis to detect transcription from C-
rich strand in BF and PF cells. The northern blot was hybridized with 
radioactively labeled (*CCCTAA) 133 probe. Samples were treated with or without 
RNase A. Tubulin was used as internal loading control. (C) Northern blot analysis 
to detect transcription from G-rich strand in BF and PF cells. Northern blot was 
hybridized with radioactively labeled (*TTAGGG)133 probe. Samples were treated 
with or without RNase A. A rRNA was used as an internal loading control.* 
indicates radiolabeled nucleotide. 
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     Northern blot analysis detected TERRA molecules ranging from the 0.5 -10 kb 
in BF cells. However, in procyclic form, the size of TERRA molecules is between 
0.5-1.5 kb with a major band of ~1.5 kb long. Upon RNase A treatment, signals 
were lost in both BF and PF samples, indicating that the TERRA signal was 
contributed specifically from the RNA and was not due to DNA contamination. 
The majority of transcription in BF cells was detected when the blot was 
hybridized with the (*CCCTAA)133 probe, suggesting that TERRA transcription 
proceeds towards telomere ends giving rise to the UUAGGG transcript. 
Transcription detected from G-strand was almost negligible in BF cells. However, 
in PF TERRA was detected from both strands, suggesting that the nature of 
TERRA molecules might be different in BF and PF cells. More experiments will 
be required to analyze the nature of TERRA molecules in PF cells.  
Interaction of TERRA with telomeric proteins 
     Our lab has characterized the telomeric complex of T. brucei. So far, three 
telomeric proteins have been identified. TbTRF is a duplex TTAGGG repeat 
binding factor, while TbRAP1 and TbTIF2 were identified as TbTRF interacting 
factors. Since TERRA is transcribed from telomeres, we are curious whether 
TERRA interacts with any of the known telomeric proteins in T. brucei (Figure 6-
2). In addition, TbKU80 has been shown to play an important role in maintaining 
telomere length (Janzen et al. 2004), although its mechanism is unknown. It is 
possible that TbKU80 may interact with TERRA in order to regulate the telomere 
length. In order to test this we performed RNA-Immunoprecipitation (RNA-IP) 
assay. Various cell lines containing telomeric proteins tagged with either GFP or 
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F2H (Flag-HA-HA tag) tags were used for this purpose. Pull-down of telomeric 
proteins was performed using antibodies against either the GFP or HA epitope. 
Co-Immunoprecipitated RNA was detected by dot blot analysis by hybridization 
with telomere specific probes. 
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FIGURE 6-2: Interaction of TERRA with telomeric proteins. (A) Western analysis 
showing expression of various tagged telomeric proteins in BF cells. Levels of 
GFP-TbTRF and GFP-TbKU80 were detected using rabbit anti-GFP antibody 
(Life Technologies). A cell line expressing GFP alone was used as a negative 
control. F2H-TbRAP1 and F2H-TbTIF2 were detected using an antibody against 
the HA tag (F-7, Santa Cruz Biotechnology Inc.). The wild-type cell line, not 
expressing any F2H tag was utilized as negative control (BF WT). (B) RNA slot 
blot analysis to detect TERRA molecules co-immunoprecipitated with various 
telomeric proteins. Dynabeads IgG without any antibody was used as negative 
control. The blot was hybridized with radioactive labeled (*CCCTAA)133 probe. (C) 
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Quantification of RNA slot blot experiments. The average of enrichment of pull-
down sample over input (%) was calculated from three independent experiments.  
Error bars represent standard deviation. 
 
     GFP-TbTRF showed an ~14 fold enrichment of TERRA RNA compared to 
control (Fig. 6-2C), suggesting that TbTRF interacts with TERRA. Our preliminary 
data showed that TbKU80 might interact with TERRA (Fig. 6-2C). The fold 
enrichment observed is much less compared to that obtained for TbTRF, 
however, it is ~5 fold more compared to no antibody control. More experiments 
are needed to confirm whether this result is reproducible. F2H-TbRAP1 does not 
interact with TERRA, as the fold enrichment is almost similar to negative control 
(when IP using the HA antibody was done in wild-type cells carrying no F2H tag) 
(Fig. 6-2C). F2H-TbTIF2 IP showed elevated levels of TERRA enrichment that 
was not significantly different from the negative control due to large variations, 
suggesting that TbTIF2 does not interact with TERRA (Figure 6-2C). All the IP 
samples were treated with DNase I, suggesting that the signal obtained on slot 
blot is due to RNA. However, additional controls such as RNase A treatment 
before IP needs to be done. Based on our current preliminary observations, we 
conclude that TbTRF and TbKU80 interact with TERRA while TbRAP1 and 
TbTIF2 do not interact with TERRA RNA. 
Regulation of TERRA levels by telomeric proteins 
     TERRA expression is influenced by telomeric protein in yeast (Greenwood 
and Cooper 2011). We therefore wanted to test whether any of the known 
telomeric proteins in T. brucei plays any role in regulation of TERRA levels. We 
depleted individual telomeric proteins by RNAi in different inducible telomeric 
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protein RNAi strains. Upon induction of RNAi using doxycycline, knockdown of 
TbTRF, TbRAP1, and TbTIF2 was confirmed by western blotting. Imaan 
Benmerzouga performed TbTRF western blot analysis and Sanaa Jehi did 
TbTIF2 western blot analysis. Total RNA was isolated before and after depletion 
of individual telomeric protein. Northern blot analysis was performed using the 
(*CCCTAA)133 probe in order to detect changes in TERRA levels and sizes. Since 
TERRA molecules have a large size distribution and it is hard to estimate the 
total amount of TERRA from the northern blot, we also performed slot blot 
analysis to quantify changes in the TERRA levels. 
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FIGURE 6-3: Regulation of TERRA RNA level by telomeric proteins. (A) Western 
blot analysis to determine knockdown of TbRAP1, TbTRF, and TbTIF2 in BF 
cells. Whole cell lysate was collected before (0 hour) and after (24 hours for 
TbRAP1 and TbTRF, 30 hours for TbTIF2) (B) Northern blot analysis to detect 
levels and distribution of TERRA before and after depletion of TbRAP1, TbTRF 
and TbTIF2. Cells transfected with an empty RNAi vector was used as a negative 
control. RNA was collected before (-)  and after (+) doxycycline induction (24 
hours for TbRAP1 and TbTRF, 30 hours for TbTIF2. The blot was hybridzed with 
the (*CCCTAA)133 probe. rRNA precursors are shown as a loading control. (C) 
Slot blot analysis to quantify changes in TERRA level. The blot was hybridzed 
with the (*CCCTAA)133 probe. Hybridization to the tubulin probe was used as an 
internal loading control. (D) Quantification of slot blot analyses. Fold changes in 
TERRA amount was calculated by dividing post-induction TERRA signal intensity 
by pre-induction signal intensity. Standard deviations are shown as error bars. P 
values of unpaired t-tests were calculated compared to control cells from four 
independent experiments. 
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     Northern analysis was performed to compare the TERRA levels and 
distribution before and after depletion of TbRAP1, TbTRF, and TbTIF2. We 
observed that the steady state level of TERRA RNA increased upon depletion of 
all telomeric proteins compared to the control cells transfected with an empty 
RNAi vector (Fig. 6-3B). However, for TbTIF2, the effect was the same as in the 
control cells (Fig. 6-3B). No major changes in the size distribution of TERRA 
molecules were detected (Fig. 6-3B). In the slot blot analysis, RNA collected 
before and after depletion of telomeric proteins was blotted on the memb rane 
followed by hybridization with the (*CCCTAA)133 probe. Figure 6-3C shows 
increases in TERRA amount upon depletion of TbRAP1 and TbTRF, suggesting 
that both proteins play important roles in TERRA expression regulation. A mild 
increase in TERRA level was also seen upon depletion of TbTIF2 (Fig. 6-3C). 
However, quantification of signals obtained from slot blot analyses (Figure 6-3D) 
showed that TbTIF2’s effect on the steady state level of TERRA was not 
significantly different from the vector control cells  (P= 0.1974). In contrast, 
depletion of TbRAP1 and TbTRF showed significant increase in the steady state 
level of TERRA. TbRAP1 appeared to have more profound effect on TERRA 
levels (~10 fold) compared to TbTRF (~5 fold). This suggests that different 
telomeric proteins may contribute differently to TERRA expression regulation. 
Telomeres contributing to TERRA transcription 
     As previously described (Rudenko and ploeg 1989), transcription of TERRA 
RNA in T. brucei is not sensitive to α-amanitin treatment, indicating that unlike 
mammalian systems, TERRA in T. brucei is not transcribed by RNA polymerase 
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II but likely by RNA polymerase I. In T. brucei, the active VSG is transcribed 
exclusively from one of ~15 BESs located at subtelomeres by RNA polymerase I 
(Gunzl et al. 2003, Hertz-Fowler et al. 2008). Hence, it is possible that the 
majority of TERRA RNA might be transcribed as a result of read-through from the 
telomere transcribing the active VSG. T. brucei  has 11 pairs of megabase 
chromosomes carrying all essential genes, ~5 intermediate chromosomes, and 
~100 of minichromosomes carrying mostly repetitive sequences  (Weiden et al. 
1991, Zomerdijk et al. 1992, Alsford et al. 2001, Wickstead et al. 2004). There 
are ~250 telomeres in a T. brucei nucleus (Figure 6-4). 
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Figure 6-4: Total telomeres in a T. brucei nucleus. T. brucei consists of 11 pairs 
of megabase chromosomes and ~5 intermediate chromosomes. Among these 
~54 telomeres, 15-20 are known to carry the well-characterized BESs. However, 
for the rest of 35-40 telomeres no sequence information is available for the 
subtelomeric region. The rest of ~200 telomeres are on minichromosomes. Many 
of these telomeres carry a VSG gene at the subtelomeric region.  
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     Although minichromosomes carry a VSG gene at their subtelomeric region, it 
is known that no active transcription occurs on minichromosomes due to the lack 
of an upstream promoter. Hence, out of these ~250 telomeres only ~54 
telomeres have a possibility of active transcription at the subtelomeric region. 15-
20 telomeres on megabase and intermediate chromosomes carry a BES at their 
subtelomeric regions. Sequences of these BESs are well known, allowing their 
easy characterization. We can also easily differentiate telomeres marked with the 
active VSG from those with silent VSGs. However, for the rest of the 35-40 
telomeres on the megabase and intermediate chromosomes, no sequence 
information is available for the subtelomeric region. Due to lack of sequence 
information it is difficult to test whether any transcription occurs at these 
telomeres. We hypothesized that TERRA is transcribed from the telomere 
carrying the active VSG. In order to test this possibility, we collected total RNA 
from cells exclusively transcribing VSG2 and cells exclusively transcribing VSG6. 
RNA was reverse transcribed using a telomeric backward primer (5’ 
CCCTAACCCTAA 3’). This would lead to reverse transcription of all the TERRA 
containing transcripts since TERRA contains UUAGGG repeat sequences. After 
reverse transcription, PCR was performed using primers specific to  the active 
and silent VSGs and cDNA as the template (Figure 6-5 A &B). Although we do 
not know the structure of mature TERRA transcripts, we are aware that TERRA 
is transcribed from chromosome internal region towards the telomere. In addition, 
T. brucei genes are transcribed in a polycistronic fashion, so is the transcription 
of BESs. Hence we predict that we will be able to detect precursor and/or mature 
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TERRA molecules using primers specific to VSGs located immediately upstream 
of telomeres if TERRA is polycistronically transcribed with other genes in the 
BES by RNA polymerase I. In addition, we predict that only primers specific to 
the active VSG can amplify the RT product but not primers specific to silent 
VSGs, if only the active BES transcription contributes significantly to TERRA 
expression.  
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Figure 6-5: TERRA transcription from an active ES. (A) cDNA and gDNA 
(genomic DNA) was obtained from BF cells exclusively expressing VSG2 and 
from PF cells where no VSG is expressed. PCR was performed using primers 
specific for VSG2 and VSG6. (B) cDNA and gDNA (genomic DNA) was obtained 
 155 
from BF cells expressing exclusively VSG6 and from PF cells. PCR was 
performed using primers specific for VSG2 and VSG6. 
 
     As seen from figure 6-5A, a PCR product was obtained using VSG2 primers 
when cDNA obtained from BF cells expressing VSG2 was used as the template. 
VSGV6 is silent in these cells. No product was obtained using VSG6 primers 
when the same cDNA was used as the template. PF cells do not express any 
VSGs. No PCR product was obtained using either VSG2 or VSG6 primers when 
cDNA prepared from PF cells was used as the template. Genomic DNA from 
either BF or PF cells gave amplification products when both VSG primers were 
used, indicating that lack of PCR product in the reactions using cDNA as the 
template was not due to loss of either VSG gene. Similarly, in figure 6-5B, a PCR 
product was obtained using VSG6 primers when cDNA obtained from BF cells 
expressing VSG6 was used as the template. No product was obtained using 
primers specific to the silent VSG2. CDNA obtained from PF cells did not give 
any amplification using either VSG6 or VSG2 primers. However, products were 
obtained when genomic DNA was used as a template, indicating that both VSG 
genes were present in these BF and PF cells. These results suggest that a 
significant amount of TERRA RNA is transcribed from the telomere with the 
active VSG in BF cells. On the other hand, in PF cells TERRA RNA appears not 
transcribed from any of the BES marked telomeres. It is possible that in PF cells 
TERRA might be transcribed from other telomeres whose sequence information 
is not avai lable. In the future, sequencing of TERRA RNA from PF cells can be 
carried out to help a better understanding of its transcription. 
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TERRA RNA in BF cells is transcribed form the telomere carrying the active 
VSG 
     We found that transcription of the active BES contributes significantly to 
TERRA expression in BF cells (Fig. 6-5). To confirm this discovery, we used an 
alternative independent approach. It is known that the active VSG marked 
telomere undergoes frequent truncations, possibly due to its highly transcribed 
status (Bernards et al. 1983). In addition, in the absence of telomerase, the 
active VSG marked telomere is not elongated after each truncation, resulting in 
this telomere being shortened within a short period time (Dressen and Cross 
2006). We decided to take advantage of this notion and obtained a telomerase 
null clone where most telomeres sti ll have similar sizes as those in WT cells but 
the active VSG marked telomere is less than 1 kb long (Fig. 6-6). We 
hypothesized that TERRA RNA size distribution will be affected when the active 
telomere is much shorter than other telomeres if the majority of TERRA is 
transcribed from the active telomere. We also expected to detect a TERRA 
transcript of precise size (in contrast to a smear) in these cells if the mature 
TERRA molecules are processed at defined positions since the active telomere 
has a precise size in these clonal cells. 
     Ranjodh Sandhu in our lab did limiting dilution of BF TbTRDKO cells 
(telomerase RNA null cells) and obtained a clone with extremely short active 
VSG2-marked telomere. Specifically, cells were plated at the density of 1 
cell/well. After reaching an appropriate concentration, cells were harvested, and 
Southern blot analysis was performed to determine the size of  the VSG2-marked 
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telomere (Fig. 6-6). The clone with the shortest active telomere was used for 
subsequent studies. It is important to note that this clone was obtained within a 
short range of time (~15 weeks), a time during which except for the active 
telomere, the majority of the bulk telomeres were still long and have similar sizes 
to wild-type telomeres. The parent BF TbTRDKO cells were also cultured for ~2 
weeks, a time during which all the telomeres are long and were used as a control 
to exclude any possible effect of TbTR deletion on TERRA. 
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Figure 6-6: Establishing TbTRDKO cells with short active ES-marked telomere. 
(A) Schematic representation of TbTRDKO cell lines on the left. A freshly 
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obtained clone of TbTRDKO (~2 weeks BF TbTRDKO) had telomeres of same 
sizes as those in wild-type BF cells (WT BF). After limiting dilution, a clonal 
population was obtained that has a very short active VSG-marked telomere 
(within 15 weeks), with the rest of the bulk telomeres still long. (B) Southern blot 
analysis to determine bulk telomere length in all cell lines. Left panel shows the 
Ethidium Brimide (EtBr) staining of the agarose gel before hybridization. Right 
panel shows hybridization results with telomere specific probe. (C) Southern blot 
analysis to determine the size of the active VSG2-marked telomere all cell lines. 
VSG2 BES has an EcoRI site upstream of the VSG2 gene. Upon digestion with 
EcoRI, a terminal restriction fragment is obtained from which the telomere length 
can be calculated. The Southern blot was hybridized with a VSG2 specific probe. 
 
     As seen from figure 6-6B, wild-type cells and TbTRDKO (~2 weeks) cells 
have telomeres of comparable sizes. The short time cultured (~15 weeks) clone 
obtained after limiting dilution has only a mild telomere shortening phenotype 
with the sizes of bulk telomeres ranging from ~2 to 12 kb and still similar to those 
in wild-type cells. Southern blot analysis using the VSG2 probe showed that wild-
type and TbTRDKO cells cultured for 2 weeks have terminal VSG2 restriction 
fragments of ~12 kb (figure 6-6C). This indicates that in both of these cell lines 
the telomere adjacent to VSG2 is long and more than 10 kb. While TbTRDKO 
cells cultured for 15 weeks have a terminal VSG2 restriction fragment of less 
than 3 kb, indicating that the size of VSG2 marked telomere is only 600-800 bp 
long. Thus we successfully obtained an experimental system to determine the 
effect of a shortened active telomere on TERRA transcription without altering the 
lengths of bulk telomeres. This will further aid in confirming that transcription of 
the active BES-marked telomere contributes significantly to the total amount of 
TERRA.  
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Figure 6-7: Amount of TERRA transcript in TbTRDKO cells and VSG 
derepression analysis. (A) Northern blot analysis to determine the size 
distribution of TERRA RNA in wild-type cells and TbTRDKO cells cultured for 2 
weeks (carrying >10 kb long VSG2-marked telomere) or for 15 weeks (carrying 
<1 kb VSG2-marked telomere). The rRNA precursor is shown as a loading 
control. (B) Slot blot analysis to determine the amount of TERRA in wild type 
cells and TbTRDKO cells. Tubulin is probed as an internal loading control. The 
quantification result is shown below the slot blot. TERRA expression level is 
calculated as percent of that in wild-type cells (BF WT). All samples are 
normalized against the tubulin hybridization signal. (C) Quantitative RT-PCR was 
performed to measure steady state mRNA levels of various VSGs in TbTRDKO 
 161 
cells cultured for 2 or 15 weeks. VSG mRNA levels in wild type cells are used as 
the normalization standard and are set to 1 (not shown in the figure). Fold 
difference in mRNA levels compared to wild type cells are calculated from three 
independent experiments. Tubulin mRNA amount was used as an internal 
loading control. 
 
      We collected RNA from all these cell lines and performed northern blot 
analysis to determine the size distribution of TERRA molecules. RNA samples 
were separated by agarose gel electrophoresis followed by in gel hybridization 
with radioactively labeled (*CCCTAA)133 probe (figure 6-7A). TERRA sizes range 
from 1.0 to 10 kb in both wild type BF cells and TbTRDKO cells cultured for only 
2 weeks, indicating that TERRA is not affected by the telomerase null 
background per se. However, in TbTRDKO cells cultured for 15 weeks that carry 
the short (<1 kb) active VSG2-marked telomere, TERRA size distribution was 2-8 
kb.  The larger sized (~ 10 kb long) molecules were not observed in these cells, 
suggesting that shortening of the active VSG2-marked telomere affected TERRA 
size distribution. We did not observe a sharp band of TERRA molecules, 
suggesting that the mature TERRA may not be processed at precise locations. 
Importantly, even though equal amount of RNA was loaded for all three lanes 
(figure 6-7A), the signal for TERRA was the weakest for the TbTRDKO cells 
cultured for 15 weeks, indicating that the total amount of TERRA transcripts is 
decreased. We subsequently performed slot blot analysis to better quantify the 
amount of TERRA transcripts. As seen in figure 6-7B, we observed a more than 
70% decrease in the amount of TERRA transcripts when the active telomere is < 
1 kb long. This result supports our hypothesis that a significant amount of 
TERRA is transcribed from the active telomere. However, our probe only 
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recognizes the telomeric sequence, hence the decrease in northern blot 
hybridization signal might be just due to the lack of telomeric repetitive 
sequences in TERRA transcripts rather than indicating a lower level of TERRA 
expression. Northern analysis using a subtelomeric probe should be able to 
distinguish between these two scenarios in the future. In either case, our 
hypothesis that a significant amount of TERRA is contributed by transcription of 
the active telomere holds true. 
     We hypothesize that TERRA might be involved in VSG silencing regulation. In 
order to test this possibility we have been trying to achieve knock down of 
TERRA using RNAi. Despite of using various versions of RNAi constructs we 
have not yet achieved knockdown of TERRA. Since we observed a decreased 
TERRA amount in TbTRDKO cells cultured for 15 weeks, we decided to test 
whether VSG silencing was affected in these cells. Total RNA was collected from 
wild type and TbTRDKO cells cultured for 2 or 15 weeks and subjected to 
reverse transcription. Quantitative RT-PCR was subsequently performed using 
VSG specific primers to detect steady state mRNA levels of several VSGs. 
Indeed, we observed 3-5 folds of de-repression of silent VSGs in TbTRDKO cells 
cultured for 15 weeks. This result suggests that TERRA is important for VSG 
silencing. 
DISCUSSION 
     Telomere transcription has been recently detected in a number of organisms. 
However, many facts about TERRA still remain to be discovered. Most 
importantly, the biological functions of TERRA are not well known. Telomere 
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transcription in T. brucei was discovered long ago. However, no further studies 
were carried out. Our lab is focused on understanding the regulation of VSG 
silencing in T. brucei. In mammalian system TERRA is known to be important for 
forming heterochromatic region around telomeres, and depletion of TERRA leads 
to telomere dysfunction (Deng et al. 2009). In T. brucei VSGs are expressed from 
subtelomerically located BESs and it is well established that telomeres play an 
important role in their regulation (Yang et al. 2009, Benmerzouga et al. 2013, 
Pandya et al. 2013). Hence, we are interested in determining whether TERRA 
plays any role in VSG silencing regulation.  
     TERRA RNA size ranges from 0.5 to 10 kb in wild-type BF cells and from 0.5 
to 1.5 kb in PF cells. This striking difference between different stages of T. brucei 
life cycle is very interesting and suggests a possible different nature of TERRA 
transcripts in both forms. In addition, TERRA is mostly transcribed from the C-
rich strand in BF cells, but in PF cells both strands appear to be transcribed. At 
this point it is unclear whether TERRA exists as dsRNA in PF cells. All VSGs are 
silent in PF and a different surface coat composed mainly of procyc ylins is 
expressed. This different nature of TERRA transcripts can be due to different 
roles played by TERRA at life cycle stages. Since  the BF form of T. brucei  is 
clinically more important, we decided to focus on this stage for further studies. 
     Telomeric proteins, such as TRF1 and TRF2 interact with TERRA in 
mammalian cells (Deng et al. 2009). Our preliminary RNA IP results in T. brucei 
showed that TbTRF and TbKU80 interact with TERRA, while TbRAP1 and 
TbTIF2 do not. Additional controls are needed, such as RNase A treatment 
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before IP to prove that the signals obtained is solely due to direct interaction 
between protein and RNA. Although all IP products were treated with DNase I, it 
will be important to perform DNase I treatment before IP to exclude any DNA-
mediated interactions.  
     We found that depletion of TbRAP1 and TbTRF elevated TERRA levels. 
Depletion of TbTIF2, on other hand, did not significantly affect TERRA levels. 
However, it seems that TERRA levels are high even before TbTIF2 RNAi 
induction (figure 6-3 B lane 5), suggesting that there might be leaky expression of 
TbTIF2 RNAi in this cell line. Different clones will be used in future analysis to 
determine whether TbTIF2 plays any role in regulation of TERRA. Effects of 
TbRAP1 and TbTRF depletion on TERRA levels were different (~10 and ~5 fold 
increase, respectively) even though both proteins were knocked-down at similar 
levels. From IP results we know that TbTRF interacts with TERRA while TbRAP1 
does not. TbRAP1 depletion in BF cells leads to de-repression of silent 
subtelomeric VSGs, while TbTRF does not affect BES-linked VSG silencing. 
Therefore, TbRAP1 and TbTRF probably regulate TERRA levels through 
different pathways. Our previous studies suggest that TbRAP1 may affect 
transcription elongation along silent BESs and therefore affect VSG silencing. It 
is possible that TbRAP1 regulates TERRA expression in a similar way. TbTRF, 
on the other hand, may play a post-transcriptional role in maintaining stability of 
TERRA transcripts.  
      TERRA transcription in T. brucei is not sensitive to α-aminitin treatment 
(Rudenko & Ploeg 1989), suggesting that it is not transcribed by RNA 
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polymerase II or III. BESs are located at subtelomeres in T. brucei and are 
transcribed at very high level by RNA polymerase I. We hypothesize that TERRA 
might result from transcription read through of the active BES-marked telomere. 
Indeed, RT-PCR analysis suggests that a significant amount of TERRA is 
transcribed from the active BES-marked telomeres. It is possible that TERRA 
might be transcribed from other telomeres as well. Metacyclic VSGs in T. brucei 
are transcribed from monocistronic transcription units (MES) located at 
subtelomeres. We will perform RT-PCR analysis to test whether TERRA can be 
transcribed from these MES-marked telomeres. However, our current knowledge 
does not allow us to test transcription from telomeres unmarked by any VSG 
transcription unit.  
     We have taken an independent approach to prove that TERRA is mostly 
contributed by transcription of the active telomere. We obtained a TbTR deletion 
cell line carrying only the shortened active telomere and long bulk telomeres. 
Northern analysis showed that TERRA size distribution was affected and longer 
transcripts were absent in the cells carrying a shortened active telomere. We did 
not observe a sharp band of TERRA RNA product even through the active 
telomere has precise size in the clonal population, suggesting that trans-splicing 
of TERRA may not occur at a precise location. Importantly, in the cells carrying a 
shortened active BES-marked telomere, the TERRA levels were significantly 
reduced and several silent VSGs were mildly de-repressed. It is possible that 
such derepression of silent BESs might lead to transcription of TERRA from 
these previously silent telomeres. Strikingly, the VSG de-repression phenotype 
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was very interesting, as it suggests that TERRA can influence VSG silencing and 
that its levels are regulated in wild type cells. Depletion of TERRA in the future  
would help to confirm this function of TERRA in T. brucei. 
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CHPATER VII 
 
SUMMARY AND FUTURE PERSPECTIVES 
 
 
 
Roles of TbRAP1 in VSG silencing 
     Telomeres play an important role in VSG silencing. TbRAP1, a telomeric 
protein was previously identified to regulate ES-linked VSG silencing in BF cells 
(Yang et al. 2009). We further established that TbRAP1 also regulates ES-linked 
VSG silencing in PF cells (where essentially all VSGs are silent). TbRAP1 is an 
essential protein and its depletion affects cell growth in the PF stage. Metacyclic 
VSGs are kept silent at BF and PF stages. So far, not much is known about its 
regulation. We determined that TbRAP1 is required for mVSG silencing at both 
BF and PF stage. The strength of the TbRAP1 mediated VSG silencing is 
stronger in PF cells compared to that in the BF cells. This is likely due to the fact 
that BF cells need to switch their active VSG regularly and, hence, VSGs might 
be less tightly regulated. On the contrary, in PF cells expression of VSGs is 
detrimental for the parasite survival and hence a stronger regulation is required. 
Interestingly, TbRAP1 regulates VSG si lencing at the PF stage through 
chromatin remodeling.                                . 
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     Depletion of TbRAP1 in PF cells led to more opened chromatin structure at 
ES-linked VSGs, mVSGs, and minichromosome VSGs. However, no significant 
change in chromatin structure was detected in BF cells. This interesting 
contradiction in mechanisms gives rise to several interesting models (discussed 
in Chapter III). One possible reason is the presence of additional regulatory 
mechanisms in BF cells. In the future, simultaneous depletion of TbRAP1 and 
histone H1 or base J can be preformed to determine whether there is any 
additional effects on VSG transcription and chromatin structure. 
     TbRAP1 was found to associate preferentially with silent ES-marked 
telomeres compared to the active ES-linked telomere in BF cells. Although the 
data are preliminary, they provide some interesting insights into the mechanism 
of TbRAP1 mediated VSG silencing. TbRAP1 needs to be physically bound to 
the chromatin to carry out its nearby gene silencing. Several studies suggest that 
epigenetic regulation is involved in VSG silencing. Previously, it was established 
that depletion of TbSir2rp1 (yeast Sir2 homolog) affected subtelomeric silencing 
without affecting VSG transcription (Alsford et al. 2007). In contrast, depletion of 
histone deacetylase DAC3 affected ES promoter transcription (Wang et al. 
2010). Finally, depletion of histone methyltransferase Dot1B affected VSG 
expression mildly (Figueiredo et al. 2008). Interestingly, unlike the mammalian 
and yeast homologues, T. brucei Dot1b lacks a chromatin-binding domain, 
suggesting an additional player is required for its recruitment to the chromatin 
(Frederiks et al. 2010). It is interesting to propose that TbRAP1 may recruit these 
factors to regulate VSG silencing. In the future, Co-Immunoprecipitation can be 
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performed to determine whether TbRAP1 interacts with these factors. Upon 
TbRAP1 knockdown, the derepressed VSGs are expressed at a level that is still 
100 – 1,000 fold lower than that of the active VSG. Simultaneous depletion of 
TbRAP1 and these factors can be carried out to determine whether there is any 
additional effect on VSG expression. 
     It will be crucial to determine how TbRAP1 is recruited to the telomere, 
knowing that TbRAP1 regulates VSG silencing and that it is preferentially bound 
to the silent ES-linked telomeres. It is thought so far that TbTRF recruits TbRAP1 
to the telomere. No direct telomere DNA binding activity of TbRAP1 was 
observed by EMSA. However, further experiments are required to confirm this 
finding. Interestingly, unlike TbRAP1, TbTRF did not show preferential binding to 
the ES-linked telomeres, suggesting that TbRAP1 might be recruited to 
telomeres through an additional factor. Another piece of evidence comes from a 
very preliminary work, where depletion of TbTRF did not affect the binding of 
TbRAP1 to the telomere (data not shown). Instead, in a few cases, increased 
binding for TbRAP1 to the telomeres was observed upon TbTRF depletion. This 
not only suggests that TbRAP1 has a TbTRF-independent mode of recruitment 
but also suggests that TbTRF and TbRAP1 likely compete with each other for 
telomere binding. Previous work in our lab by Dr. Yang found that TbRAP1 can 
co-immunoprecipitate with histones. It is possible that TbTRF might still be a 
primary means for TbRAP1 recruitment to the telomere. However, TbRAP1 might 
also interact with histones or additional factors to be targeted to silent ES-linked 
telomeres. The TbTRFH domain in TbTRF is known to interact with TbRAP1. We 
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have established several TbTRFH mutants (discussed in Chapter V). Analyzing 
loss of interaction mutants in vivo can further shed light on recruitment of 
TbRAP1 to the telomere. 
     TbRAP1 was found to be important for maintaining telomere G-overhang 
length. Depletion of TbRAP1 led to a decrease in G-overhangs signal when 
analyzed by in-gel native hybridization. It is known that in mammalian cells, DNA 
damage at telomeres results in reduced histone biosynthesis (Sullivan et al. 
2010). Additionally, in budding yeast it was found that during senescence (due to 
telomere shortening), ScRAP1 binds to the promoters of core-histone encoding 
genes and repress their transcription (Platt et al. 2013).  We wanted to test 
whether histone levels were affected upon TbRAP1 depletion. 
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Figure 7-1: Histone levels upon TbRAP1 depletion. (A) RT-PCR analysis was 
performed to measure steady state mRNA levels of histone H3 before (day 0) 
and after (day 2 and 3) depletion of TbRAP1 in PRi-pool cells (PF). Fold change 
in mRNA level was calculated compared to day 0 whose value was arbitrarily set 
to 1.Total cell lysate was collected before and after depletion of TbRAP1 in (B) 
PRi-pool (PF), (C) Ri-CT and Ri-BRCT (BF) cells. Levels of histone H2A and 
histone H3 was determined by western analysis using antibodies specific to 
histone H2A and H3. 
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     We determined whether TbRAP1 depletion affected levels of histones in PF 
and BF cells. No change in mRNA levels of histone H3 was observed upon 
depletion of TbRAP1 in PF cells (figure 7-1 A). However, the protein levels of 
core histones H2A and H3 were decreased upon depletion of TbRAP1 in both PF 
and BF cells (figure 7-1 B and C).  The decrease in the levels of histone protein 
was similar to that of the TbRAP1 protein in PF cells (figure 7-1 B, day 2) 
possibly explaining the loosening of chromatin structure observed upon TbRAP1 
depletion. However, in BF cells the depletion of histones was observed at much 
later stage after TbRAP1 depletion (figure 7-1 C, 24 and 36 hours). We know that 
even at later stages the chromatin structure in BF cells remains unaffected even 
though the total histone protein level decreased.  However, we only analyzed ES 
loci during FAIRE experiments and it is possible that its chromatin compaction 
may still remain unaffected. Another possible reason might be due to the 
presence of linker histone H1, which is known to form a higher order chromatin 
structure. Depletion of histone H1 affects chromatin structure only in BF cells, 
suggesting its role in maintaining higher order chromatin compaction at this stage 
(Povelones et al. 2012). Western blot analysis could not differentiate between the 
nucleosome bound versus the nucleosome free fraction of histone proteins. 
Hence it is not clear at this moment that the decline observed is in free fraction or 
nucleosome bound fraction or both. Also, T. brucei histones are very divergent 
hence; due to lack of specific antibodies it is not feasible at this time to test levels 
of all histone proteins or specifically modified histones. TbRAP1 depletion leads 
to cell growth arrest in PF and BF cells. Is there a DNA damage response? Is the 
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depletion of levels in histone due to trigger of such pathways and is it related to 
growth arrest? If so can histones (being highly divergent) be used as a drug 
target? These are few interesting questions that to be answered need further 
research in the future. 
TbTRF and its role at telomeres 
     TbTRF directly binds to telomeric DNA (Li et al 2005). The homodimerization 
domain of TbTRF is required for self-dimerization of TbTRF as well as for 
interaction with other telomeric proteins, such as TbRAP1 and TbTIF2. We 
speculate that TbTRF acts at the center of the telomeric complex and holds the 
entire complex together. Depletion of TbTRF leads to very acute growth arrest (Li 
et al. 2005), making it impossible to elucidate all of its function in telomere end 
protection. We established seven TbTRFH domain mutants and tested their 
interaction with wild-type TbTRF and mutant TbTRF in vitro. We determined the 
helices required for TbTRF homodimerization function. In the future, these 
mutants can be utilized to determine critical helices required for interactio n with 
other telomeric proteins. Loss of interaction mutants can then be introduced in 
vivo to study the role of TbTRF in telomere complex maintenance and telomere 
protection. 
     Depletion of TbTRF does not lead to ES-linked VSG derepression in BF and 
PF cells (Li et al. 2005). For VSG derepression to occur, a certain level of 
functional transcription machinery is required in the cell. TbTRF depletion had a 
very acute growth arrest and it is possible that due to disruption of the whole 
telomeric complex and trigger of DNA damage response we do not observe VSG 
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derepression. However, TbTRF being directly bound to telomeric DNA we 
wanted to determine whether it has any role in chromatin remodeling at 
telomeres. Depletion of TbTRF led to more opened chromatin structure at ES-
linked VSGs in PF but not BF cells. TbTRF depletion did not affect transcription 
of mVSGs, however, loosening of chromatin structure was observed at mVSGs 
in PF cells. These results collectively suggest that TbTRF possesses the ability 
to modulate chromatin at telomeres. In the future, mutants of TbTRF can be 
utilized to study its role in regulating VSG silencing. 
TERRA and its function in antigenic variation 
     Telomeres are transcribed into long non-coding RNA called TERRA. TERRA 
was reported in T. brucei in 1989 but no further characterization was performed 
(Rudenko and Ploeg 1989). With increasing knowledge of TERRA function in 
telomere regulation, we decided to characterize it and to determine whether it 
plays any role in antigenic variation. We characterized that TERRA is transcribed 
from the C-rich strand in BF cells and from both strands in PF cells. RNA-IP 
determined that TERRA interacts with TbTRF and TbKU80, but not with TbRAP1 
and TbTIF2, suggesting that TERRA might be associated to telomeres through 
the telomeric complex. However, its association with telomeres in vivo needs to 
be determined. 
     Telomeric protein TbRAP1 and TbTRF regulates TERRA transcription and 
their depletion leads to elevated levels of TERRA, suggesting that telomeric 
complex regulates TERRA expression. Elevated or deregulated TERRA 
transcription is known to induce telomere shortening in yeast (Sandell et al. 1994, 
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Maicher et al. 2012). Hence, it is very important to regulate its level in vivo and it 
seems that in T. brucei telomeric complex is one of the key regulators of TERRA 
transcription. By performing PCR analysis we determined that within ES-linked 
telomeres, TERRA is transcribed from active ES. This result correlates with the 
high RNA Pol I mediated transcription of active ES. Most interestingly, shortening 
of the active ES-linked telomeres led to a significant decrease in the amount of 
TERRA molecules and mild derepression of silent ES-linked VSGs. Thus, we 
hypothesize that TERRA plays a role in antigenic variation and it regulates VSG 
silencing at least in BF cells. However, to confirm its role in VSG silencing and to 
study its function in PF cells, it is critical to achieve knockdown of TERRA. So far, 
all the efforts to knockdown TERRA by RNAi have been fruitless and all the 
strategies employed were unsuccessful. In the future alternative strategies need 
to be employed to achieve knock down of TERRA molecules. 
     The work performed in this thesis collectively determined that telomeres are a 
key regulator of antigenic variation in T. brucei. We have further contributed to 
the understanding of pathogenesis of T. brucei. This knowledge can be applied 
towards the eradication of this parasite in the future. 
 
 
 
 
 
 
 
 176 
BIBLIOGRAPHY 
 
Alarcon, C. M., Son, H. J., Hall, T., & Donelson, J. E. (1994). A monocistronic 
transcript for a trypanosome variant surface glycoprotein. Mol Cell Biol, 14(8), 
5579-5591.  
Alsford, S., & Horn, D. (2012). Cell-cycle-regulated control of VSG expression 
site silencing by histones and histone chaperones ASF1A and CAF-1b in 
Trypanosoma brucei. Nucleic Acids Res, 40(20), 10150-10160. doi: 
10.1093/nar/gks813 
Alsford, S., Kawahara, T., Isamah, C., & Horn, D. (2007). A sirtuin in the African 
trypanosome is involved in both DNA repair and telomeric gene silencing but is 
not required for antigenic variation. Mol Microbiol, 63(3), 724-736. doi: 
10.1111/j.1365-2958.2006.05553.x 
Alsford, S., Wickstead, B., Ersfeld, K., & Gull, K. (2001). Diversity and dynamics 
of the minichromosomal karyotype in Trypanosoma brucei. Mol Biochem 
Parasitol, 113(1), 79-88.  
Atouguia, J.L.M. & Kennedy, P.G.E. (2000) Neurological aspects of human 
African trypanosomiasis. In Infectious diseases of the nervous system [L.E. Davis 
& P.G.E. Kennedy (eds.)]. Butterworth-Heinemann. Oxford, United Kingdom. 
321– 372. 
Azzalin, C. M., & Lingner, J. (2008). Telomeres: the silence is broken. Cell Cycle, 
7(9), 1161-1165.  
 177 
Azzalin, C. M., Reichenbach, P., Khoriauli, L., Giulotto, E., & Lingner, J. (2007). 
Telomeric repeat containing RNA and RNA surveillance factors at mammalian 
chromosome ends. Science, 318(5851), 798-801. doi: 10.1126/science.1147182 
Bae, N. S., & Baumann, P. (2007). A RAP1/TRF2 complex inhibits 
nonhomologous end-joining at human telomeric DNA ends. Mol Cell, 26(3), 323-
334. doi: 10.1016/j.molcel.2007.03.023 
Bah, A., Wischnewski, H., Shchepachev, V., & Azzalin, C. M. (2012). The 
telomeric transcriptome of Schizosaccharomyces pombe. Nucleic Acids Res, 
40(7), 2995-3005. doi: 10.1093/nar/gkr1153 
Baker, A. M., Fu, Q., Hayward, W., Lindsay, S. M., & Fletcher, T. M. (2009). The 
Myb/SANT domain of the telomere-binding protein TRF2 alters chromatin 
structure Nucleic Acids Res (2009/06/18 ed., Vol. 37, pp. 5019-5031). 
Baker, A. M., Fu, Q., Hayward, W., Victoria, S., Pedroso, I. M., Lindsay, S. M., & 
Fletcher, T. M. (2011). The telomere binding protein TRF2 induces chromatin 
compaction. PLoS One, 6(4), e19124. doi: 10.1371/journal.pone.0019124 
Balk, B., Maicher, A., Dees, M., Klermund, J., Luke-Glaser, S., Bender, K., & 
Luke, B. (2013). Telomeric RNA-DNA hybrids affect telomere-length dynamics 
and senescence. Nat Struct Mol Biol, 20(10), 1199-1205. doi: 
10.1038/nsmb.2662 
Barnes, R. L., & McCulloch, R. (2007). Trypanosoma brucei homologous 
recombination is dependent on substrate length and homology, though displays a 
differential dependence on mismatch repair as substrate length decreases. 
Nucleic Acids Res, 35(10), 3478-3493. doi: 10.1093/nar/gkm249 
 178 
Barry, J. D., Graham, S. V., Fotheringham, M., Graham, V. S., Kobryn, K., & 
Wymer, B. (1998). VSG gene control and infectivity strategy of metacyclic stage 
Trypanosoma brucei. Mol Biochem Parasitol, 91(1), 93-105.  
Barry, J. D., Marcello, L., Morrison, L. J., Read, A. F., Lythgoe, K., Jones, N., . . . 
Berriman, M. (2005). What the genome sequence is revealing about 
trypanosome antigenic variation. Biochem Soc Trans, 33(Pt 5), 986-989. doi: 
10.1042/BST20050986 
Barry, J. D., & McCulloch, R. (2001). Antigenic variation in trypanosomes: 
enhanced phenotypic variation in a eukaryotic parasite. Adv Parasitol, 49, 1-70.  
Baur, J. A., Zou, Y., Shay, J. W., & Wright, W. E. (2001). Telomere position effect 
in human cells. Science, 292(5524), 2075-2077. doi: 10.1126/science.1062329 
Benetti, R., Garcia-Cao, M., & Blasco, M. A. (2007). Telomere length regulates 
the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet, 
39(2), 243-250. doi: 10.1038/ng1952 
Benetti, R., Schoeftner, S., Munoz, P., & Blasco, M. A. (2008). Role of TRF2 in 
the assembly of telomeric chromatin. Cell Cycle, 7(21), 3461-3468.  
Benmerzouga, I., Concepcion-Acevedo, J., Kim, H. S., Vandoros, A. V., Cross, 
G. A., Klingbeil, M. M., & Li, B. (2013). Trypanosoma brucei Orc1 is essential for 
nuclear DNA replication and affects both VSG silencing and VSG switching. Mol 
Microbiol, 87(1), 196-210. doi: 10.1111/mmi.12093 
Bernards, A., Michels, P. A., Lincke, C. R., & Borst, P. (1983). Growth of 
chromosome ends in multiplying trypanosomes. Nature, 303(5918), 592-597.  
 179 
Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., 
Bartholomeu, D. C., . . . El-Sayed, N. M. (2005). The genome of the African 
trypanosome Trypanosoma brucei. Science, 309(5733), 416-422. doi: 
10.1126/science.1112642 
Berriman, M., Hall, N., Sheader, K., Bringaud, F., Tiwari, B., Isobe, T., . . . 
Rudenko, G. (2002). The architecture of variant surface glycoprotein gene 
expression sites in Trypanosoma brucei. Mol Biochem Parasitol, 122(2), 131-
140.  
Bianchi, A., Smith, S., Chong, L., Elias, P., & de Lange, T. (1997). TRF1 is a 
dimer and bends telomeric DNA. EMBO J, 16(7), 1785-1794. doi: 
10.1093/emboj/16.7.1785 
Blackburn, E. H., & Challoner, P. B. (1984). Identification of a telomeric DNA 
sequence in Trypanosoma brucei. Cell, 36(2), 447-457.  
Blum, J., Schmid, C., & Burri, C. (2006). Clinical aspects of 2541 patients with 
second stage human African trypanosomiasis. Acta Trop, 97(1), 55-64. doi: 
10.1016/j.actatropica.2005.08.001 
Bombarde, O., Boby, C., Gomez, D., Frit, P., Giraud-Panis, M. J., Gilson, E., . . . 
Calsou, P. (2010). TRF2/RAP1 and DNA-PK mediate a double protection against 
joining at telomeric ends. EMBO J, 29(9), 1573-1584. doi: 
10.1038/emboj.2010.49 
Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., & Koonin, E. 
V. (1997). A superfamily of conserved domains in DNA damage-responsive cell 
cycle checkpoint proteins. FASEB J, 11(1), 68-76.  
 180 
Borst, P. (1986). Discontinuous transcription and antigenic variation in 
trypanosomes. Annu Rev Biochem, 55, 701-732. doi: 
10.1146/annurev.bi.55.070186.003413 
Boulton, S. J., & Jackson, S. P. (1998). Components of the Ku-dependent non-
homologous end-joining pathway are involved in telomeric length maintenance 
and telomeric silencing. EMBO J, 17(6), 1819-1828. doi: 
10.1093/emboj/17.6.1819 
Bourns, B. D., Alexander, M. K., Smith, A. M., & Zakian, V. A. (1998). Sir 
proteins, Rif proteins, and Cdc13p bind Saccharomyces telomeres in vivo. Mol 
Cell Biol, 18(9), 5600-5608.  
Broccoli, D., Smogorzewska, A., Chong, L., & de Lange, T. (1997). Human 
telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet, 
17(2), 231-235. doi: 10.1038/ng1097-231 
Brun, R., Blum, J., Chappuis, F., & Burri, C. (2010). Human African 
trypanosomiasis. Lancet, 375(9709), 148-159. doi: 10.1016/S0140-
6736(09)60829-1 
Buguet, A., Bisser, S., Josenando, T., Chapotot, F., & Cespuglio, R. (2005). 
Sleep structure: a new diagnostic tool for stage determination in sleeping 
sickness. Acta Trop, 93(1), 107-117. doi: 10.1016/j.actatropica.2004.10.001 
Burri, C., & Brun, R. (2003). Eflornithine for the treatment of human African 
trypanosomiasis. Parasitol Res, 90 Supp 1, S49-52. doi: 10.1007/s00436-002-
0766-5 
 181 
Burton, P., McBride, D. J., Wilkes, J. M., Barry, J. D., & McCulloch, R. (2007). Ku 
heterodimer-independent end joining in Trypanosoma brucei cell extracts relies 
upon sequence microhomology. Eukaryot Cell, 6(10), 1773-1781. doi: 
10.1128/EC.00212-07 
Callejas, S., Leech, V., Reitter, C., & Melville, S. (2006). Hemizygous 
subtelomeres of an African trypanosome chromosome may account for over 75% 
of chromosome length. Genome Res, 16(9), 1109-1118. doi: 10.1101/gr.5147406 
Cano, M. I., Dungan, J. M., Agabian, N., & Blackburn, E. H. (1999). Telomerase 
in kinetoplastid parasitic protozoa. Proc Natl Acad Sci U S A, 96(7), 3616-3621.  
Capewell, P., Veitch, N. J., Turner, C. M., Raper, J., Berriman, M., Hajduk, S. L., 
& MacLeod, A. (2011). Differences between Trypanosoma brucei gambiense 
groups 1 and 2 in their resistance to killing by trypanolytic factor 1. PLoS Negl 
Trop Dis, 5(9), e1287. doi: 10.1371/journal.pntd.0001287 
Cesare, A. J., Groff-Vindman, C., Compton, S. A., McEachern, M. J., & Griffith, J. 
D. (2008). Telomere loops and homologous recombination-dependent telomeric 
circles in a Kluyveromyces lactis telomere mutant strain. Mol Cell Biol, 28(1), 20-
29. doi: 10.1128/MCB.01122-07 
Cockell, M., Palladino, F., Laroche, T., Kyrion, G., Liu, C., Lustig, A. J., & Gasser, 
S. M. (1995). The carboxy termini of Sir4 and Rap1 affect Sir3 localization: 
evidence for a multicomponent complex required for yeast telomeric silencing. J 
Cell Biol, 129(4), 909-924.  
 182 
Conrad, M. N., Wright, J. H., Wolf, A. J., & Zakian, V. A. (1990). RAP1 protein 
interacts with yeast telomeres in vivo: overproduction alters telomere structure 
and decreases chromosome stability. Cell, 63(4), 739-750.  
. Control and surveillance of African trypanosomiasis. Report of a WHO Expert 
Committee. (1998) World Health Organ Tech Rep Ser (1999/03/10 ed., Vol. 881, 
pp. I-VI, 1-114). 
Conway, C., McCulloch, R., Ginger, M. L., Robinson, N. P., Browitt, A., & Barry, 
J. D. (2002). Ku is important for telomere maintenance, but not for differential 
expression of telomeric VSG genes, in African trypanosomes. J Biol Chem, 
277(24), 21269-21277. doi: 10.1074/jbc.M200550200 
Cornelissen, A. W., Bakkeren, G. A., Barry, J. D., Michels, P. A., & Borst, P. 
(1985). Characteristics of trypanosome variant antigen genes active in the tsetse 
fly. Nucleic Acids Res, 13(13), 4661-4676.  
Cross, G. A. (1975). Identification, purification and properties of clone-specific 
glycoprotein antigens constituting the surface coat of Trypanosoma brucei. 
Parasitology, 71(3), 393-417.  
Cusanelli, E., Romero, C. A., & Chartrand, P. (2013). Telomeric noncoding RNA 
TERRA is induced by telomere shortening to nucleate telomerase molecules at 
short telomeres. Mol Cell, 51(6), 780-791. doi: 10.1016/j.molcel.2013.08.029 
De Lange, T., & Borst, P. (1982). Genomic environment of the expression-linked 
extra copies of genes for surface antigens of Trypanosoma brucei resembles the 
end of a chromosome. Nature, 299(5882), 451-453.  
 183 
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & 
Varmus, H. E. (1990). Structure and variability of human chromosome ends. Mol 
Cell Biol, 10(2), 518-527.  
Denchi, E. L., & de Lange, T. (2007). Protection of telomeres through 
independent control of ATM and ATR by TRF2 and POT1. Nature, 448(7157), 
1068-1071. doi: 10.1038/nature06065 
Deng, X., & Meller, V. H. (2006). Non-coding RNA in fly dosage compensation. 
Trends Biochem Sci, 31(9), 526-532. doi: 10.1016/j.tibs.2006.07.007 
Deng, Z., Norseen, J., Wiedmer, A., Riethman, H., & Lieberman, P. M. (2009). 
TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC 
recruitment at telomeres. Mol Cell, 35(4), 403-413. doi: 
10.1016/j.molcel.2009.06.025 
Denninger, V., Fullbrook, A., Bessat, M., Ersfeld, K., & Rudenko, G. (2010). The 
FACT subunit TbSpt16 is involved in cell cycle specific control of VSG 
expression sites in Trypanosoma brucei. Mol Microbiol, 78(2), 459-474. doi: 
10.1111/j.1365-2958.2010.07350.x 
Dobson, R., Stockdale, C., Lapsley, C., Wilkes, J., & McCulloch, R. (2011). 
Interactions among Trypanosoma brucei RAD51 paralogues in DNA repair and 
antigenic variation. Mol Microbiol, 81(2), 434-456. doi: 10.1111/j.1365-
2958.2011.07703.x 
Doksani, Y., Wu, J. Y., de Lange, T., & Zhuang, X. (2013). Super-resolution 
fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. 
Cell, 155(2), 345-356. doi: 10.1016/j.cell.2013.09.048 
 184 
Dorn, P. L., Aman, R. A., & Boothroyd, J. C. (1991). Inhibition of protein 
synthesis results in super-induction of procyclin (PARP) RNA levels. Mol 
Biochem Parasitol, 44(1), 133-139.  
Dreesen, O., & Cross, G. A. (2006). Consequences of telomere shortening at an 
active VSG expression site in telomerase-deficient Trypanosoma brucei. 
Eukaryot Cell, 5(12), 2114-2119. doi: 10.1128/EC.00059-06 
Dreesen, O., & Cross, G. A. (2008). Telomere length in Trypanosoma brucei. 
Exp Parasitol, 118(1), 103-110. doi: 10.1016/j.exppara.2007.07.016 
Dreesen, O., Li, B., & Cross, G. A. (2005). Telomere structure and shortening in 
telomerase-deficient Trypanosoma brucei. Nucleic Acids Res, 33(14), 4536-
4543. doi: 10.1093/nar/gki769 
Dreesen, O., Li, B., & Cross, G. A. (2007). Telomere structure and function in 
trypanosomes: a proposal. Nat Rev Microbiol, 5(1), 70-75. doi: 
10.1038/nrmicro1577 
Duraisingh, M. T., Voss, T. S., Marty, A. J., Duffy, M. F., Good, R. T., Thompson, 
J. K., . . . Cowman, A. F. (2005). Heterochromatin silencing and locus 
repositioning linked to regulation of virulence genes in Plasmodium falciparum. 
Cell, 121(1), 13-24. doi: 10.1016/j.cell.2005.01.036 
Fairall, L., Chapman, L., Moss, H., de Lange, T., & Rhodes, D. (2001). Structure 
of the TRFH dimerization domain of the human telomeric proteins TRF1 and 
TRF2. Mol Cell, 8(2), 351-361.  
Fairlamb, A. H. (2003). Chemotherapy of human African trypanosomiasis: current 
and future prospects. Trends Parasitol, 19(11), 488-494.  
 185 
Fairlamb, A. H., Henderson, G. B., & Cerami, A. (1989). Trypanothione is the 
primary target for arsenical drugs against African trypanosomes. Proc Natl Acad 
Sci U S A, 86(8), 2607-2611.  
Ferguson, M. A. (1999). The structure, biosynthesis and functions of 
glycosylphosphatidylinositol anchors, and the contributions of trypanosome 
research. J Cell Sci, 112 ( Pt 17), 2799-2809.  
Figueiredo, L. M., & Cross, G. A. (2010). Nucleosomes are depleted at the VSG 
expression site transcribed by RNA polymerase I in African trypanosomes. 
Eukaryot Cell, 9(1), 148-154. doi: 10.1128/EC.00282-09 
Figueiredo, L. M., Janzen, C. J., & Cross, G. A. (2008). A histone 
methyltransferase modulates antigenic variation in African trypanosomes. PLoS 
Biol, 6(7), e161. doi: 10.1371/journal.pbio.0060161 
Frederiks, F., van Welsem, T., Oudgenoeg, G., Heck, A. J., Janzen, C. J., & van 
Leeuwen, F. (2010). Heterologous expression reveals distinct enzymatic 
activities of two DOT1 histone methyltransferases of Trypanosoma brucei. J Cell 
Sci, 123(Pt 23), 4019-4023. doi: 10.1242/jcs.073882 
Freitas-Junior, L. H., Hernandez-Rivas, R., Ralph, S. A., Montiel-Condado, D., 
Ruvalcaba-Salazar, O. K., Rojas-Meza, A. P., . . . Scherf, A. (2005). Telomeric 
heterochromatin propagation and histone acetylation control mutually exclusive 
expression of antigenic variation genes in malaria parasites. Cell, 121(1), 25-36. 
doi: 10.1016/j.cell.2005.01.037 
Galati, A., Magdinier, F., Colasanti, V., Bauwens, S., Pinte, S., Ricordy, R., . . . 
Gilson, E. (2012). TRF2 controls telomeric nucleosome organization in a cell 
 186 
cycle phase-dependent manner. PLoS One, 7(4), e34386. doi: 
10.1371/journal.pone.0034386 
Galati, A., Rossetti, L., Pisano, S., Chapman, L., Rhodes, D., Savino, M., & 
Cacchione, S. (2006). The human telomeric protein TRF1 specifically recognizes 
nucleosomal binding sites and alters nucleosome structure. J Mol Biol, 360(2), 
377-385. doi: 10.1016/j.jmb.2006.04.071 
Ganapathi, M., Palumbo, M. J., Ansari, S. A., He, Q., Tsui, K., Nislow, C., & 
Morse, R. H. (2011). Extensive role of the general regulatory factors, Abf1 and 
Rap1, in determining genome-wide chromatin structure in budding yeast. Nucleic 
Acids Res, 39(6), 2032-2044. doi: 10.1093/nar/gkq1161 
Garcia-Salcedo, J. A., Gijon, P., Nolan, D. P., Tebabi, P., & Pays, E. (2003). A 
chromosomal SIR2 homologue with both histone NAD-dependent ADP-
ribosyltransferase and deacetylase activities is involved in DNA repair in 
Trypanosoma brucei. EMBO J, 22(21), 5851-5862. doi: 10.1093/emboj/cdg553 
Gibson, W. C., & Borst, P. (1986). Size-fractionation of the small chromosomes 
of Trypanozoon and Nannomonas trypanosomes by pulsed field gradient gel 
electrophoresis. Mol Biochem Parasitol, 18(2), 127-140.  
Ginger, M. L., Blundell, P. A., Lewis, A. M., Browitt, A., Gunzl, A., & Barry, J. D. 
(2002). Ex vivo and in vitro identification of a consensus promoter for VSG genes 
expressed by metacyclic-stage trypanosomes in the tsetse fly. Eukaryot Cell, 
1(6), 1000-1009.  
Giresi, P. G., & Lieb, J. D. (2009). Isolation of active regulatory elements from 
eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of 
 187 
Regulatory Elements). Methods, 48(3), 233-239. doi: 
10.1016/j.ymeth.2009.03.003 
Glover, L., & Horn, D. (2006). Repression of polymerase I-mediated gene 
expression at Trypanosoma brucei telomeres. EMBO Rep, 7(1), 93-99. doi: 
10.1038/sj.embor.7400575 
Glover, L., Jun, J., & Horn, D. (2011). Microhomology-mediated deletion and 
gene conversion in African trypanosomes. Nucleic Acids Res, 39(4), 1372-1380. 
doi: 10.1093/nar/gkq981 
Glover, L., McCulloch, R., & Horn, D. (2008). Sequence homology and 
microhomology dominate chromosomal double-strand break repair in African 
trypanosomes. Nucleic Acids Res, 36(8), 2608-2618. doi: 10.1093/nar/gkn104 
Gommers-Ampt, J. H., Van Leeuwen, F., de Beer, A. L., Vliegenthart, J. F., 
Dizdaroglu, M., Kowalak, J. A., . . . Borst, P. (1993). beta-D-glucosyl-
hydroxymethyluracil: a novel modified base present in the DNA of the parasitic 
protozoan T. brucei. Cell, 75(6), 1129-1136.  
Gottschling, D. E., Aparicio, O. M., Billington, B. L., & Zakian, V. A. (1990). 
Position effect at S. cerevisiae telomeres: reversible repression of Pol II 
transcription. Cell, 63(4), 751-762.  
Grandin, N., Damon, C., & Charbonneau, M. (2001). Ten1 functions in telomere 
end protection and length regulation in association with Stn1 and Cdc13. EMBO 
J, 20(5), 1173-1183. doi: 10.1093/emboj/20.5.1173 
 188 
Grandin, N., Reed, S. I., & Charbonneau, M. (1997). Stn1, a new 
Saccharomyces cerevisiae protein, is implicated in telomere size regulation in 
association with Cdc13. Genes Dev, 11(4), 512-527.  
Gravel, S., Larrivee, M., Labrecque, P., & Wellinger, R. J. (1998). Yeast Ku as a 
regulator of chromosomal DNA end structure. Science, 280(5364), 741-744.  
Greenwood, J., & Cooper, J. P. (2012). Non-coding telomeric and subtelomeric 
transcripts are differentially regulated by telomeric and heterochromatin 
assembly factors in fission yeast. Nucleic Acids Res, 40(7), 2956-2963. doi: 
10.1093/nar/gkr1155 
Greider, C. W., & Blackburn, E. H. (1987). The telomere terminal transferase of 
Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. 
Cell, 51(6), 887-898.  
Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., & 
de Lange, T. (1999). Mammalian telomeres end in a large duplex loop. Cell, 
97(4), 503-514.  
Gruszynski, A. E., van Deursen, F. J., Albareda, M. C., Best, A., Chaudhary, K., 
Cliffe, L. J., . . . Bangs, J. D. (2006). Regulation of surface coat exchange by 
differentiating African trypanosomes. Mol Biochem Parasitol, 147(2), 211-223. 
doi: 10.1016/j.molbiopara.2006.02.013 
Gunzl, A., Bruderer, T., Laufer, G., Schimanski, B., Tu, L. C., Chung, H. M., . . . 
Lee, M. G. (2003). RNA polymerase I transcribes procyclin genes and variant 
surface glycoprotein gene expression sites in Trypanosoma brucei. Eukaryot 
Cell, 2(3), 542-551.  
 189 
Gupta, S. K., Kolet, L., Doniger, T., Biswas, V. K., Unger, R., Tzfati, Y., & 
Michaeli, S. (2013). The Trypanosoma brucei telomerase RNA (TER) homologue 
binds core proteins of the C/D snoRNA family. FEBS Lett, 587(9), 1399-1404. 
doi: 10.1016/j.febslet.2013.03.017 
Hardy, C. F., Sussel, L., & Shore, D. (1992). A RAP1-interacting protein involved 
in transcriptional silencing and telomere length regulation. Genes Dev, 6(5), 801-
814.  
Hartley, C. L., & McCulloch, R. (2008). Trypanosoma brucei BRCA2 acts in 
antigenic variation and has undergone a recent expansion in BRC repeat number 
that is important during homologous recombination. Mol Microbiol, 68(5), 1237-
1251. doi: 10.1111/j.1365-2958.2008.06230.x 
Hazelrigg, T., Levis, R., & Rubin, G. M. (1984). Transformation of white locus 
DNA in drosophila: dosage compensation, zeste interaction, and position effects. 
Cell, 36(2), 469-481.  
Hecht, A., Laroche, T., Strahl-Bolsinger, S., Gasser, S. M., & Grunstein, M. 
(1995). Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins: a 
molecular model for the formation of heterochromatin in yeast. Cell, 80(4), 583-
592.  
Hertz-Fowler, C., Figueiredo, L. M., Quail, M. A., Becker, M., Jackson, A., Bason, 
N.,Berriman, M. (2008). Telomeric expression sites are highly conserved in 
Trypanosoma brucei. PLoS One, 3(10), e3527. doi: 
10.1371/journal.pone.0003527 
 190 
Hockemeyer, D., Sfeir, A. J., Shay, J. W., Wright, W. E., & de Lange, T. (2005). 
POT1 protects telomeres from a transient DNA damage response and 
determines how human chromosomes end. EMBO J, 24(14), 2667-2678. doi: 
10.1038/sj.emboj.7600733 
Holmes, P. (2013). Tsetse-transmitted trypanosomes--their biology, disease 
impact and control. J Invertebr Pathol, 112 Suppl, S11-14. doi: 
10.1016/j.jip.2012.07.014 
Horn, D., & Barry, J. D. (2005). The central roles of telomeres and subtelomeres 
in antigenic variation in African trypanosomes. Chromosome Res, 13(5), 525-
533. doi: 10.1007/s10577-005-0991-8 
Horn, D., & Cross, G. A. (1995). A developmentally regulated position effect at a 
telomeric locus in Trypanosoma brucei. Cell, 83(4), 555-561.  
Horn, D., & McCulloch, R. (2010). Molecular mechanisms underlying the control 
of antigenic variation in African trypanosomes. Curr Opin Microbiol, 13(6), 700-
705. doi: 10.1016/j.mib.2010.08.009 
Houghtaling, B. R., Cuttonaro, L., Chang, W., & Smith, S. (2004). A dynamic 
molecular link between the telomere length regulator TRF1 and the chromosome 
end protector TRF2. Curr Biol, 14(18), 1621-1631. doi: 
10.1016/j.cub.2004.08.052 
Hovel-Miner, G. A., Boothroyd, C. E., Mugnier, M., Dreesen, O., Cross, G. A., & 
Papavasiliou, F. N. (2012). Telomere length affects the frequency and 
mechanism of antigenic variation in Trypanosoma brucei. PLoS Pathog, 8(8), 
e1002900. doi: 10.1371/journal.ppat.1002900 
 191 
Hsu, H. L., Gilley, D., Galande, S. A., Hande, M. P., Allen, B., Kim, S. H., . . . 
Chen, D. J. (2000). Ku acts in a unique way at the mammalian telomere to 
prevent end joining. Genes Dev, 14(22), 2807-2812.  
Hughes, K., Wand, M., Foulston, L., Young, R., Harley, K., Terry, S., . . . 
Rudenko, G. (2007). A novel ISWI is involved in VSG expression site 
downregulation in African trypanosomes. EMBO J, 26(9), 2400-2410. doi: 
10.1038/sj.emboj.7601678 
Hughes, T. R., Evans, S. K., Weilbaecher, R. G., & Lundblad, V. (2000). The 
Est3 protein is a subunit of yeast telomerase. Curr Biol, 10(13), 809-812.  
Iglesias, N., Redon, S., Pfeiffer, V., Dees, M., Lingner, J., & Luke, B. (2011). 
Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and 
Rap1/Sir complexes in yeast. EMBO Rep, 12(6), 587-593. doi: 
10.1038/embor.2011.73 
Imai, S., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000). Transcriptional 
silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. 
Nature, 403(6771), 795-800. doi: 10.1038/35001622 
Janzen, C. J., Lander, F., Dreesen, O., & Cross, G. A. (2004). Telomere length 
regulation and transcriptional silencing in KU80-deficient Trypanosoma brucei. 
Nucleic Acids Res, 32(22), 6575-6584. doi: 10.1093/nar/gkh991 
Jehi, S. E., Wu, F., & Li, B. (2014). Trypanosoma brucei TIF2 suppresses VSG 
switching by maintaining subtelomere stability. Cell Res, manuscript accepted.  
Kabir, S., Sfeir, A., & de Lange, T. (2010). Taking apart Rap1: an adaptor protein 
with telomeric and non-telomeric functions. Cell Cycle, 9(20), 4061-4067.  
 192 
Kamper, S. M., & Barbet, A. F. (1992). Surface epitope variation via mosaic gene 
formation is potential key to long-term survival of Trypanosoma brucei. Mol 
Biochem Parasitol, 53(1-2), 33-44.  
Kanoh, J., & Ishikawa, F. (2001). spRap1 and spRif1, recruited to telomeres by 
Taz1, are essential for telomere function in fission yeast. Curr Biol, 11(20), 1624-
1630.  
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999). p53- and 
ATM-dependent apoptosis induced by telomeres lacking TRF2. Science, 
283(5406), 1321-1325.  
Kawahara, T., Siegel, T. N., Ingram, A. K., Alsford, S., Cross, G. A., & Horn, D. 
(2008). Two essential MYST-family proteins display distinct roles in histone 
H4K10 acetylation and telomeric silencing in trypanosomes. Mol Microbiol, 69(4), 
1054-1068. doi: 10.1111/j.1365-2958.2008.06346.x 
Kennedy, P. G. (2004). Human African trypanosomiasis of the CNS: current 
issues and challenges. J Clin Invest, 113(4), 496-504. doi: 10.1172/JCI21052 
Kennedy, P. G. (2006). Diagnostic and neuropathogenesis issues in human 
African trypanosomiasis. Int J Parasitol, 36(5), 505-512. doi: 
10.1016/j.ijpara.2006.01.012 
Kennedy, P. G. (2007). The Fatal Sleep. Edinburgh, United Kingdom:Luath Press 
Ltd. 
  
 193 
Kennedy, P. G. (2008a). The continuing problem of human African 
trypanosomiasis (sleeping sickness). Ann Neurol, 64(2), 116-126. doi: 
10.1002/ana.21429 
Kennedy, P. G. (2008b). Diagnosing central nervous system trypanosomiasis: 
two stage or not to stage? Trans R Soc Trop Med Hyg, 102(4), 306-307. doi: 
10.1016/j.trstmh.2007.11.011 
Kennedy, P. G. (2013). Clinical features, diagnosis, and treatment of human 
African trypanosomiasis (sleeping sickness). Lancet Neurol, 12(2), 186-194. doi: 
10.1016/S1474-4422(12)70296-X 
Kieft, R., Stephens, N. A., Capewell, P., MacLeod, A., & Hajduk, S. L. (2012). 
Role of expression site switching in the development of resistance to human 
Trypanosome Lytic Factor-1 in Trypanosoma brucei brucei. Mol Biochem 
Parasitol, 183(1), 8-14. doi: 10.1016/j.molbiopara.2011.12.004 
Kim, H. S., & Cross, G. A. (2010). TOPO3alpha influences antigenic variation by 
monitoring expression-site-associated VSG switching in Trypanosoma brucei. 
PLoS Pathog, 6(7), e1000992. doi: 10.1371/journal.ppat.1000992 
Kim, H. S., & Cross, G. A. (2011). Identification of Trypanosoma brucei 
RMI1/BLAP75 homologue and its roles in antigenic variation. PLoS One, 6(9), 
e25313. doi: 10.1371/journal.pone.0025313 
Kim, H. S., Park, S. H., Gunzl, A., & Cross, G. A. (2013). MCM-BP is required for 
repression of life-cycle specific genes transcribed by RNA polymerase I in the 
mammalian infectious form of Trypanosoma brucei. PLoS One, 8(2), e57001. 
doi: 10.1371/journal.pone.0057001 
 194 
Kim, M. K., Kang, M. R., Nam, H. W., Bae, Y. S., Kim, Y. S., & Chung, I. K. 
(2008). Regulation of telomeric repeat binding factor 1 binding to telomeres by 
casein kinase 2-mediated phosphorylation. J Biol Chem, 283(20), 14144-14152. 
doi: 10.1074/jbc.M710065200 
Kim, S. H., Kaminker, P., & Campisi, J. (1999). TIN2, a new regulator of telomere 
length in human cells. Nat Genet, 23(4), 405-412. doi: 10.1038/70508 
Klobutcher, L. A., Swanton, M. T., Donini, P., & Prescott, D. M. (1981). All gene-
sized DNA molecules in four species of hypotrichs have the same terminal 
sequence and an unusual 3' terminus. Proc Natl Acad Sci U S A, 78(5), 3015-
3019.  
Konig, E., Delius, H., Carrington, M., Williams, R. O., & Roditi, I. (1989). 
Duplication and transcription of procyclin genes in Trypanosoma brucei. Nucleic 
Acids Res, 17(21), 8727-8739.  
Konig, P., Giraldo, R., Chapman, L., & Rhodes, D. (1996). The crystal structure 
of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA. Cell, 
85(1), 125-136.  
Kooter, J. M., & Borst, P. (1984). Alpha-amanitin-insensitive transcription of 
variant surface glycoprotein genes provides further evidence for discontinuous 
transcription in trypanosomes. Nucleic Acids Res, 12(24), 9457-9472.  
Kooter, J. M., van der Spek, H. J., Wagter, R., d'Oliveira, C. E., van der Hoeven, 
F., Johnson, P. J., & Borst, P. (1987). The anatomy and transcription of a 
telomeric expression site for variant-specific surface antigens in T. brucei. Cell, 
51(2), 261-272.  
 195 
Kyrion, G., Boakye, K. A., & Lustig, A. J . (1992). C-terminal truncation of RAP1 
results in the deregulation of telomere size, stability, and function in 
Saccharomyces cerevisiae. Mol Cell Biol, 12(11), 5159-5173.  
Kyrion, G., Liu, K., Liu, C., & Lustig, A. J. (1993). RAP1 and telomere structure 
regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev, 
7(7A), 1146-1159.  
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature, 227(5259), 680-685.  
Landeira, D., Bart, J. M., Van Tyne, D., & Navarro, M. (2009). Cohesin regulates 
VSG monoallelic expression in trypanosomes. J Cell Biol, 186(2), 243-254. doi: 
10.1083/jcb.200902119 
Landeira, D., & Navarro, M. (2007). Nuclear repositioning of the VSG promoter 
during developmental silencing in Trypanosoma brucei. J Cell Biol, 176(2), 133-
139. doi: 10.1083/jcb.200607174 
Legros, D., Evans, S., Maiso, F., Enyaru, J. C., & Mbulamberi, D. (1999). Risk 
factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense 
trypanosomiasis in Uganda. Trans R Soc Trop Med Hyg, 93(4), 439-442.  
Lei, M., Baumann, P., & Cech, T. R. (2002). Cooperative binding of single-
stranded telomeric DNA by the Pot1 protein of Schizosaccharomyces pombe. 
Biochemistry, 41(49), 14560-14568.  
Lei, M., Podell, E. R., & Cech, T. R. (2004). Structure of human POT1 bound to 
telomeric single-stranded DNA provides a model for chromosome end-protection. 
Nat Struct Mol Biol, 11(12), 1223-1229. doi: 10.1038/nsmb867 
 196 
Lenardo, M. J., Rice-Ficht, A. C., Kelly, G., Esser, K. M., & Donelson, J. E. 
(1984). Characterization of the genes specifying two metacyclic variable antigen 
types in Trypanosoma brucei rhodesiense. Proc Natl Acad Sci U S A, 81(21), 
6642-6646.  
Li, B., & de Lange, T. (2003). Rap1 affects the length and heterogeneity of 
human telomeres. Mol Biol Cell, 14(12), 5060-5068. doi: 10.1091/mbc.E03-06-
0403 
Li, B., Espinal, A., & Cross, G. A. (2005). Trypanosome telomeres are protected 
by a homologue of mammalian TRF2. Mol Cell Biol, 25(12), 5011-5021. doi: 
10.1128/MCB.25.12.5011-5021.2005 
Li, B., Oestreich, S., & de Lange, T. (2000). Identification of human Rap1: 
implications for telomere evolution. Cell, 101(5), 471-483.  
Liu, C., Mao, X., & Lustig, A. J. (1994). Mutational analysis defines a C-terminal 
tail domain of RAP1 essential for Telomeric silencing in Saccharomyces 
cerevisiae. Genetics, 138(4), 1025-1040.  
Loayza, D., & De Lange, T. (2003). POT1 as a terminal transducer of TRF1 
telomere length control. Nature, 423(6943), 1013-1018. doi: 
10.1038/nature01688 
Loayza, D., Parsons, H., Donigian, J., Hoke, K., & de Lange, T. (2004). DNA 
binding features of human POT1: a nonamer 5'-TAGGGTTAG-3' minimal binding 
site, sequence specificity, and internal binding to multimeric sites. J Biol Chem, 
279(13), 13241-13248. doi: 10.1074/jbc.M312309200 
 197 
Luke, B., Panza, A., Redon, S., Iglesias, N., Li, Z., & Lingner, J. (2008). The 
Rat1p 5' to 3' exonuclease degrades telomeric repeat-containing RNA and 
promotes telomere elongation in Saccharomyces cerevisiae. Mol Cell, 32(4), 
465-477. doi: 10.1016/j.molcel.2008.10.019 
Lustig, A. J., Kurtz, S., & Shore, D. (1990). Involvement of the silencer and UAS 
binding protein RAP1 in regulation of telomere length. Science, 250(4980), 549-
553.  
Maicher, A., Kastner, L., Dees, M., & Luke, B. (2012). Deregulated telomere 
transcription causes replication-dependent telomere shortening and promotes 
cellular senescence. Nucleic Acids Res, 40(14), 6649-6659. doi: 
10.1093/nar/gks358 
Mair, G., Shi, H., Li, H., Djikeng, A., Aviles, H. O., Bishop, J. R., . . . Tschudi, C. 
(2000). A new twist in trypanosome RNA metabolism: cis-splicing of pre-mRNA. 
RNA, 6(2), 163-169.  
Marcand, S., Gilson, E., & Shore, D. (1997). A protein-counting mechanism for 
telomere length regulation in yeast. Science, 275(5302), 986-990.  
Marcello, L., & Barry, J. D. (2007). Analysis of the VSG gene silent archive in 
Trypanosoma brucei reveals that mosaic gene expression is prominent in 
antigenic variation and is favored by archive substructure. Genome Res, 17(9), 
1344-1352. doi: 10.1101/gr.6421207 
Martinez, P., Thanasoula, M., Carlos, A. R., Gomez-Lopez, G., Tejera, A. M., 
Schoeftner, S.,Blasco, M. A. (2010). Mammalian Rap1 controls telomere function 
 198 
and gene expression through binding to telomeric and extratelomeric sites. Nat 
Cell Biol, 12(8), 768-780. doi: 10.1038/ncb2081 
Matthews, K. R. (2005). The developmental cell biology of Trypanosoma brucei. 
J Cell Sci, 118(Pt 2), 283-290. doi: 10.1242/jcs.01649 
Matthews, K. R., Ellis, J. R., & Paterou, A. (2004). Molecular regulation of the life 
cycle of African trypanosomes. Trends Parasitol, 20(1), 40-47.  
McCulloch, R. (2004). Antigenic variation in African trypanosomes: monitoring 
progress. Trends Parasitol, 20(3), 117-121. doi: 10.1016/j.pt.2003.12.004 
McCulloch, R., & Barry, J. D. (1999). A role for RAD51 and homologous 
recombination in Trypanosoma brucei antigenic variation. Genes Dev, 13(21), 
2875-2888.  
McElligott, R., & Wellinger, R. J. (1997). The terminal DNA structure of 
mammalian chromosomes. EMBO J, 16(12), 3705-3714. doi: 
10.1093/emboj/16.12.3705 
Melville, S. E., Gerrard, C. S., & Blackwell, J. M. (1999). Multiple causes of size 
variation in the diploid megabase chromosomes of African tyrpanosomes. 
Chromosome Res, 7(3), 191-203.  
Melville, S. E., Leech, V., Gerrard, C. S., Tait, A., & Blackwell, J. M. (1998). The 
molecular karyotype of the megabase chromosomes of Trypanosoma brucei and 
the assignment of chromosome markers. Mol Biochem Parasitol, 94(2), 155-173.  
Melville, S. E., Leech, V., Navarro, M., & Cross, G. A. (2000). The molecular 
karyotype of the megabase chromosomes of Trypanosoma brucei stock 427. Mol 
Biochem Parasitol, 111(2), 261-273.  
 199 
Mitchell, J. R., Cheng, J., & Collins, K. (1999). A box H/ACA small nucleolar 
RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol, 19(1), 567-
576.  
Moazed, D., Kistler, A., Axelrod, A., Rine, J., & Johnson, A. D. (1997). Silent 
information regulator protein complexes in Saccharomyces cerevisiae: a 
SIR2/SIR4 complex and evidence for a regulatory domain in SIR4 that inhibits its 
interaction with SIR3. Proc Natl Acad Sci U S A, 94(6), 2186-2191.  
Morcillo, G., Barettino, D., Carmona, M. J., Carretero, M. T., & Diez, J. L. (1988). 
Telomeric DNA sequences differentially activated by heat shock in two 
Chironomus subspecies. Chromosoma, 96(2), 139-144.  
Moretti, P., Freeman, K., Coodly, L., & Shore, D. (1994). Evidence that a 
complex of SIR proteins interacts with the silencer and telomere-binding protein 
RAP1. Genes Dev, 8(19), 2257-2269.  
Moretti, P., & Shore, D. (2001). Multiple interactions in Sir protein recruitment by 
Rap1p at silencers and telomeres in yeast. Mol Cell Biol, 21(23), 8082-8094. doi: 
10.1128/MCB.21.23.8082-8094.2001 
Mowatt, M. R., & Clayton, C. E. (1987). Developmental regulation of a novel 
repetitive protein of Trypanosoma brucei. Mol Cell Biol, 7(8), 2838-2844.  
Mowatt, M. R., & Clayton, C. E. (1988). Polymorphism in the procyclic acidic 
repetitive protein gene family of Trypanosoma brucei. Mol Cell Biol, 8(10), 4055-
4062.  
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. 
D.,Wu, J. R. (1988). A highly conserved repetitive DNA sequence, (TTAGGG)n, 
 200 
present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A, 
85(18), 6622-6626.  
Mugasa, C. M., Adams, E. R., Boer, K. R., Dyserinck, H. C., Buscher, P., 
Schallig, H. D., & Leeflang, M. M. (2012). Diagnostic accuracy of molecular 
amplification tests for human African trypanosomiasis--systematic review. PLoS 
Negl Trop Dis, 6(1), e1438. doi: 10.1371/journal.pntd.0001438 
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., 
Lingner, J.,Cech, T. R. (1997). Telomerase catalytic subunit homologs from 
fission yeast and human. Science, 277(5328), 955-959.  
Narayanan, M. S., Kushwaha, M., Ersfeld, K., Fullbrook, A., Stanne, T. M., & 
Rudenko, G. (2011). NLP is a novel transcription regulator involved in VSG 
expression site control in Trypanosoma brucei. Nucleic Acids Res, 39(6), 2018-
2031. doi: 10.1093/nar/gkq950 
Navarro, M., Cross, G. A., & Wirtz, E. (1999). Trypanosoma brucei variant 
surface glycoprotein regulation involves coupled activation/inactivation and 
chromatin remodeling of expression sites. EMBO J, 18(8), 2265-2272. doi: 
10.1093/emboj/18.8.2265 
Navarro, M., & Gull, K. (2001). A pol I transcriptional body associated with VSG 
mono-allelic expression in Trypanosoma brucei. Nature, 414(6865), 759-763. doi: 
10.1038/414759a 
Negrini, S., Ribaud, V., Bianchi, A., & Shore, D. (2007). DNA breaks are masked 
by multiple Rap1 binding in yeast: implications for telomere capping and 
telomerase regulation. Genes Dev, 21(3), 292-302. doi: 10.1101/gad.400907 
 201 
Nergadze, S. G., Farnung, B. O., Wischnewski, H., Khoriauli, L., Vitelli, V., 
Chawla, R., . . . Azzalin, C. M. (2009). CpG-island promoters drive transcription 
of human telomeres. RNA, 15(12), 2186-2194. doi: 10.1261/rna.1748309 
Ng, L. J., Cropley, J. E., Pickett, H. A., Reddel, R. R., & Suter, C. M. (2009). 
Telomerase activity is associated with an increase in DNA methylation at the 
proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids 
Res, 37(4), 1152-1159. doi: 10.1093/nar/gkn1030 
Nugent, C. I., Hughes, T. R., Lue, N. F., & Lundblad, V. (1996). Cdc13p: a single-
strand telomeric DNA-binding protein with a dual role in yeast telomere 
maintenance. Science, 274(5285), 249-252.  
O'Sullivan, R. J., Kubicek, S., Schreiber, S. L., & Karlseder, J. (2010). Reduced 
histone biosynthesis and chromatin changes arising from a damage signal  at 
telomeres. Nat Struct Mol Biol, 17(10), 1218-1225. doi: 10.1038/nsmb.1897 
Odiit, M., Coleman, P. G., Liu, W. C., McDermott, J. J., Fevre, E. M., Welburn, S. 
C., & Woolhouse, M. E. (2005). Quantifying the level of under-detection of 
Trypanosoma brucei rhodesiense sleeping sickness cases. Trop Med Int Health, 
10(9), 840-849. doi: 10.1111/j.1365-3156.2005.01470.x 
Ogawa, Y., Sun, B. K., & Lee, J. T. (2008). Intersection of the RNA interference 
and X-inactivation pathways. Science, 320(5881), 1336-1341. doi: 
10.1126/science.1157676 
Okamoto, K., & Shinkai, Y. (2009). TRFH domain is critical for TRF1-mediated 
telomere stabilization. Cell Struct Funct, 34(2), 71-76.  
 202 
Pandey, R. R., Mondal, T., Mohammad, F., Enroth, S., Redrup, L., Komorowski, 
J.,Kanduri, C. (2008). Kcnq1ot1 antisense noncoding RNA mediates lineage-
specific transcriptional silencing through chromatin-level regulation. Mol Cell, 
32(2), 232-246. doi: 10.1016/j.molcel.2008.08.022 
Pandya, U. M., Sandhu, R., & Li, B. (2013). Silencing subtelomeric VSGs by 
Trypanosoma brucei RAP1 at the insect stage involves chromatin structure 
changes. Nucleic Acids Res, 41(16), 7673-7682. doi: 10.1093/nar/gkt562 
Pardo, B., & Marcand, S. (2005). Rap1 prevents telomere fusions by 
nonhomologous end joining. EMBO J, 24(17), 3117-3127. doi: 
10.1038/sj.emboj.7600778 
Pauler, F. M., Koerner, M. V., & Barlow, D. P. (2007). Silencing by imprinted 
noncoding RNAs: is transcription the answer? Trends Genet, 23(6), 284-292. doi: 
10.1016/j.tig.2007.03.018 
Payer, B., & Lee, J. T. (2008). X chromosome dosage compensation: how 
mammals keep the balance. Annu Rev Genet, 42, 733-772. doi: 
10.1146/annurev.genet.42.110807.091711 
Pays, E., Hanocq-Quertier, J., Hanocq, F., Van Assel, S., Nolan, D., & Rolin, S. 
(1993). Abrupt RNA changes precede the first cell division during the 
differentiation of Trypanosoma brucei bloodstream forms into procyclic forms in 
vitro. Mol Biochem Parasitol, 61(1), 107-114.  
Pays, E., Lips, S., Nolan, D., Vanhamme, L., & Perez-Morga, D. (2001). The 
VSG expression sites of Trypanosoma brucei: multipurpose tools for the 
 203 
adaptation of the parasite to mammalian hosts. Mol Biochem Parasitol, 114(1), 1-
16.  
Pays, E., Vanhamme, L., & Perez-Morga, D. (2004). Antigenic variation in 
Trypanosoma brucei: facts, challenges and mysteries. Curr Opin Microbiol, 7(4), 
369-374. doi: 10.1016/j.mib.2004.05.001 
Pedram, M., Sprung, C. N., Gao, Q., Lo, A. W., Reynolds, G. E., & Murnane, J. 
P. (2006). Telomere position effect and silencing of transgenes near telomeres in 
the mouse. Mol Cell Biol, 26(5), 1865-1878. doi: 10.1128/MCB.26.5.1865-
1878.2006 
Platt, J. M., Ryvkin, P., Wanat, J. J., Donahue, G., Ricketts, M. D., Barrett, S. P., 
Johnson, F. B. (2013). Rap1 relocalization contributes to the chromatin-mediated 
gene expression profile and pace of cell senescence. Genes Dev, 27(12), 1406-
1420. doi: 10.1101/gad.218776.113 
Polotnianka, R. M., Li, J., & Lustig, A. J. (1998). The yeast Ku heterodimer is 
essential for protection of the telomere against nucleolytic and recombinational 
activities. Curr Biol, 8(14), 831-834.  
Poulet, A., Pisano, S., Faivre-Moskalenko, C., Pei, B., Tauran, Y., Haftek-
Terreau, Z., . . . Giraud-Panis, M. J. (2012). The N-terminal domains of TRF1 and 
TRF2 regulate their ability to condense telomeric DNA. Nucleic Acids Res, 40(6), 
2566-2576. doi: 10.1093/nar/gkr1116 
Proudfoot, C., & McCulloch, R. (2005). Distinct roles for two RAD51-related 
genes in Trypanosoma brucei antigenic variation. Nucleic Acids Res, 33(21), 
6906-6919. doi: 10.1093/nar/gki996 
 204 
Raper, J., Fung, R., Ghiso, J., Nussenzweig, V., & Tomlinson, S. (1999). 
Characterization of a novel trypanosome lytic factor from human serum. Infect 
Immun, 67(4), 1910-1916.  
Reichenbach, P., Hoss, M., Azzalin, C. M., Nabholz, M., Bucher, P., & Lingner, J. 
(2003). A human homolog of yeast Est1 associates with telomerase and uncaps 
chromosome ends when overexpressed. Curr Biol, 13(7), 568-574.  
Rifkin, M. R. (1978). Identification of the trypanocidal factor in normal human 
serum: high density lipoprotein. Proc Natl Acad Sci U S A, 75(7), 3450-3454.  
Roditi, I., Furger, A., Ruepp, S., Schurch, N., & Butikofer, P. (1998). Unravelling 
the procyclin coat of Trypanosoma brucei. Mol Biochem Parasitol, 91(1), 117-
130.  
Roditi, I., Schwarz, H., Pearson, T. W., Beecroft, R. P., Liu, M. K., Richardson, J. 
P., . . . et al. (1989). Procyclin gene expression and loss of the variant surface 
glycoprotein during differentiation of Trypanosoma brucei. J Cell Biol, 108(2), 
737-746.  
Rudenko, G. (2011). African trypanosomes: the genome and adaptations for 
immune evasion. Essays Biochem, 51, 47-62. doi: 10.1042/bse0510047 
Rudenko, G., & Van der Ploeg, L. H. (1989). Transcription of telomere repeats in 
protozoa. EMBO J, 8(9), 2633-2638.  
Ruepp, S., Furger, A., Kurath, U., Renggli, C. K., Hemphill, A., Brun, R., & Roditi, 
I. (1997). Survival of Trypanosoma brucei in the tsetse fly is enhanced by the 
expression of specific forms of procyclin. J Cell Biol, 137(6), 1369-1379.  
 205 
Rusche, L. N., Kirchmaier, A. L., & Rine, J. (2002). Ordered nucleation and 
spreading of silenced chromatin in Saccharomyces cerevisiae. Mol Biol Cell, 
13(7), 2207-2222. doi: 10.1091/mbc.E02-03-0175 
Sandell, L. L., Gottschling, D. E., & Zakian, V. A. (1994). Transcription of a yeast 
telomere alleviates telomere position effect without affecting chromosome 
stability. Proc Natl Acad Sci U S A, 91(25), 12061-12065.  
Sandhu, R., Sanford, S., Basu, S., Park, M., Pandya, U. M., Li, B., & Chakrabarti, 
K. (2013). A trans-spliced telomerase RNA dictates telomere synthesis in 
Trypanosoma brucei. Cell Res, 23(4), 537-551. doi: 10.1038/cr.2013.35 
Sarthy, J., Bae, N. S., Scrafford, J., & Baumann, P. (2009). Human RAP1 inhibits 
non-homologous end joining at telomeres. EMBO J, 28(21), 3390-3399. doi: 
10.1038/emboj.2009.275 
Schoeftner, S., & Blasco, M. A. (2008). Developmentally regulated transcription 
of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol, 
10(2), 228-236. doi: 10.1038/ncb1685 
Schwede, A., & Carrington, M. (2010). Bloodstream form Trypanosome plasma 
membrane proteins: antigenic variation and invariant antigens. Parasitology, 
137(14), 2029-2039. doi: 10.1017/S0031182009992034 
Shampay, J., Szostak, J. W., & Blackburn, E. H. (1984). DNA sequences of 
telomeres maintained in yeast. Nature, 310(5973), 154-157.  
Shore, D. (1994). RAP1: a protean regulator in yeast. Trends Genet, 10(11), 408-
412.  
 206 
Shaw, P. (2004). Economics of African Trypanosomiasis. In: Maudlin I, Holmes 
PH, Miles MA, editors. The Trypanosomiases. Wallingford, UK: CABI Publishing. 
369–402. 
Simarro, P. P., Diarra, A., Ruiz Postigo, J. A., Franco, J. R., & Jannin, J. G. 
(2011). The human African trypanosomiasis control and surveillance programme 
of the World Health Organization 2000-2009: the way forward. PLoS Negl Trop 
Dis, 5(2), e1007. doi: 10.1371/journal.pntd.0001007 
Simarro, P. P., Jannin, J., & Cattand, P. (2008). Eliminating human African 
trypanosomiasis: where do we stand and what comes next? PLoS Med, 5(2), 
e55. doi: 10.1371/journal.pmed.0050055 
Singer, M. S., & Gottschling, D. E. (1994). TLC1: template RNA component of 
Saccharomyces cerevisiae telomerase. Science, 266(5184), 404-409.  
Snow, B. E., Erdmann, N., Cruickshank, J., Goldman, H., Gill, R. M., Robinson, 
M. O., & Harrington, L. (2003). Functional conservation of the telomerase protein 
Est1p in humans. Curr Biol, 13(8), 698-704.  
Solovei, I., Gaginskaya, E. R., & Macgregor, H. C. (1994). The arrangement and 
transcription of telomere DNA sequences at the ends of lampbrush 
chromosomes of birds. Chromosome Res, 2(6), 460-470.  
Song, K., Jung, D., Jung, Y., Lee, S. G., & Lee, I. (2000). Interaction of human 
Ku70 with TRF2. FEBS Lett, 481(1), 81-85.  
Stanne, T. M., Kushwaha, M., Wand, M., Taylor, J. E., & Rudenko, G. (2011). 
TbISWI regulates multiple polymerase I (Pol I)-transcribed loci and is present at 
 207 
Pol II transcription boundaries in Trypanosoma brucei. Eukaryot Cell, 10(7), 964-
976. doi: 10.1128/EC.05048-11 
Stanne, T. M., & Rudenko, G. (2010). Active VSG expression sites in 
Trypanosoma brucei are depleted of nucleosomes. Eukaryot Cell, 9(1), 136-147. 
doi: 10.1128/EC.00281-09 
Takai, H., Smogorzewska, A., & de Lange, T. (2003). DNA damage foci at 
dysfunctional telomeres. Curr Biol, 13(17), 1549-1556.  
Teo, H., Ghosh, S., Luesch, H., Ghosh, A., Wong, E. T., Malik, N., . . . 
Tergaonkar, V. (2010). Telomere-independent Rap1 is an IKK adaptor and 
regulates NF-kappaB-dependent gene expression. Nat Cell Biol, 12(8), 758-767. 
doi: 10.1038/ncb2080 
Truc, P., Lejon, V., Magnus, E., Jamonneau, V., Nangouma, A., Verloo, D., . . . 
Buscher, P. (2002). Evaluation of the micro-CATT, CATT/Trypanosoma brucei 
gambiense, and LATEX/T b gambiense methods for serodiagnosis and 
surveillance of human African trypanosomiasis in West and Central Africa. Bull 
World Health Organ, 80(11), 882-886.  
Van der Ploeg, L. H., Cornelissen, A. W., Barry, J. D., & Borst, P. (1984). 
Chromosomes of kinetoplastida. EMBO J, 3(13), 3109-3115.  
Van der Ploeg, L. H., Cornelissen, A. W., Michels, P. A., & Borst, P. (1984). 
Chromosome rearrangements in Trypanosoma brucei. Cell, 39(1), 213-221.  
van Leeuwen, F., Dirks-Mulder, A., Dirks, R. W., Borst, P., & Gibson, W. (1998). 
The modified DNA base beta-D-glucosyl-hydroxymethyluracil is not found in the 
tsetse fly stages of Trypanosoma brucei. Mol Biochem Parasitol, 94(1), 127-130.  
 208 
van Leeuwen, F., Taylor, M. C., Mondragon, A., Moreau, H., Gibson, W., Kieft,  
R., & Borst, P. (1998). beta-D-glucosyl-hydroxymethyluracil is a conserved DNA 
modification in kinetoplastid protozoans and is abundant in their telomeres. Proc 
Natl Acad Sci U S A, 95(5), 2366-2371.  
van Steensel, B., & de Lange, T. (1997). Control of telomere length by the human 
telomeric protein TRF1. Nature, 385(6618), 740-743. doi: 10.1038/385740a0 
van Steensel, B., Smogorzewska, A., & de Lange, T. (1998). TRF2 protects 
human telomeres from end-to-end fusions. Cell, 92(3), 401-413.  
Vanhamme, L., Poelvoorde, P., Pays, A., Tebabi, P., Van Xong, H., & Pays, E. 
(2000). Differential RNA elongation controls the variant surface glycoprotein gene 
expression sites of Trypanosoma brucei. Mol Microbiol, 36(2), 328-340.  
Vickerman, K. (1985). Developmental cycles and biology of pathogenic 
trypanosomes. Br Med Bull, 41(2), 105-114.  
Vodenicharov, M. D., Laterreur, N., & Wellinger, R. J. (2010). Telomere capping 
in non-dividing yeast cells requires Yku and Rap1. EMBO J, 29(17), 3007-3019. 
doi: 10.1038/emboj.2010.155 
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993). Mammalian Ras 
interacts directly with the serine/threonine kinase Raf. Cell, 74(1), 205-214.  
Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R., & Lei, M. 
(2007). The POT1-TPP1 telomere complex is a telomerase processivity factor. 
Nature, 445(7127), 506-510. doi: 10.1038/nature05454 
 209 
Wang, Q. P., Kawahara, T., & Horn, D. (2010). Histone deacetylases play distinct 
roles in telomeric VSG expression site silencing in African trypanosomes. Mol 
Microbiol, 77(5), 1237-1245. doi: 10.1111/j.1365-2958.2010.07284.x 
Weiden, M., Osheim, Y. N., Beyer, A. L., & Van der Ploeg, L. H. (1991). 
Chromosome structure: DNA nucleotide sequence elements of a subset of the 
minichromosomes of the protozoan Trypanosoma brucei. Mol Cell Biol, 11(8), 
3823-3834.  
Wickstead, B., Ersfeld, K., & Gull, K. (2004). The small chromosomes of 
Trypanosoma brucei involved in antigenic variation are constructed around 
repetitive palindromes. Genome Res, 14(6), 1014-1024. doi: 10.1101/gr.2227704 
Wirtz, E., Leal, S., Ochatt, C., & Cross, G. A. (1999). A tightly regulated inducible 
expression system for conditional gene knock-outs and dominant-negative 
genetics in Trypanosoma brucei. Mol Biochem Parasitol, 99(1), 89-101.  
Wotton, D., & Shore, D. (1997). A novel Rap1p-interacting factor, Rif2p, 
cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiae. 
Genes Dev, 11(6), 748-760.  
Xin, H., Liu, D., Wan, M., Safari, A., Kim, H., Sun, W., . . . Songyang, Z. (2007). 
TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit 
telomerase. Nature, 445(7127), 559-562. doi: 10.1038/nature05469 
Yang, D., Xiong, Y., Kim, H., He, Q., Li, Y., Chen, R., & Songyang, Z. (2011). 
Human telomeric proteins occupy selective interstitial sites. Cell Res, 21(7), 
1013-1027. doi: 10.1038/cr.2011.39 
 210 
Yang, Q., Zheng, Y. L., & Harris, C. C. (2005). POT1 and TRF2 cooperate to 
maintain telomeric integrity. Mol Cell Biol, 25(3), 1070-1080. doi: 
10.1128/MCB.25.3.1070-1080.2005 
Yang, X., Figueiredo, L. M., Espinal, A., Okubo, E., & Li, B. (2009). RAP1 is 
essential for silencing telomeric variant surface glycoprotein genes in 
Trypanosoma brucei. Cell, 137(1), 99-109. doi: 10.1016/j.cell.2009.01.037 
Yarragudi, A., Parfrey, L. W., & Morse, R. H. (2007). Genome-wide analysis of 
transcriptional dependence and probable target sites for Abf1 and Rap1 in 
Saccharomyces cerevisiae. Nucleic Acids Res, 35(1), 193-202. doi: 
10.1093/nar/gkl1059 
Zhong, Z., Shiue, L., Kaplan, S., & de Lange, T. (1992). A mammalian factor that 
binds telomeric TTAGGG repeats in vitro. Mol Cell Biol, 12(11), 4834-4843.  
Zhou, J., Hidaka, K., & Futcher, B. (2000). The Est1 subunit of yeast telomerase 
binds the Tlc1 telomerase RNA. Mol Cell Biol, 20(6), 1947-1955.  
Zomerdijk, J. C., Kieft, R., & Borst, P. (1992). A ribosomal RNA gene promoter at 
the telomere of a mini-chromosome in Trypanosoma brucei. Nucleic Acids Res, 
20(11), 2725-2734.  
 
 
 
